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RESUMO 
 
Os bacteriófagos, ou fagos, são vírus que infetam exclusivamente bactérias. Os fagos de 
DNA de cadeia dupla utilizam o sistema holina-endolisina para lisar a célula hospedeira, 
garantindo deste modo a libertação da descendência viral e a realização de novos ciclos 
de infeção. A endolisina é uma enzima que degrada o peptidoglicano (PG), o principal 
constituinte da parede celular (CW) bacteriana. A holina é uma proteína transmembranar 
que forma poros na membrana citoplasmática (CM), os quais levam à dissipação da força 
proto motriz (pmf) e consequentemente à morte celular. A pmf deriva do gradiente 
eletroquímico formado através da CM, sendo essencial para a realização de funções que 
requerem energia celular. Considerando o modo como as endolisinas acedem à CW, estas 
podem classificar-se em dois tipos: i) endolisinas canónicas (c-endolisinas), quando o 
acesso é feito através dos poros das holinas, ou ii) endolisinas exportadas (e-endolisinas), 
quando o transporte ocorre por uma via independente da holina. Considera-se que, uma 
vez sintetizadas, as c-endolisinas adquirem de imediato a sua conformação ativa no 
citoplasma, tendo portanto a capacidade de degradar eficientemente o PG se o contacto 
com a CW for permitido. Embora exportadas para a CW pela maquinaria da célula 
hospedeira, as e-endolisinas descritas até à data necessitam de ser ativadas por 
mecanismos que dependem da ação da holina. 
 
Devido à sua atividade lítica, as c-endolisinas têm ganho grande destaque como potenciais 
agentes antimicrobianos, para a eliminação de bactérias patogénicas Gram-positivas, 
principalmente no contexto do crescente aumento das resistências aos antibióticos. Esta 
abordagem assenta na observação de que, pelo menos em certas condições, as c-
endolisinas são capazes de lisar de forma eficiente bactérias alvo, quando as enzimas são 
adicionadas exogenamente, na forma de proteínas recombinantes (enzibióticos). A 
realização deste trabalho teve como objetivo principal o de contribuir com conhecimentos 
que permitam melhorar o potencial das endolisinas enquanto agentes antibacterianos, 
quer pelo desenvolvimento de estratégias visando o aumento da sua produção, 
solubilidade e ação lítica, quer pela compreensão de fatores e mecanismos que 
influenciam a sua atividade.  
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Este trabalho iniciou-se com a construção de endolisinas quiméricas com ação lítica sobre 
Staphylococcus aureus (Capítulo 2). Para além da obtenção de enzimas com largo 
espectro de ação sobre estirpes clínicas desta espécie, pretendia-se também obviar o 
problema frequente da baixa solubilidade das endolisinas dos fagos de S. aureus, quando 
estas são superproduzidas em Escherichia coli. Produziram-se e purificaram-se duas 
proteínas quiméricas (Lys168-87 e Lys170-87), em que o mesmo domínio de ligação à 
parede celular (CWBD) da endolisina Lys87, produzida pelo fago de S. aureus F87s/06, 
foi fundido ao domínio catalítico (CD) das endolisinas Lys168 ou Lys170, produzidas 
pelos fagos de Enterococcus faecalis F168/08 e F170/08, respetivamente. A fusão entre 
o CD de endolisinas solúveis e o CWBD de uma endolisina com fraca solubilidade, aliada 
a condições de expressão otimizadas, permitiu que se produzissem eficazmente enzimas 
quiméricas na forma solúvel. A atividade lítica das quimeras foi inicialmente avaliada 
qualitativamente por “spot assay” em isolados bacterianos obtidos em meio hospitalar e 
na comunidade Portuguesa (n = 100). As endolisinas evidenciaram um elevado potencial 
lítico, apresentando atividade em mais de 90% dos isolados de S. aureus testados, 
incluindo uma elevada fração destes com resistência à meticilina (MRSA; n = 42). Esta 
capacidade lítica foi igualmente observada numa coleção de estirpes de S. aureus 
geneticamente caracterizadas, a qual abrangia representantes dos clones pandémicos 
MRSA mais relevantes, isolados em diferentes partes do mundo (n= 30), e clones 
dominantes de S. aureus sensíveis à meticilina (MSSA; n= 13). Em ensaios 
semiquantitativos (curvas de lise), as endolisinas Lys168-87 e Lys170-87 foram eficazes 
na eliminação da estirpe MRSA USA200, quando testadas num tampão fisiológico, 
registando-se um efeito sinergístico pela ação conjunta das duas quimeras. Curiosamente, 
ao contrário das endolisinas parentais, as quimeras apresentaram um espectro de ação 
alargado, sendo também ativas contra Staphylococcus epidermidis, Staphylococcus 
haemolyticus, Staphylococcus saprophyticus, E. faecalis, Enterococcus faecium e 
Streptococcus pyogenes. Globalmente, Lys168-87 apresentou uma atividade lítica 
superior à de Lys170-87, invertendo-se esta característica apenas quando testadas em 
Enterococcus spp.  
 
Os resultados da nossa investigação e de muitos outros laboratórios suportam a 
capacidade lítica das c-endolisinas e derivados quiméricos quando testados in vitro, 
nomeadamente quando as células alvo são transferidas para tampões fisiológicos antes da 
adição das enzimas. No entanto, verificámos que essa eficácia lítica é frequentemente 
 ix 
perdida ou significativamente diminuída quando as bactérias alvo são mantidas em meios 
nutritivos, i.e., em condições que garantem a manutenção da pmf e um crescimento 
celular ativo. Assim, na segunda parte do trabalho pretendeu-se elucidar que fatores e 
mecanismos poderiam estar na base deste fenómeno. Nesse sentido, fomos guiados pelo 
facto de que no contexto natural da infeção fágica ambos os tipos de endolisinas, c- e e-
endolisinas, atuam sempre em células hospedeiras previamente mortas pela ação da 
holina. Tendo por base esta observação, decidiu-se estudar o modo como a manutenção 
ou a dissipação da pmf poderia influenciar a atividade das c-endolisinas, quer quando 
estas alcançam a CW pelo interior da célula, quer quando são aplicadas externamente. 
Selecionou-se como exemplo de c-endolisina a do fago SPP1 de Bacillus subtilis 
(LysSPP1) e procedeu-se inicialmente à sua transformação numa e-endolisina artificial. 
Para isso, fundiu-se a sequência sinal (SP) da bacilopeptidase F de B. subtilis (proteína 
Bpr) com a extremidade N-terminal de LysSPP1. O gene recombinante da e-endolisina 
artificial SP-LysSPP1 foi clonado num plasmídeo replicativo em B. subtilis sob o controlo 
de um promotor induzível. Surpreendentemente, a produção e exportação continuada de 
SP-LysSPP1 para a CW, através do sistema de secreção (sistema Sec) de B. subtilis, não 
produziu efeitos óbvios ao nível da viabilidade e crescimento celular, quando comparados 
com o comportamento de uma estirpe produtora da versão nativa, não exportada, de 
LysSPP1. A localização extracitoplasmática e o carácter lítico da forma madura de SP-
LysSPP1 foram evidenciados após o tratamento das culturas com um ionóforo dissipador 
da pmf, a gramicidina D. Tal como esperado, a adição deste ionóforo resultou na 
estagnação do crescimento das culturas em estudo. No entanto, apenas a estirpe produtora 
de SP-LysSPP1 apresentou lise celular imediata após a adição de gramicidina D. 
Paralelamente, demonstrou-se que a sensibilização prévia de B. subtilis com gramicidina 
D ou a sua manutenção em meio tamponado sem fontes de energia, potencia 
significativamente a atividade lítica da endolisina quando adicionada exogenamente. 
Estimou-se que a quantidade de LysSPP1 necessária para lisar células previamente 
mortas pela ação da holina de SPP1, ou pela ação de um agente dissipador da pmf, é cerca 
de 60 vezes menor do que a quantidade necessária para lisar células em crescimento 
exponencial ativo. A mesma linha de resultados foi obtida quando se testou a atividade 
lítica da c-endolisina Lys11, do fago 11 de S. aureus, em condições promotoras ou 
inibidoras da pmf/crescimento. Os resultados obtidos demonstram assim que a dissipação 
da pmf, que no contexto da infeção fágica ocorre pela ação da holina, pode ter um efeito 
ativador ou potenciador da ação lítica das c-endolisinas, tal como descrito anteriormente 
x 
para as e-endolisinas. Curiosamente, esta característica tem sido igualmente observada 
em outras hidrólases do PG, como as autolisinas, cuja regulação está dependente da 
manutenção da pmf. Estes resultados podem ter implicações na seleção e desenho de 
endolisinas destinadas à enzibioterapia (ver Capítulo 3). 
 
Finalmente, uma terceira parte do trabalho teve por objetivo identificar e caracterizar a 
função de holina do fago SPP1, condição necessária para conduzir parte dos estudos 
apresentados no Capítulo 3. Foi anteriormente proposto que a holina de SPP1 seria 
codificada pela orf 26. O seu produto (gp26) partilha homologia e características 
hidrofóbicas com a proteína XhlB, a qual foi implicada na função holina do fago críptico 
PBSX de B. subtilis. Contudo, a nossa análise revelou a montante a orf 24.1 que codifica 
para uma proteína do tipo holina análoga à XhlA, também envolvida na lise medida pelo 
PBSX. Assim, decidiu-se estudar o papel de gp24.1 e gp26 enquanto possíveis holinas do 
fago SPP1. Dada a sua potencial toxicidade, frequentemente as holinas de sistemas Gram-
positivos são estudadas em sistemas heterólogos, tipicamente em E. coli. Contudo, ainda 
que apresentando algumas vantagens, por vezes torna-se difícil a extrapolação dos 
resultados para os sistemas nativos. Deste modo, para se perceber o contributo de gp24.1 
e gp26 para a função de holina do fago SPP1, as respetivas orfs foram clonadas em 
separado e na forma de uma fusão transcricional num plasmídeo replicativo em B. subtilis 
e sob a dependência de um promotor induzível. Os resultados revelaram que, nas 
condições de expressão utilizadas, a produção individual destas proteínas não tem 
impacto significativo no crescimento celular de B. subtilis, apesar de se inserirem na CM. 
A cessação do crescimento e morte celular típicas da ação da holina só foram observadas 
após coprodução de gp24.1 e gp26, sugerindo que em SPP1 a função holina poderá 
envolver a produção destas duas proteínas. Surpreendentemente, foi identificado um 
promotor constitutivo interno à orf 24.1, o qual deverá corresponder ao promotor precoce 
PE5 anteriormente descrito para o fago SPP1. A presença deste promotor levanta questões 
relativamente à regulação da lise neste fago (ver Capítulo 4). 
 
 
Palavras-chave: endolisina, holina, potencial de membrana, pmf, B. subtilis, SPP1, S. 
aureus, endolisina quimérica, resistência aos antibióticos.  
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ABSTRACT 
 
Bacteriophages, or phages, are viruses that strictly infect bacteria. Double-stranded DNA 
phages use the holin-endolysin system to lyse host cells, thus ensuring the release of the 
viral progeny and the realization of new infection cycles. The endolysin is an enzyme that 
degrades the peptidoglycan (PG), the main constituent of the bacteria cell wall (CW). The 
holin is a transmembrane protein that forms pores in the cytoplasmic membrane (CM), 
leading to dissipation of the proton motive force (pmf) and consequently to the cell death. 
The pmf is created by the electrochemical gradient across the CM and is responsible for 
driving many energy-requiring functions in the cell. According to the way how endolysins 
reach the CW, these can be classified into two types: i) canonical endolysins (c-
endolysins), when access occurs through the holin pores, or ii) exported endolysins (e-
endolysins), when transport is performed in a holin-independent pathway. It is considered 
that once synthesized c-endolysins immediately acquire their active conformation in the 
cytoplasm, thus having the capacity to effectively degrade the PG if the contact with the 
CW is allowed. Although exported to the CW by the host cell machinery, all e-endolysins 
described so far need to be activated by mechanisms that depend on the holin action. 
 
Due to their lytic activity, c-endolysins have gained great attention as potential 
antimicrobial agents for the elimination of pathogenic Gram-positive bacteria, especially 
in the actual context of increasing resistance to antibiotics. This approach relies on the 
observation that, at least under certain conditions, c-endolysins are able to efficiently lyse 
target bacteria when the enzymes are exogenously added in the form of recombinant 
proteins (enzybiotics). The main objective of the work here presented was to contribute 
with knowledge for increasing the potential of endolysins as antibacterial agents, namely 
by developing strategies to improve their production, solubility and lytic performance, 
and by deepening our understanding of factors and mechanisms that influence their 
enzymatic activity. 
 
This work began with the construction of chimerical endolysins with lytic activity against 
Staphylococcus aureus (Chapter 2). In addition to obtain enzymes displaying a broad lytic 
spectrum on clinical strains of this species, we also intended to overcome the problem of 
low solubility that is commonly observed when overproducing endolysins of S. aureus 
phages in Escherichia coli. We produced and purified two chimerical proteins (Lys168-
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87 and Lys170-87) by fusing the same cell wall binding domain (CWBD) of endolysin 
Lys87, produced by S. aureus phage F87s/06, to the catalytic domain (CD) of endolysins 
Lys168 or Lys170, produced by Enterococcus faecalis phages F168/08 and F170/08, 
respectively. This fusion between the CD of highly soluble endolysins and the CWBD of 
an endolysin with poor solubility, combined with optimized expression conditions, 
allowed the efficient production of chimerical enzymes in the soluble form. The lytic 
activity of the chimeras was initially assessed qualitatively by the "spot assay", using 
bacterial isolates from Portuguese community and hospital settings (n = 100). The 
endolysins showed high lytic potential, lysing more than 90% of the tested S. aureus 
isolates, including a high fraction that was methicillin-resistant (MRSA, n = 42). This 
lytic capacity was also observed in a collection of genetically characterized and typed S. 
aureus strains, which included representatives of the most relevant MRSA pandemic 
clones from different parts of the world (n = 30), and representative clones of the 
dominant methicillin-sensitive S. aureus (MSSA; n = 13). In semi-quantitative assays 
(lysis curves), Lys168-87 and Lys170-87 were effective in eliminating MRSA strain 
USA200 suspended in a physiological buffer, being observed a synergistic effect when 
the chimeras were simultaneously used. Interestingly, unlike the parental endolysins, the 
chimeras showed a wide lytic spectrum, being also active against Staphylococcus 
epidermidis, Staphylococcus haemolyticus, Staphylococcus saprophyticus, E. faecalis, 
Enterococcus faecium and Streptococcus pyogenes. Globally, Lys168-87 presented 
superior lytic performance than Lys170-87, being this result only inverted when the 
chimeras were tested on the enterococcal isolates.  
 
The results of our research and from many other laboratories support the lytic capacity of 
c-endolysins and chimeric derivatives when tested in vitro, particularly when the enzymes 
are added to cells previously suspended in physiological buffers. Nevertheless, we have 
found that lytic efficacy is often lost or greatly lessened when target bacteria are kept in 
nutritious media, i.e., in conditions that guarantee maintenance of the pmf and active cell 
growth. Thus, in a second part of this work we aimed at uncovering factors and 
mechanisms that underlie this phenomenon. Accordingly, we were led by the fact that in 
the phage infection context both c- and e-endolysins always act after cells have been 
killed by the holin. Based on this observation, we decided to study how maintenance or 
dissipation of the pmf could influence the activity of c-endolysins, either when they reach 
the CW from the cell inside or when applied externally. The c-endolysin of Bacillus 
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subtilis phage SPP1 (LysSPP1) was chosen as study model, being in a first step 
transformed into an artificial e-endolysin. For this, the signal sequence (SP) of 
bacillopeptidase F of B. subtilis (Bpr protein) was fused to the N-terminal end of 
LysSPP1. The recombinant gene of the artificial e-endolysin SP-LysSPP1 was cloned in 
a B. subtilis replicative plasmid under the control of an inducible promoter. Surprisingly, 
the continued production and export of SP-LysSPP1 to the CW, through the secretion 
system (Sec system) of B. subtilis, produced no obvious effects on the viability and cell 
growth when compared with a strain that produced the native and not exported LysSPP1. 
The extracytoplasmic localization and lytic character of the mature form of SP-LysSPP1 
was evidenced when cultures were treated with a pmf-dissipating ionophore, gramicidin 
D. As expected, the addition of the ionophore resulted in immediate growth interruption. 
However, only the culture producing SP-LysSPP1 showed quick cell lysis after addition 
of gramicidin D. Similarly, the prior sensitization of B. subtilis with gramicidin D or the 
maintenance of cells in a buffered medium without energy sources significantly enhanced 
the lytic activity of the endolysin when added exogenously. It was estimated that the 
amount of LysSPP1 necessary to lyse cells previously killed by the SPP1 holin action, or 
by a pmf-dissipating agent, was about 60 times lower than the amount needed to lyse 
exponentially growing cells. The results followed the same trend when the c-endolysin 
Lys11, of S. aureus phage 11, was tested in conditions promoting or decreasing the 
pmf/cell growth. Therefore, the results demonstrate that dissipation of the pmf, which in 
the context of phage infection occurs by the holin action, can have an activating or 
potentiating effect on the lytic action of c-endolysins, similarly to what was previously 
described for e-endolysins. Interestingly, this feature has also been observed with other 
PG hydrolases, such as autolysins, whose regulation is dependent on the maintenance of 
the pmf. These results may have implications on the selection and design of endolysins 
intended for enzybiotic therapy (see Chapter 3). 
 
Finally, in a third part of this work we aimed to identify and characterize the holin 
function of phage SPP1, a necessary condition to perform some of the studies presented 
in Chapter 3. It was previously proposed that the holin of SPP1 would be encoded by orf 
26. Its deduced product (gp26) shares homology and hydrophobic characteristics with the 
XhlB protein, which was implicated in the holin function of the cryptic phage PBSX of 
B. subtilis. However, our analysis revealed the upstream orf 24.1 that encodes a holin-
like protein analogous to XhlA, also involved in PBSX-mediated lysis. Therefore, we 
xiv 
decided to study the role of gp24.1 and gp26 as possible SPP1 holins. Because of its 
potential toxicity, holins of Gram-positive systems are often studied in heterologous 
systems, typically E. coli. However, despite some advantages, it is sometimes difficult to 
extrapolate the results obtained to the native systems. Thus, to understand the contribution 
of gp24.1 and gp26 to the SPP1holin function, the corresponding orfs were cloned 
separately and as a transcriptional fusion in a B. subtilis replicative plasmid, under the 
control of an inducible promoter. The results showed that in the assay conditions the 
individual production of these proteins did not produce significant impact on B. subtilis 
cell growth, despite their insertion and accumulation in the CM. Growth cessation and 
cell death typical of the holin action were only observed after co-production of gp24.1 
and gp26, suggesting that in SPP1 the holin function may involve the production of these 
two proteins. Surprisingly, a constitutive promoter was identified within orf 24.1, which 
we believe should correspond to the previously described early promoter PE5. The 
presence of this promoter raises questions regarding lysis regulation in phage SPP1 (see 
Chapter 4). 
 
 
Keywords: endolysin, holin, membrane potential, pmf, B. subtilis, SPP1, S. aureus, 
chimerical endolysin, antibiotic resistance. 
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1.1 Bacteriophages: general features and life cycle 
 
Bacteriophages, or phages, are viruses that specifically infect bacteria and were first 
described, independently, by Frederick Twort in 1915 (Twort, 1915) and Felix d’Herelle 
in 1917 (D’Herelle, 1917). In the Earth’s biosphere they are the predominant biological 
entity estimated in more than 1031 particles. The phage population is also highly dynamic, 
with a rapid turnover occurring within a relatively short period of time, with 3.7 x 1030 
phages being produced every year only in the deep hot biosphere (Breitbart et al., 2004).  
 
A phage classification system was first proposed by Bradley in 1967, recognizing six 
basic groups, in agreement with the type of nucleic acid, single (ss) or double (ds) 
stranded DNA or RNA, and gross morphology (Bradley, 1967). Nowadays, this scheme 
was adapted by the International Committee for Taxonomy of Viruses (ICTV) and 
archaeal viruses are classified into 15 families or corresponding groups, while those from 
Eubacteria belong to 10 families (Ackermann, 2012; King et al., 2012). Over 96% of the 
phages described in the literature are tailed and contain a genome of linear dsDNA 
enclosed in an icosahedral head or capsid, comprising the order Caudovirales 
(Ackermann, 2011). This order includes 3 families characterized according to the 
morphological features of the tail: 61% are Siphoviridae (long, non-contractile tails), 25% 
Myoviridae (contractile tails) and 14% Podoviridae (short tail) (Fig. 1.1) (Maniloff, 
2012). The remaining families represent 4% of the studied phages, including polyhedral, 
filamentous and pleomorphic phages (Maniloff, 2012). 
 
 
 
Fig. 1.1. Phages of the order Caudovirales. Transmission electron micrographs of a T4-like 
virus, HK97 and P22 are shown to represent the families Myoviridae, Siphoviridae and 
Podoviridae, respectively. Adapted from Krupovic et al. (2011). 
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According to their lifestyle, phages can be classified as virulent (or strictly lytic), when 
they replicate only by means of a lytic cycle, or as temperate when they have the 
possibility to follow either a lytic or a lysogenic pathway of development. Both cycles 
are initiated with virus particle attachment to the bacterial host cell, a process classically 
known as phage adsorption. This occurs through specific interactions between virion 
receptor binding proteins (RBPs) and receptors on the host cell surface (Vinga et al., 
2006). Adsorption can take place in two steps. In a first step, the contact with bacterial 
surface may lead to reversible adsorption of the virus, with phages being released from 
the cells as infectious particles. This is a dynamic process that usually facilitates the 
second step, the irreversible adsorption, where phages become irredeemably committed 
to infection. As result of this irreversible interaction, the virion structure suffers a series 
of conformational changes that culminate in the injection of the viral nucleic acid into the 
host cell cytoplasm (Fokine and Rossmann, 2014; Maniloff, 2012; Molineux and Panja 
2013; Vinga et al., 2006).  
 
In the lytic cycle, phages like T4 immediately takeover the cellular machinery to express 
their genomes for phage nucleic acid replication and production of viral proteins. These 
are used to assemble the virion progeny that in the end is released through lysis of the 
infected cell (Kutter et al 2005; Maniloff, 2012). Under certain physiological conditions, 
temperate phages can follow the lysogenic pathway in a fraction of the infected cell 
population. In this case the virus maintains a stable relationship with the host cell and 
propagates its genetic material along with that of the bacterium, being passed to daughter 
cells during cell division. A common form of establishing lysogeny (e.g. phage λ) 
involves the integration of the viral genome into the host’s chromosome, after which the 
integrated phage DNA is called prophage. Bacteria hosting a prophage are said lysogenic. 
Under some stress conditions, the prophage can be excised from the bacterial genome and 
“switch” to the lytic cycle (Kutter et al 2005; Maniloff, 2012). 
 
1.2 Bacterial cell envelope: barrier to virus entry and release 
 
The bacterial cell envelope is a complex multilayered structure that serves as the first and 
major line of defense against threats from the unpredictable and often hostile 
environment. It has the key function of maintaining cell homeostasis, providing at the 
same time structural and cell shape integrity by counteracting the high internal osmotic 
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pressure. It is also a remarkable physical barrier that phages need to overcome during the 
infectious cycle, firstly in order to transport their genome into the bacterial cytoplasm and 
in the end to release the viral offspring. The minimal components of the bacterial cell 
envelope are a cytoplasmic membrane (CM) and a cell wall (CW). Gram-negative 
bacteria and mycobacteria have in addition an outer membrane (OM) (Fig. 1.2). 
 
 
 
Fig. 1.2. Schematic representation of the bacterial cell envelope. (A) Gram-negative bacteria. 
(B) Gram-positive bacteria. (C) Mycobacteria. Adapted from Brown et al., 2015. 
 
The CM is a phospholipid bilayer with embedded proteins (Singer, 1972) that isolates the 
cytoplasm and cellular components from the exterior. It is common to all bacteria and 
plays a central role in maintaining ion and solute gradients, which are essential to produce 
energy. It is the difference in the concentration and charges of ions on opposite sides of 
the CM that generates, respectively, the electrical potential (ΔΨ) and the chemical 
potential (pH gradient, ΔpH), the two components of proton motive force (pmf). The pmf 
is involved in the generation of ATP, control of bacterial autolysis, glucose transport and 
chemotaxis (Harold and Van Brunt, 1977; Nicholls and Ferguson, 1992). Any treatment 
that reduces either or both components of the pmf is said to depolarize the cell, which 
depending on the magnitude may affect cell viability (Novo et al., 1999). The importance 
of pmf during phage infection will be discussed in more detail in section 1.3.  
 
Bacteria do not lyse when put into distilled water because they have a rigid exoskeleton, 
the CW, which is at the same time sufficiently dynamic to allow maintenance of cell 
shape, cellular growth and cellular division (Archibald et al., 1993). The CW is mainly 
composed of peptidoglycan (PG), a polymer having as repeating unit a disaccharide made 
of N-acetyl glucosamine (NAG) and N-acetyl muramic acid (NAM), linked by glycosidic 
bonds β (1  4). The glycan chains are cross-linked by penta/tetrapeptide side stems that 
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are attached to NAM via amide bonds (Vollmer, 2008). Typically, the peptide stems are 
interconnected by an interpeptide bond in Gram-negative bacteria and by an interpeptide 
bridge of varying amino acid composition in Gram-positive bacteria (Labischinski and 
Maidhof, 1994). The amino acid sequence of stem peptides and of their cross-bridges 
accounts for more than 100 different PG types (Schleifer and Kandler, 1972; Vollmer, 
2008). 
 
In Gram-positive bacteria the CW is a multilayered network of cross-linked PG ranging 
between 20 and 40nm in thickness, whereas in Gram-negative cells the PG layer is much 
thinner (2-6nm) (Labischinski and Maidhof, 1994). This heteropolymer is the most 
conserved component of the cell envelope in bacteria, making it a major target for 
clinically used antibiotics, such as penicillin and vancomycin (Silhavay et al., 2010), and 
for phage-encoded PG hydrolases, such as endolysins, which act at the end of the lytic 
cycle to lyse infected cells. 
 
The PG layers of Gram-positive bacteria are most often heavily modified with phosphate-
rich molecules, the teichoic acids (TAs). These can be grouped into lipoteichoic acids 
(LTAs), which are anchored to the CM and extend through the PG layer, and wall teichoic 
acids (WTAs), which are covalently attached to the NAM residues of the PG and extend 
through and beyond the CW (Neuhaus and Baddiley, 2003; Weidenmaier and Peschel, 
2008). Although their structures may be highly variable between species or even strains 
(Weidenmaier and Peschel, 2008), frequently the WTA backbones are polymers of 
glycerol phosphate (e.g., in B. subtilis 168) or ribitol phosphate (e.g., in S. aureus and 
Listeria monocytogenes) (Xia and Peschel, 2008), which are often modified and 
substituted with different sugars or amino acids, such as -glucose and D-alanine 
(Neuhaus and Baddiley, 2003). Alone, WTAs can account for as much as 60% of the total 
CW mass, varying among organisms (Swoboda et al., 2010). LTAs, which are attached 
to the CM via a glycolipid anchor show less structural diversity than WTA, being usually 
formed by glycerol phosphate repeating units (Weidenmaier and Peschel, 2008). Together 
with PG, TAs make up a polyanionic matrix that plays a role in cation homeostasis, in 
trafficking of nutrients, proteins and antibiotics, and in the regulation of autolysins (see 
section 1.4) and presentation of envelope proteins (Neuhaus and Baddiley, 2003, and 
references therein). Even the Gram-positive bacteria lacking these polymers generally 
have functional anionic analogues, such as the lipomannan in Micrococcus luteus (Owen 
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and Salton, 1975; Powel et al., 1975). Bacterial strains with combined mutations that 
impair the expression of LTAs and WTAs are not viable (Oku et al., 2009; Schirner et 
al., 2009). B. subtilis and S. aureus mutants deficient in LTA biosynthesis can be obtained 
but are temperature sensitive and present several growth defects. WTA mutants also 
manifest increased sensitivity to temperature and certain buffer components, having the 
tendency to aggregate in culture (Oku et al., 2009; Schirner et al., 2009). 
 
Also imbedded in the PG meshwork are sugar polymers, proteins and lipoproteins 
(DiRienzo et al., 1978). Many of these components are employed by phages to adsorb to 
their host cells. Mutations affecting the pathway of poly(glycerolphosphate) 
glucolysation have been associated with B. subtilis resistance to several phages such as 
25, 29 and SP01(Yasbin et al., 1973) and in reducing the infectivity of SPP1 (Baptista 
et al., 2008).  
 
The presence or absence of an OM is one of the major differences between Gram-negative 
and Gram-positive bacteria (Fig. 1.2). In Gram-negative the OM performs some of the 
functions attributed to Gram-positive TAs and in addition it establishes a compartment, 
the periplasm, which retains extracytoplasmic enzymes required for CW growth and 
degradation (DiRienzo et al., 1978). The OM is covalently linked to the thin layer of PG 
and serves as an additional stabilizing and protective barrier of the cell controlling the 
traffic of solutes. It is a lipid bilayer of asymmetrical composition, with the outer leaflet 
being composed of glycolipids, principally lipopolysaccharides (LPS), and the inner 
leaflet of phospholipids. The OM also contains integral proteins and lipoproteins (Kamio 
and Nikaido 1976; Ruiz et al., 2006).  
 
The structure of the mycobacteria cell envelope is much more complex at the OM level. 
The mycobacterial OM presents a notable feature as in its inner side a mycolic acid-rich 
double layer is covalently attached to a layer of arabinogalactan, which in turn is 
covalently linked to the peptidoglycan that surrounds the CM (Hoffman et al., 2008). The 
outermost leaflet is composed of various glycolipids, including trehalose mono- and 
dimycolate phospholipids and species-specific lipids (Hoffmann et al., 2008; Zuber et al., 
2008). Outside of the mycobacterial OM is a layer of proteins, polysaccharides and a 
small amount of lipids known as the capsule (Lemassu & Daffé, 1994; Lemassu et al. 
1996; Sani et al., 2010). 
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1.3 Phage release from infected cells 
 
As opposed to filamentous phages, such as M13, which are released from their hosts by 
a secretion-related mechanism (Russel et al., 1997), phages are bacteriolytic by nature 
(São-José et al., 2003, 2007). The ability to induce bacterial lysis is crucial for survival 
and ecological fitness of lytic phages. The destruction of the host immediately stops the 
production of new virions, raising an interesting biological question: when to destroy the 
infected cell to release newly assembled phages? Delaying lyses would compromise the 
opportunity to infect new hosts whereas a premature burst would release none or too little 
descendants (Wang et al., 2000). 
 
Tailed phages with dsDNA genomes (e.g. phage λ) accomplish bacterial cell lysis through 
the concerted action of at least two phage-encoded products: a small hydrophobic protein 
called holin that oligomerizes in the CM until it induces formation of pores (holes), and 
an endolysin, which is an enzyme that acts by digesting the PG in the bacterial CW 
(Young & Wang, 2006; São-José et al., 2007; Catalão et al., 2013). In the so-called 
canonical lysis model holins form micron-scale holes, which are essential to allow 
passage of the cytoplasm-accumulated endolysin to the CW (Dewey et al., 2010; Savva 
et al., 2014). 
 
1.3.1 Lysis players: holin/endolysin molecular diversity 
 
Endolysins 
 
As mentioned above endolysins are phage-encoded PG hydrolases that act in the last 
stages of the infectious cycle to release the newly formed virion progeny. Phages infecting 
Gram-positive hosts and mycobacteria typically produce endolysins with a modular 
structure (López, et al., 1997; Payne and Hatfull,, 2012), where the enzyme’s N-terminal 
region generally exhibits one or two catalytic domains (CDs) responsible for PG 
cleavage, and the C-terminal domain has one to several motifs (often repeats) involved in 
cell wall binding (CWBD) (Fischetti, 2005; Loessner, 2005; Nelson et al., 2012). With a 
reduced number of known exceptions (Briers et al., 2007; Walmagh et al., 2012), phages 
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of Gram-negative bacteria produce smaller endolysins comprising a single CD and no 
CWBD. 
 
Endolysin CDs can be classified according to their cleavage specificities as N-acetyl-β-
D-muramidases (lysozymes), N-acetylmuramoyl-L-alanine amidases, N-acetyl-β-D-
glucosaminidases (glucosaminidases), endopeptidases, and lytic transglycosylases 
(Young et al., 2000) (Fig. 1.3). Lysozymes, glucosaminidases and lytic transglycosylases 
act on the glycan strands, breaking the β-1,4 glycosidic bonds between NAM and NAG. 
Amidases cleave the amide bond connecting NAM to the the first residue of the peptide 
stem, typically an L-Ala. Endopeptidases cleave within or between the peptide stems. 
Most of the reported endolysins are classified as muramidases and amidases.  
 
 
Fig. 1.3. Basic structure of peptidoglycan with indication of the bonds that are targeted by 
the five main types of enzymatic activities found in endolysins. m-DAP, which is found in the 
PG of E. coli and B. subtilis, is replaced by L-Lys in most Gram-positive bacteria. Linking 
between amino acid residues in positions 3 and 4 of adjacent stem peptides can occur via direct 
bonding or by an interpeptide bridge of variable amino acid composition. The D-Ala residue in 
blue is not always present. 
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It is important to note that most endolysin CDs and corresponding enzymatic specificities 
are identified solely based on homology and in silico analysis (Oliveira et al., 2013). 
Occasionally, the biochemical determination of endolysin cleavage products reveals 
enzymatic specificities different from those predicted by bioinformatics studies. 
Interesting examples are the streptococcal endolysins λSa1 and λSa2, which were initially 
predicted to have N- acetylmuramoyl-L-alanine amidase activity. However, electrospray 
ionization mass spectrometry analysis revealed that the endolysins displayed D-
glutaminyl-L-lysine endopeptidase activity (Pritchard et al., 2007). In addition, the same 
CD family assigned in silico can specify different enzymatic activities. For instance the 
CDs of CHAP family can display amidase (Nelson et al., 2006) or endopeptidase 
(Navarre et al., 1999; Pritchard et al., 2004) activities, and there is at least one example 
where a single CHAP was shown to exhibit both activities (Linden et al., 2014). 
Nevertheless, nowadays there are several examples of endolysins that have been 
characterized by different biochemical methods, in addition to the examples provided 
above. These include the endolysins of S. aureus phages 11 and K (Navarre et al., 1999; 
Becker et al., 2009), the endolysin of Streptococcus agalactiae phage B30 (Pritchard et 
al., 2004) and the Listeria phage endolysins Ply500 and Ply118 (Loessner et al., 1995). 
 
A curious feature that is shared by many staphylococcal and streptococcal endolysins, 
including the enzymes referred to above, is the presence of two independent CDs with 
distinct catalytic activities. The endolysins of phages 11 and K exhibit N-
acetylmuramoyl-L-alanine amidase and D-alanyl-glycyl endopeptidase CDs (Navarre et 
al., 1999; Becker et al., 2009), the group B streptococcal B30 endolysin displays N-
acetylmuramidase and D-alanyl-L-alanyl endopeptidase CDs (Pritchard et al., 2004), and 
the streptococcal Sa2 endolysin has a C-terminal N-acetylglucosaminidase CD in 
addition to the N-terminal endopeptidase domain (Pritchard et al., 2007). For other 
examples see the review Nelson et al., 2012. 
 
Unlike CDs, CWBDs are much less conserved and this variability may be due to a 
selection made through evolution. Endolysins recognize not only single components of 
the CW but also those that are essential to the viability of the host cell, thus ensuring 
effective host cell lysis for liberation of the viral progeny. One of the first CWBD 
identified was that of the Cpl-7 endolysin encoded by the Streptococcus pneumoniaee 
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bacteriophage Cp-7, a lysozyme requiring choline or ethanolamine to achieve full 
activation (Garcia et al., 1990). Other common CWBDs in endolysins from Gram-
positive systems are the motifs LysM and SH3 (with subtypes SH3b, SH3_3 or SH3_5) 
(Nelson et al., 2012; Oliveira et al., 2013). The former has been shown to bind the NAG 
residues of the PG (Ohnuma et al., 2008; Mesnage et al., 2014). SH3 CWBDs seem to 
target PG hydrolases to different components of the CW, including the PG peptide side 
chains and/or its cross bridges and also TAs (Loessner et al., 2002; Gründling and 
Schneewind, 2006; Lu et al., 2006; Tamai et al., 2014). Interestingly, although CWBDs 
are responsible for directing the endolysins to the CW, some studies seem to indicate that 
this is not always essential for lytic activity and for some endolysins their absence resulted 
even in increased lytic activity (Gaeng et al., 2000). However, other endolysins require 
both domains to maintain lytic activity at optimal levels (Loessner et al., 2002; Morita et 
al., 2001).  
  
The generality of the endolysins of Gram-positive systems are, or are thought to be, 
monomeric products of a single gene. A remarkable exception is the pneumococcal 
endolysin PlyC that is composed by two different subunits, PlyCA and PlyCB, which are 
encoded by separate genes. PlyCA is a CD-containing polypeptide that associates with 
eight PlyCB subunits responsible for CW binding (Nelson et al., 2006; McGowan et al., 
2012). Another exception is the two-component multimeric endolysin Lys170 that was 
shown to exhibit broad in vitro lytic activity against Enterococcus faecalis clinical strains 
(Proença et al., 2012). However, Lys170 subunits are produced from a single gene, due 
to the presence of an in frame internal translation start site that governs the independent 
production of the enzyme’s CWBD (CWB170) (Proença et al., 2015a). Biochemical 
analysis indicated that Lys170 is composed of a full-length monomer of Lys170 
associated with up to three CWB170 subunits (Proença et al., 2015a). Lys170 seems thus 
to exhibit an alternative strategy to increase the number of CWBDs, which was shown to 
favor the lytic activity of the endolysin. Alternative translation initiation (and eventually 
proteolytic processing) seems also to be on the genesis of multimeric endolysins in some 
clostridial phages (Dunne et al., 2016) 
 
Endolysins must be distinguished from other phage-encoded PG hydrolases, the virion-
associated lysins (VALs). These are integral components of the virion structure and are 
thought to locally digest the CW to facilitate injection of the phage genome into the host 
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cell (Rodríguez-Rubio et al, 2013). VALs generally lack a CWBD and in phages infecting 
Gram-positive bacteria they typically display two CDs, whereas those from phages 
infecting Gram-negative hosts usually have only one CD (Rodríguez-Rubio et al., 2013). 
In addition to the PG hydrolase activity, VALs frequently play a role in the assembly of 
the phage tail (Piuri and Hatfull, 2006; Boulanger et al., 2008). A reported exception to 
these features seems to be the VAL P17 of the staphylococcal phage 68, which shows the 
typical endolysin domain organization, that is, an N-terminal CD connected to a C-
terminal CWBD (Takác et al., 2005). Curiously, a study performed by Rodríguez et al. 
(2011) showed that the two CDs of the VAL HydH5, encoded by the S. aureus phage 
phiIPLA88, had the ability to bind target cells. VALs may be part of different components 
of the tail, frequently tail knobs, tape measures, fibers or spikes (Moak and Molineux, 
2000; Kanamaru et al., 2002; Kenny et al., 2004; Piuri and Hatfull, 2006; Xiang et al., 
2008; Boulanger et al., 2008; Rodríguez-Rubio et al., 2012).  
 
Holins 
 
Holins constitute a very diverse functional group. Typically they are small hydrophobic 
proteins (<150 aa) with a hydrophilic and highly charged C-terminus (Wang et al., 2000; 
Young 2002). Holins and holin-like proteins are hole-forming transmembrane devices 
that mediate bacterial cell lysis during programmed cell death (PCD) or following phage 
infection (Reddy and Saier, 2013). A recent database survey and in silico analysis 
identified 52 holin families and representative members of these have been included in 
the Transporter Classification Database (TCDB; www.tcdb.org). Based on phylogenetic 
relationships, 21 one of the 52 families could be further grouped into 7 superfamilies, 
each with distinctive characteristics in terms of protein size, number of transmembrane 
domains (TMDs), probable membrane topology and organism source distribution (Reddy 
and Saier, 2013; Saier and Reddy, 2015).  
 
In bacteria, holin-like proteins have been suggested to be responsible for the release of 
proteins from uninfected bacteria (Desvaux and Hebraud, 2006; Desvaux et al., 2005, 
2009). The Gram-positive bacteria Clostridium difficile, the major cause of antibiotic-
associated diarrhea, encodes two toxins, TcdA and TcdB within a pathogenicity locus 
(PaLoc) as well as the holin-like protein TcdE (Burdon et al., 1981). Govind and Dupuy 
(2012) showed that TcdE facilitates the release of both C. difficile toxins to the 
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extracellular environment. However, unlike most phage holins it did not cause the non-
specific release of cytoplasmic contents. In other systems holin-like proteins are involved 
in the regulation of murein hydrolase activity and apoptosis of bacteria, as exemplified 
by the S. aureus CM-associated proteins CidA and LrgA, which resemble structurally and 
functionally holin and antiholin (see below) proteins, respectively (Ranjit et al., 2011). 
The regulation of operons cid and lrg will be detailed in section 1.4.2).  
 
Regarding holins of phage origin, they were initially grouped into three main classes 
based on the number of TMDs: class I, with 3 TMDs, class II with 2 TMDs and class III 
with 1 TMD, as represented by the holins of E. coli phages λ, 21 and T4, respectively 
(Wang et al., 2000) (Fig. 1.4). However, the recent study referred to above that defined 
the 52 holin families (and 7 superfamilies) raised the possibility of holins with 4 TMDs 
and membrane topologies alternative to those depicted in Fig. 1.4. In addition, it was 
proposed for at least two phages that the holin functional unit may be a complex of two 
distinct holin-like proteins (see below). 
 
 
Fig. 1.4. Topological models of three classes of holins and of one antiholin. Holin classes (dark 
orange) are represented by the S105 holin of phage λ (class I, 3 TMDs), the S21 holin of phage 21 
(class II, 2 TMDs) and the T holin of phage T4 (class III, 1 TMD). The topology of phage λ 
antiholin S107 (light orange) in an energized membrane is shown, where the first TMD does not 
insert in the CM due to two extra positively charged amino acids at the N-terminus. After pmf 
dissipation the first S107 TMD enters the CM and adopts a S105-like topology, with the two proteins 
contributing to hole formation (see text for details). Adapted from São-José et al., 2007. 
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Holins have been described has having two main functions in the phage infection cycle: 
i) to determine the end of infection by means of its pmf-dissipation activity (the killing 
effect), and ii) allow the release to the CW of the cytosol-accumulated endolysins, since 
the majority of these lack secretory or export signals (the transport effect) (Catalão et al., 
2013; Young, 2013, 2014). Such signals are nevertheless present in some endolysins, 
which are thus transported to the CW via a holin-independent pathway (see below). In 
these cases the holin killing effect seems crucial to fully activate the exported endolysins. 
In these systems holins may perform small-sized holes (“pinholes”) and for that reason 
they are called pinholins (Pang et al., 2009, 2013; Park et al., 2007). 
 
As long as the pmf is maintained above a certain threshold, holins progressively and 
harmlessly accumulate as mobile oligomers in the CM during the course of phage 
infection, until they reach an allele-specific critical concentration (To and Young, 2014; 
White et al., 2011; Young and Wang, 2006). After this point, holin nucleation and 
aggregation occurs with formation of few large rafts that are proposed to permeabilize 
the CM to protons and ions. The pmf dissipation is then thought to suddenly cause 
conformational changes that allow the holin rafts to convert into the final holes (To and 
Young, 2014; White et al., 2011). This event ends macromolecular synthesis and thus 
effectively terminates infection, reason way these proteins are considered the clocks of 
phage infection (Wang et al., 2000; Young et al., 2000). 
 
To fine tune the host cell lysis timing some phages, notably the lambdoid phages, encode 
also a holin antagonist, referred to as antiholin. In phage λ the holin S gene itself, through 
the dual-start motif encodes both the lysis and inhibitor functions (Bläsi and Young, 
1996). The S holin, or S105, is a 105 aa polypeptide with 3 TMDs that adopts an N-out, 
C-in topology (Fig. 1.4; Gründling et al., 2000a). S105 results from translation initiation 
at the second start codon (Met3) of the S gene. The antiholin S107, which initiates at the 
first start codon (Met1) of S differs from S105 by two residues at the N-terminus, Met and 
Lys, which confer to the antiholin N-terminus 2 extra positive charges (one charge from 
the deformylated Met1 and another from the Lys2 residue, White et al., 2010). These 
positive charges prevent insertion of the first TMD of S107 into the CM (Fig. 1.4; 
Gründling et al., 2000a). This, associated to the capacity of the antiholin to dimerize with 
S105 (Gründling et al., 2000b) is what confers to S107 its inhibitory effect. Quite 
remarkably, dissipation of the pmf triggers the insertion of the first antiholin TMD into 
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the CM, adopting thus the same topology of S105 and contributing similarly to hole 
formation (Young, 2002 and references therein).  
 
The holin dual-start motif seems also to be present in some phages infecting Gram-
positive hosts, like for example in phages 29 and A118 of B. subtilis and Listeria 
monocytogenes, respectively (Tedin et al., 1995; Vukov et al., 2003). However, in the 
latter phage the dual-start motif in the holin gene hol118 did not seem to be involved in 
the regulation of holin activity. Curiously, a third in frame and internal translation start 
was found further downstream in hol118 (Met14), which was shown to direct the synthesis 
of an inhibitor function of Hol118 (Vukov et al., 2003).  
 
T4 also presents a regulatory paradigm in terms of holin function. The T4 holin T has all 
the characteristics presented by other canonical holins (Wang et al., 2003), however this 
protein can also respond to environmental stimulus, such as superinfection by other T4 
virions. In this condition the infected cells engage in a LIN ("lysis inhibition") state where 
holin-mediated lysis is delayed (Doermann, 1948). T4 LIN state involves a complex of 
three proteins that span the cellular envelope, and which is composed by the holin T, the 
antiholin RI and the associated factor RIII (Chen and Young, 2016). After activation by 
superinfection, the protein RI is secreted to periplasm and binds to periplasmic domain 
of holin T blocking its lethal permeabilization of the CM (Dressman and Drake, 1999; 
Ramanculov and Young, 2001). Conversely, the RIII interacts with cytoplasmic domain 
of T, which blocks the membrane hole-formation (Chen and Young, 2016). This state can 
be subverted in the presence of energy poisons or if the superinfection decreases (Abedon, 
1994; Tran et al., 2005). 
 
It is relatively common to find in the genome of phages infecting Gram-positive bacteria 
two holin-like genes clustering with that of the endolysin (Sheehan et al., 1999; Catalão 
et al., 2013). Certainly inspired by the lambdoid lysis mechanisms, some authors have 
speculated that these genes might encode the antiholin/holin functions. At least for two 
phages however, this pair of holin-like proteins seems to be needed for efficient lysis of 
the infected cell. This has been shown for the holin-like pairs Gp4 and Gp5 of 
mycobacteriophage Ms6 (Catalão et al., 2011) and XhlA and XhlB of B. subtilis phage 
PBSX (Krogh et al., 1998). It was proposed in these cases that the holin “functional unit” 
could be a complex made of each pair of holin-like proteins. 
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Besides the holin/endolysin pair, in Gram-negative bacteria and mycobacteria other 
proteins proved to be important for efficient host cell lysis in certain conditions. The most 
studied examples are the Rz and Rz1 proteins of phage λ, a type II integral membrane 
protein and an OM lipoprotein, respectively (Hanych et al., 1993; Kedzierska et al., 
1996). Both proteins interact through the C-terminal end of their periplasmic domains and 
form a complex that spans the periplasm, connecting the CM to the OM (Berry et al., 
2010, 2013). This complex termed spanin accumulates in the cell envelope throughout 
the infectious cycle (Berry et al., 2010, 2013). In the lack of Rz/Rz1, after the infectious 
cycle, the host cell terminates in a spherical form (Young et al., 1979; Zhang and Young, 
1999), in which the CM has been lethally permeabilized by the holin and the PG destroyed 
by the endolysin, but the OM is intact. The spanin complex is responsible for the 
elimination of this last barrier, most probably by promoting the fusion between the IM 
and OM (Rajaure et al., 2015). This final step can be essential for the efficient release of 
the virion progeny, which likely explains the broad dissemination of spanins among 
phages of Gram-negative bacteria (Summer et al., 2007). 
 
Other phage proteins can be viewed as functional analogues of spanins, such as LysB 
from mycobacteriophages (Gil et al., 2008; Catalão et al., 2013) and LysB-homologues 
identified in phages infecting Rhodococcus equi (Summer et al., 2011). LysB from phage 
Ms6 of Mycobacterium smegmatis was shown to hydrolyze ester bonds in esterase and 
lipase substrates (Gil et al., 2008), cleaving the bonds between OM mycolic acids and the 
arabinogalactan of the mycobacterial cell envelope (Payne et al., 2009; Gil et al., 2010). 
It was proposed that LysB acts together with the endolysin LysA, degrading the mycolyl-
arabinogalactan-peptidoglycan complex, thus ensuring efficient host cell lysis at the end 
of a phage infection cycle (Gil et al., 2010). As R. equi also has an OM composed of 
mycolic acids covalently linked to PG (Sutcliffe, 1998), it is legitimate to assume that the 
function of the LysB-homologues is the same as that described for LysB of MS6. 
 
1.3.2 Lysis mechanisms in tailed phages 
 
Endolysin release to the CW can absolutely depend on the holin-formed CM lesions or, 
less frequently, the enzyme can be actively transported by machinery of the host 
bacterium. In fact, apart from details specific of each system, known host cell lysis 
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mechanisms of tailed phages can grossly be divided in two major types, depending on 
whether endolysin transport is holin-dependent or -independent (Fig. 1.5). 
 
In this thesis the designations canonical endolysin (c-endolysin) or exported endolysin (e-
endolysin) will be used when referring to the enzymes that are holin-dependent or -
independent for export, respectively. An interesting observation is that even phages 
encoding e-endolysins, to which a holin function could be thought as dispensable, also 
produce holin-like proteins (Schmidt et al., 1996; São-José et al., 2004; Frias et al 2009; 
Catalão et al 2011). In these systems, holins still maintain the key role of defining the 
proper time for lysis thanks to their scheduled pmf-dissipating action, which directly or 
indirectly relieves the mechanisms restraining lytic activity of e-endolysins (Xu et al., 
2004, 2005; Nascimento et al., 2008; Sun et al., 2009; Catalão et al., 2010; Frias et al., 
2013) (Fig. 1.5).  
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Figure 1.5. Models for export and activation of phage endolysins. C-endolysins reach the CW 
through the holin pores, as represented by phage λ (A). E-endolysins are exported to the CW in a 
holin-independent manner. Export occurs through the Sec-system of the host bacterium when 
endolysins are produced with a typical signal peptide (SP) or with a signal-anchor-release (SAR) 
sequence, as observed in oenophage fOg44 and in coliphage P1, respectively (B). In 
mycobacteriophage Ms6 the Sec-mediated export of the full-length endolysin Lysin384 is assisted 
by the chaperone Gp1, whereas the truncated endolysin Lysin241 is predicted to access the CW 
through the holin channels (C). E-endolysins might be exported to the CW along with TAs 
precursors, in a holin- and Sec-independent way, as proposed for the pneumococcal phage SV1 
(D). PG, peptidoglycan; CM, cytoplasmic membrane; Cyt, cytoplasm. Endolysins with the 
“Pacman” shape represents c-endolysins and e-endolysins activated after pmf collapse. Adapted 
from Catalão et al., 2013. 
 
In the following sections the different lysis mechanisms employed by dsDNA tailed 
phages will be presented in more detail.  
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1.3.2.1 Holin-dependent export of endolysins 
 
 The model mechanism of E. coli phage λ 
 
The λ lysis cassette consists of four genes, S, R, Rz and Rz1. The S gene encodes the holin 
(S105) and the antiholin (S107) functions by the dual-start motif, the R gene the endolysin, 
and the Rz and Rz1 products compose the spanin function (see above) (Berry et al., 2008; 
Rajaure et al., 2015). In the phage λ lytic system, the prototype of the canonical lysis 
model, the holin accumulates in the CM during late gene expression without disturbing 
its integrity, while the enzymatically active endolysin builds in the cytoplasm. At a 
genetically-defined time, the membrane potential is dissipated and the holin triggers to 
form holes (Young, 2002 and references therein). Although these are lethal to the cell, 
complete lysis requires the action of the R endolysin (Young et al., 2000). At the time of 
its lethal triggering the S holin exists in large aggregates, forming lesions in the CM that 
are large enough to allow access of the endolysin to the CW. Once in this cell 
compartment, the lytic enzyme rapidly cleaves the PG substrate, which is thought to 
facilitate IM and OM fusion by the Rz/Rz1 spanin complex, finally leading to host cell 
lysis (Dewey et al., 2010; White et al., 2011; Rajaure et al., 2015). 
 
1.3.2.2 Holin-independent export of endolysins 
 
 Phage endolysins that engage the bacterial Sec-system for their targeting to 
the CW 
 
Oenococcus oeni phage fOg44 and its endolysin with a signal peptide. A lysis strategy 
deviating from the  paradigm was first described in the temperate phage fOg44, which 
infects the Gram-positive bacterium O. oeni. The fOg44 endolysin Lys44 was shown to 
be equipped with a typical signal peptide (SP) sequence, which engages the general 
secretion pathway of bacteria (the Sec system) for its transport to the CW, with the 
subsequent removal of the SP after export to produce the mature and active endolysin 
(São-José et al., 2000). The active Lys44 is detected half-way through the phage latent 
period, accumulating progressively until cell lysis. This indicates that the endolysin is 
targeted to the CW from the moment of its synthesis (São-José et al., 2000). Although at 
first sight dispensable, the fact is that fOg44 also produces a functional holin (Hol44) 
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(São-José et al., 2004). The transcription of lys44 and hol44 during fO44 lytic growth 
appears to result in a stable dicistronic mRNA (Parreira et al., 1999), suggesting a 
concomitant production of both lysis products during phage infection as observed in λ 
(São-José et al., 2007). To understand the holin role in this lytic system, Nascimento et 
al. (2008) performed an elegant study in which efficient sensitization of metabolically 
active cells to Lys44 action was only achieved with agents that promoted the non-
selective permeabilization of the CM to ions (in this case nisin and chloroform), i.e., 
agents that mimic the holin disruption of the CM electrical and chemical gradients. These 
results revealed that even in these strategies the lysis timing is determined by the holin-
mediated dissipation of the pmf, which should activate the e-endolysins pre-localized in 
the CW. 
 
Phage endolysins with SAR sequences. The endolysins LyzP1 and R21, produced by E. 
coli phages P1 and 21, respectively, have in their N-terminus an unusual TMD 
characterized by the presence of weakly hydrophobic amino acids, flanked by charged 
residues (Xu et al., 2004). This domain currently known as signal-anchor-release (SAR) 
sequence is not cleaved as the SP of Lys44, although it also enables the endolysin export 
through the host Sec system (Xu et al., 2004, 2005). As for Lys44, a model based on pmf 
disruption was proposed to explain the triggering of lysis with SAR endolysins. In this 
model the holin accumulates in CM without affecting the pmf, whereas the endolysin is 
secreted but retained in an inactive form, tethered to the CM. At the programmed lysis 
time the holin triggers, disrupting the membrane and leading to pmf abolishment. This 
depolarization promotes release of the SAR sequence from the membrane, which results 
in endolysin refolding into its catalytically active form (Xu et al., 2004, 2005; Sun et al., 
2009). This functional regulation is essential to avoid premature lysis of the infected host. 
For phages encoding SAR endolysins, the holin protein needs only to produce lesions 
large enough to allow passage of ions and depolarize the CM, in order to fulfill its role in 
controlling the timing of lysis. In fact, it was demonstrated that the holes formed by some 
cognate holins (e.g. S21) of SAR endolysins are too small to allow passage of the λ 
endolysin (Park et al., 2007). Detailed structural and biochemical studies showed that 
instead of the micron-scale holes formed by the S holin of , S21 formed channels with a 
lumen estimated at ~2 nm (Pang et al., 2009). For this reason the term “pinholin” has 
been proposed to differentiate the small-hole (pinhole)-forming character of the phage 21 
holin from the canonical holins that form large holes (Park et al., 2007). 
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Endolysin export mediated by a chaperon in mycobacteriophage Ms6. In addition to 
the predicted endolysin (LysA) and holin (Gp4), the temperate M. smegmatis phage Ms6 
encodes three additional proteins within its lysis module: Gp1, LysB and Gp5 (Garcia et 
al., 2002). An interesting novel feature in this mycobacteriophage is that Gp1 is a 
chaperon-like protein that interacts with LysA and promotes its export to the CW in a 
holin-independent way (Catalão et al., 2010). A deletion of gp1 from the Ms6 genome 
revealed that, although not essential for plaque formation, the chaperone is necessary for 
the phage to achieve an efficient lysis, with its absence resulting in a decrease of ~70% 
in the burst size. Curiously, experiments in E. coli showed that lysis could be prevented 
in mutants of the Sec system, even with the concomitant expression of Gp1 and LysA, 
indicating an involvement of this bacterial secretion system also in LysA export (Catalão 
et al., 2010). As referred previously, the protein LysB is probably an auxiliary agent in 
lysis that functions analogously to spanins of Gram-negative phages. 
 
Ms6 lysis regulation seems also to display other peculiar features. Gp4 was described as 
a class II holin, with the first TMD having SAR features, followed by a typical TMD 
(Catalão et al., 2011). Results suggest that Gp4 forms pores too small to allow passage of 
the 43-KDa Ms6 endolysin, thus behaving as a pinholin. A second putative holin gene 
(gp5), encoding a protein with a single predicted TMD at the N-terminal region, was also 
identified at the end of the Ms6 lytic operon. Neither the putative class II holin nor the 
single TMD polypeptide could trigger E. coli lysis when produced in pairwise 
combinations with the endolysin LysA (Catalão et al 2011). However, cross-linking 
experiments showed that Gp4 and Gp5 oligomerize and that both proteins interact, 
suggesting that the correct and programmed timing of lysis is achieved by the combined 
action of Gp4 and Gp5 (Catalão et al 2011). 
 
As referred for the other secreted endolysins, holin function in Ms6 seems also to be 
confined to the regulation of lysis timing through endolysin activation. Indeed, co-
expression of Gp1 and LysA in M. smegmatis caused only partial lysis, but the addition 
of nisin led to complete lysis (Catalão et al., 2010). The authors suggested that the 
endolysin was already positioned next to its target, the PG, at lysis onset, since the pore 
diameter produced by nisin (2.5 nm) should not allow the passage of a protein as large as 
the Ms6 endolysin (Ruhr and Sahl, 1985). Accordingly, the authors also envisaged that 
the Ms6 holin needs only to depolarize the mycobacterial CM to accomplish its role in 
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controlling the timing of lysis (Catalão et al., 2010). However, how the Ms6 endolysin is 
kept inactive until the holin trigger is a question that remains to be elucidated (Catalão et 
al., 2013). 
 
 SV1 phage, a new type of endolysin transport? 
 
Recently, a new mechanism of endolysin transport to the CW was proposed for phage 
SV1 that infects the Gram-positive bacterium S. pneumoniaee. In this system, endolysin 
transport does not rely on the holin function and it is yet to prove the involvement of the 
Sec system. Phage SV1, like all known phages infecting S. pneumoniae has a typical 
endolysin (Svl) that lacks any recognizable secretory signal such as SAR or SP (López 
and García, 2004). Therefore, until recently, it had been proposed that endolysin release 
to the PG occurred as described in the canonical holin-endolysin model (Haro et al., 2003; 
López and García, 2004; Martín et al., 1998). However, a recent work performed by Frias 
et al. (2013) demonstrated that Svl export and anchoring to the cell surface is most likely 
dependent on the presence of choline residues in the TAs of the CW. Choline is 
metabolized to decorate the TAs chains (Tomasz, 1967), serving as an anchor for a family 
of choline binding proteins (CBPs). These surface exposed CBPs are involved in the 
virulence and pathogenesis of S. pneumoniaee (Gosink et al., 2000; Rosenow et al., 
1997). In the absence of choline, cells grow in chains and fail to lyse in the stationary 
phase due to the lack of activity of the septum-cleaving LytB glucosaminidase and of the 
autolysin LytA, both of which are CBPs (Tomasz et al., 1971). Interestingly, the authors 
noted that as already observed for LytA (Díaz et al., 1989), the phage endolysin Sv1 was 
not found in the CW when host cells were grown in the presence of ethanolamine, which 
is used to replace choline in TAs (Ware et al., 2005). Thus, although the exact mechanism 
by which Sv1 is translocated to the CW is still unknown, the high homology observed 
between the endolysin and LytA (Romero et al., 1990) lead the authors to speculate that 
both proteins may share the same export pathway (Frias et al., 2013). Since choline 
anchors the lytic enzymes to the CW, it was hypothesized that they could bind 
intracellularly the TA precursors loaded with choline and then be co-transported across 
the CM by the TA biosynthetic machinery (Frias et al., 2013). As observed for other e-
endolysins, it is the pmf disruption achieved by the holin function, or by pmf-dissipating 
agents such as DCCD, the key factor for Sv1 endolysin activation (Frias et al., 2013). 
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1.4 Lysis regulation: insights from autolysis in Gram-positive bacteria  
 
Regardless the lysis strategy used by tailed phages, it is clear that the moment of killing 
and burst of the infected cell must be tightly regulated to avoid premature end of the virus 
reproductive cycle. The regulation of lysis functions in time and/or space can be imposed 
at the transcription, post-transcription, translation and post-translation levels (for a 
detailed review on the possible stages at which regulation of lysis functions can occur see 
Pohane and Jain, 2015). Relevant to the work presented in this thesis are the post-
translation mechanisms acting on endolysins, firstly on the regulation of their 
translocation across the CM (which can be either holin-dependent or –independent), and 
then after reaching the CW compartment. 
 
One aspect that is common to the already discussed lysis strategies is the killing of the 
infected cell through the holin pmf-dissipation action, regardless of how endolysins are 
exported to their site of action. It is well known for many bacteria that lysis can be a 
secondary response to cell death, in the so-called autolytic phenomenon, i.e., autolysis is 
a post-mortem effect (Smith et al. 2000). Considering the high level of homology that can 
be observed between phage endolysins and bacterial autolysins (López and García, 2004; 
Oliveira et al., 2013), it seems legitimate to considerer that the same factors that regulate 
autolysins might also be involved in the regulation of the activity of endolysins during 
phage development, especially in the case of e-endolysins (São-José et al., 2000, 2003).  
 
Autolysins are bacterial PG hydrolases that form a vast and highly diverse group of 
enzymes capable of degrading PG, in a similar way as described for endolysins (Fig. 1.3). 
These enzymes are universal among bacteria that possess PG and due to their potential 
lethality they are under a tight control. Beyond autolysis, autolysins are also involved in 
numerous cellular processes including cell division, CW turnover, PG maturation, cell 
elongation, motility, chemotaxis, genetic competence, protein secretion, differentiation 
and pathogenesis (Foster, 1994; Blackman et al., 1998). 
 
B. subtilis, a bacterial species central to the work presented in this thesis (see next 
chapters), encodes at least 35 differentially regulated autolysins, clustered into 11 families 
on the basis of amino acid sequence similarities (Smith et al., 2000). The major autolysins 
present during vegetative growth are LytC, LytD and LytF (Blackman et al., 1998; Smith 
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et al., 2000). LytC is an amidase that localizes uniformly to the CW, (Yamamoto et al. 
2003), being required for efficient swarming motility, cell separation and CW turnover, 
and it is the major PG hydrolase involved in autolysis of B. subtilis (Kuroda and 
Sekiguchi, 1991; Blackman et al., 1998; Smith et al., 2000). LytD is an N-
acetylglucosamine, whose CD is homologous to the corresponding CD of the bifunctional 
autolysin Atl of S. aureus (Foster, 1995). LytD seems to cooperate with LytC in the same 
cellular processes (Smith et al., 2000). Curiously, under certain conditions the absence of 
LytD does not seem to lead to obvious cell phenotypes (Margot et al., 1994). LytF is a 
member of DL-endopeptidase II and, as LytE, it localizes to the division septa and 
contributes to vegetative daughter cell separation (Margot et al., 1998; Smith et al., 2000).   
 
1.4.1 The phenomenon of bacterial autolysis: first dissipate pmf and then lyse 
 
In B. subtilis there are many studies describing that autolysis is triggered after treating 
cells with different membrane-depolarizing agents, such as gramicidin, monensin 
(selectively disrupts ΔpH), valinomycin (disrupts only Δ), CCCP and energy poisons 
like sodium azide (Chung et al., 2009; Joliffe et al., 1981). It has also been observed that 
lack of oxygen in B. subtilis cultures enhances autolysis and when these become static, 
cell lysis progressively occurs within few hours (Joliffe et al., 1981 and references 
therein). Autolysis is also triggered after brief starvation for a carbon source. 
Interestingly, the addition of electron-donating agents (e.g. phenazine methosulfate or 
ascorbate) or carbon sources (e.g. glucose or glycerol) to lysing bacteria retards or inhibits 
autolysis (Joliffe et al., 1981). Additionally, it was demonstrated that when applied 
exogenously the peptide toxin SDP rapidly collapses the pmf, presenting as secondary 
effect the trigger of the slow process of autolysis (Lamsa et al., 2012). Indeed, SDP was 
proved to cause cell death without lysis in B. subtilis strains defective in autolysins LytC, 
LytD, LytE and LytF (Lamsa et al., 2012). In conclusion, membrane energy and autolysis 
are tightly coupled in B. subtilis. 
 
In S. pneumoniaee, the collapse of the membrane pmf induced by the holin of phage SV1 
was shown to activate not only the phage endolysin Svl, but also the autolysin LytA (Frias 
et al., 2009, 2013). The holin of the pneumococcal phage EJ-1 seemed also capable to 
activate LytA and cause cell death when the proteins where co-produced in E. coli (Díaz 
et al., 1996). A similar phenomenon is probably induced by B. subtilis phage PBSX, since 
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the presumable XhlA/XhlB complex responsible for the holin function was shown to 
induce bacterial lysis, through autolysin activation, in the absence of the phage endolysin 
XlyA (Krogh et al., 1998). These results support the previous speculation that, at least in 
Gram-positive systems, the holin-mediated pmf dissipation could also activate the 
bacterial autolytic machinery, which is known to be turned on upon CM injury (São-José 
et al., 2000, 2003, 2007).  
 
Bacteriocins that cause lesions in the CM of sensitive cells due to their small size, high 
hydrophobicity and predicted amphipatic α-helixes (Hauge et al., 1998) are also capable 
of inducing autolysis in some Lactococcus and Lactobacillus strains (Martínez-Cuesta et 
al., 2000). Again, bacterial lysis is a consequence of bacteriocin-induced depletion of the 
cellular energy (Martínez-Cuesta et al., 2000) and it is worth noting that the biophysical 
properties of some of these agents resemble those of phage holins (São-José et al., 2003).  
 
The β-lactam and glycopeptides antibiotics (e.g. penicillin and vancomycin, respectively) 
inhibit proper CW synthesis at different stages of the process, leading to bacterial cell 
lysis (Ruzin et al., 2004). However, it was shown for some bacteria that such lysis is 
preceded by cell death, which in fact activates the autolytic enzymes. This was observed 
with the S. pneumoniaee autolysin LytA after addition of penicillin, vancomycin and 
bacitracin (Tomasz et al., 1970; Tomasz and Waks 1975; Mellroth et al., 2012). The same 
phenomenon could be observed in B. subtilis with cloxacillin, a β-lactam antibiotic 
(Blackman et al., 1998). Interestingly, whereas the B. subtilis autolysins LytC and LytE 
mediate lysis in response to cell death induced by energy poisons, LytD appears not to 
respond to these stimuli (Margot et al., 1998). 
 
The S. aureus operons cid and lrg are known to be involved in the control of bacterial 
PCD (Bayles, 2007). These operons encode the predicted membrane-associated proteins 
CidA, CidB, LrgA and LrgB, all containing multiple TMDs (Groicher et al., 2000; Rice 
et al., 2003). Their expression is regulated by LytSR, a two-component regulatory system 
also involved in murein hydrolase activity and tolerance to penicillin (Brunskill and 
Bayles, 1996; Groicher et al., 2000). A study performed by Ranjit et al. (2011) lend 
support to the early proposals (Groicher et al., 2000; Rice et al., 2003) that CidA and 
LrgA are analogous to the  holin and antiholin proteins, respectively, functioning in the 
control of cell death and lysis during biofilm formation. A mutation in the lrgAB operon 
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resulted in increased PG degradation and its overexpression caused increased penicillin 
tolerance in both lrgAB mutants and parental strains during early exponential phase 
(Groicher et al., 2000). Conversely, a cidA mutant had decreased PG hydrolase activity 
when compared with the parental strain and a high tolerance to antibiotics such as 
penicillin, rifampicin and vancomycin (Rice et al., 2003; Rice et al., 2005). This 
regulatory system is activated by the collapse of pmf, specially the Δ component. When 
this occurs the transcription of the lrg operon increases and lysis occurs, probably because 
LrgA converts into a holin function, after pmf dissipation, as it happens with λ S107 (Patton 
et al., 2006). Additionally, it was demonstrated that transcription of the cid operon was 
unaffected by pmf alterations, being instead activated by the presence of acetic acid 
(Patton et al., 2006). The cid operon plays also an important role in biofilm development 
as its mutation leads to biofilms loosely compacted and less adherent to the substrate 
(Rice et al., 2007). 
 
The above described cid and lrg regulatory system is widely conserved in bacteria but it 
also shares interesting similarities with the Bcl-2 family of proteins, which are involved 
in the regulation of apoptosis in eukaryotic cells (Bayles, 2003). Mitochondrial 
permeabilization is controlled by Bcl-2 proteinsthat include the antiapoptotic protein Bcl-
2 and the proapoptotic protein Bax. In response to apoptotic signals the mitochondria 
undergo OM permeabilization releasing cytochrome c and other cytoplasmic proteins 
(Kromer et al., 2007). An experiment performed by Pang et al. (2011) showed that when 
Bax is expressed in bacteria it displays holin like-behavior, causing endolysin release and 
cell lysis in a process dependent on Bax oligomerization. Like antiholins, the interaction 
of Bcl-2 with Bax inhibited the induction of cell death (Kroemer et al., 2007). 
 
1.4.2 Autolysis regulation 
 
The autolysis phenomenon in bacteria is influenced by a variety of factors such as ion and 
carbon source content of the medium (e.g. NaCl and glucose), pH, growth phase, 
proteases, cardiolipin, TAs, temperature and oxygen (Rice and Bayles, 2008 and 
references therein). Although the role of pmf in autolysis control seems safely established, 
the exact mechanism(s) underlying this regulation is poorly understood. 
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In a work performed by Calamita et al., (2001), pH-dependent fluorophores and pH-
dependent chemical modification reactions were used to show that the CW of respiring 
B. subtilis cells is protonated, having thus a relatively low pH environment. It has been 
proposed that this pmf-dependent acidification of the CW during growth could 
downregulate the activity of autolysins (Calamita et al., 2001; Kemper et al., 1993).  
 
As already indicated, the majority of Gram-positive bacteria contain TAs, which are 
polyanionic glycopolymers associated to the CW. In B. subtilis and S. aureus proton and 
cation homeostasis in the CW during respiratory metabolism seems to depend on the 
presence of TAs (Calamita et al., 2001; Schirner et al., 2009; Biwas et al., 2012). Rice 
and Bayles (2008) proposed that the acidic pH could suppress the activity of autolysins 
associated with TAs by promoting the protonation of the D-Ala ester linkages of these 
CW polymers. Upon dissipation of the membrane potential, the pH in the cell wall 
increases and destabilizes or deprotonates the D-Ala ester linkages, activating autolysins 
(Rice and Bayles, 2008). Staphylococcal cell separation depends largely on the 
bifunctional autolysin Atl, which displays amidase and glucosaminidase activities 
(Heilmann et al., 1997). Schlag et al., (2010) demonstrated that WTA prevented Atl 
binding to the PG in the bacterial side walls but not in the septum, where WTA appeared 
to be less abundant or have an altered structure. Similar observations have been made 
with the autolysins LytF of B. subtilis (Yamamoto et al., 2008) and Sle1 (or Aaa) and 
LytN of S. aureus (Frankel and Schneewind, 2012), all of which have motifs of the LysM 
family as CWBD. A recent study further supported the interrelationship between activity 
of the respiratory chain (a major source of protons in the CW), the presence of WTA and 
autolysis regulation, with authors proposing that WTA contribute to the control of 
autolysin activity by governing the abundance of protons in the CW (Biswas et al., 2012). 
 
In spite of all the indicated studies, the mechanisms by which loss of the pmf induces 
autolysis are still largely unknown. It appears though that collapse of the CM proton 
gradient might activate enzymes with distinct substrate specificities or localization, 
somehow connected to the presence or absence of WTA and LTA (and their substituents) 
in the bacterial CW. 
 
 
1. GENERAL INTRODUCTION 
28 
1.5 Exploration of endolysins as antibacterial agents  
 
After years of almost exclusive use of antibiotics in the treatment of infectious diseases 
caused by bacteria, the emergence of multidrug resistant bacteria and the slowdown in 
the discovery of new classes of antibiotics (Wenzel, 2004; Theuretzbacher, 2012; Cole, 
2014) has created the need to develop new strategies that ensure the elimination of these 
pathogens (Czaplewski et al., 2016). Phage endolysins by having the ability to degrade 
an essential component of the bacterial CW, the PG, have been intensively explored as 
alternative antimicrobial agents (for reviews see Nelson et al., 2012; Schmelcher et al., 
2012a; Pastagia et al., 2013).  
 
Many studies have shown that when applied externally, as purified recombinant proteins, 
endolysins can lead to ‘lysis from without’ of target bacteria (Borysowski et al., 2006; 
O’Flaherty et al., 2009; Fischetti, 2010). This effect is most obviously seen with Gram-
positive bacteria, as the OM of Gram-negative and mycobacteria hinders endolysin access 
to the PG. Nevertheless, in recent years considerable progress has been made in the search 
of endolysins with killing activity against Gram-negative bacteria. Researchers are 
working on identifying naturally occurring endolysins capable of lysing these bacteria 
from the outside, on engineering endolysins with motifs for targeting and crossing of the 
OM, and on combining endolysins with OM-permeabilizing agents (Lai et al., 2011; 
Lukacik et al., 2012; Briers and Lavigne, 2015). The majority of the studied endolysins 
have a reduced lytic spectrum, which is tipically restricted to the species (or subspecies) 
of bacteria against which they were naturally designed to act on. There are some cases 
however of enzymes with broader lytic activity, as for example the enterococcal endolysin 
PlyV12 that can kill enterococci and other Gram-positive pathogens such as S. agalactiae 
and S. pyogenes, making it one of the broadest-acting endolysin ever identified (Yoong 
et al., 2004).  
 
In 2001, Nelson et al., were the first to prove that an endolysin (PlyC from the 
streptococcal phage C1) could be used in vivo to protect mice from colonization of S. 
pyogenes in the upper respiratory tract. This and other results (Nelson et al., 2006) 
motivated the term enzybiotics, which is used to describe the therapeutic potential of 
phage endolysins. Endolysins have been evaluated in animal models of pneumoniae, 
endocarditis and sepsis with a focus on efficacy and host immune response (Loeffler et 
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al., 2001, 2003; Entenza et al., 2005; McCullers et al., 2007; Grandgirard et al., 2008; 
Witzenrath et al., 2009). Some reports highlighted the ability of endolysins to eliminate 
S. aureus biofilms, namely the endolysin of phage 11 (Sass and Bierbaum, 2007), LysK 
(O’Flaherty et al., 2005), LysH5 (Gutiérrez et al., 2014) and SAL-2 (Son et al., 2010). A 
synergistic lytic effect has been described when two different endolysins (with distinct 
CDs) are simultaneously used, as observed for the pneumococcal endolysins Pal and Cpl-
1 (Loeffler and Fishetti, 2003), or when endolysins are combined with other PG 
hydrolases (e.g. LysK in conjunction with lysostaphin, Becker et al., 2008). Endolysins 
and conventional antibiotics can also exhibit synergistic interaction, as demonstrated for 
Cpl-1 with either penicillin or gentamicin (Djurkovic et al., 2005). 
 
The high affinity for bacterial CW substrates allows endolysins to quickly identify and 
kill target bacteria. Some of these lytic enzymes proved effective in vivo, either by 
protecting/rescuing mice after animal inoculation with pathogenic bacteria, or by 
promoting the decolonization of mucosal surfaces (Loeffler et al., 2001, 2003; Schuch et 
al., 2002; Daniel et al., 2010). This feature could also be important on disinfection of 
implanted medical devices, such as implantable cardiac devices, cardiac valves, 
orthopedic prostheses and indwelling catheters. Nevertheless, until now only PlyC has 
been tested specifically as an environmental disinfectant (Hoopes et al., 2009).  
 
1.5.1 Engineering of endolysins 
 
Endolysins exhibit important characteristics as antibacterial agents, but they can also 
present some limitations, such as narrow host range, low solubility during large scale 
production and reduced activity in in vivo experiments. During the last years, many 
examples of engineered phage endolysins have been reported that aimed to overcome 
these problems (see reviews Nelson et al., 2012; Schmelcher and Loessner, 2016). An 
interesting approach is the development of chimerical endolysins by swapping and/or 
combining different PG hydrolase domains, namely CDs and CWBDs (Yang et al., 2014). 
Some of these chimeras are listed in Table 1.1. 
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Table 1.1. Chimerical Endolysins and Main Features. 
 
Chimerical 
Endolysin 
Relevant Characteristics Reference 
Fusion of PG Domains between Autolysins and Endolysins 
CLC muramidase 
Acquired hydrolyzing activity against choline-containing 
pneumococcal CW. 
Croux et al., 
1993 
λSA2-E-Lyso-SH3B 
Activity against staphylococcal and streptococcal bovine 
mastitis isolates; synergy with lysostaphin. 
Schmelcher et 
al., 2012b 
PL3 
Better lytic performance than parental enzymes against S. 
pyogenes and other choline-containing bacteria 
(encapsulated and multiresistant isolates); improved 
stability; bactericidal activity in vivo. 
Blázquez et 
al., 2016 
Fusion of PG Domains between Endolysins 
Ply187AN-KSH3b 
Active against multiple staphylococcal strains; diminished 
the progression of endophthalmitis in mice. 
Singh et al., 
2014 
Ply187N-V12C 
Broad activity spectrum across multiple genera, 
staphylococcal, streptococcal and enterococcal strains. 
Dong et al., 
2015 
PlyGVE2CpCWB 
Active against Clostridium perfringens; improved 
thermostability. 
Swift et al., 
2015 
Cpl-711 
Improved lytic activity of the parental endolysins against S. 
pneumoniaee in vivo and in vitro. 
Díez-Martínez 
et al., 2015 
Fusion between PG Domains of Phage Structural Proteins and Endolysins 
P16-17 
Strong activity against S. aureus; improved solubility of the 
chimera over the parental enzymes; synergistic effect with 
gentamicin. 
Manoharadas 
et al., 2009 
EC300 
Higher lytic activity than the parental endolysin Lys170 
against E. faecalis, especially in growth-promoting media. 
Proença et al., 
2015a 
Duplication of PG Domains  
CBD500 
Increase of CW binding affinity by approximately 50-fold in 
Listeria strains; great lytic performance at higher ionic 
strength. 
Schmelcher et 
al., 2011 
 
Likewise, engineered truncations of endolysins can yield enzymes with greater lytic 
specific activity and/or extended lytic spectrum when compared to the parental full-length 
PG hydrolases. This was verified with the staphylococcal and clostridial endolysins LysK 
and CD27L, respectively (Horgan et al., 2009; Mayer et al., 2011). Other truncations 
resulting in hyperactivity were reported for the streptococcal endolysin PlyGBS after 
application of random mutagenesis (Cheng and Fischetti, 2007). 
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As endolysins are below the 60-65 kDa cutoff, they are expected to be rapidly eliminated 
from the human body by glomerular filtration (Maack et al. 1979). Interestingly, the 
artificial dimerization of the pneumococcal endolysin Cpl-1 resulted in higher lytic 
activity and increased half-life in mice when compared to the natural monomeric form 
(Resch et al., 2011).  
 
Regarding the utilization of endolysins against Gram-negative bacteria, different 
strategies have been pursued to overcome the physical barrier imposed by the OM, 
namely with endolysins targeting Pseudomonas, E. coli and Salmonella (Briers et al., 
2011). For instance, endolysins K2144 and EL188 were able to display lytic activity 
against a broad range of Gram-negative bacteria when the OM was permeabilized with 
EDTA (Briers et al., 2007). Also, Artilysins, which are endolysins modified with LPS-
destabilizing peptides, such as (poly)cationic peptides, presented interesting lytic effects 
against Pseudomonas aeruginosa and Acinetobacter baumannii (Briers et al., 2014). In 
another study, the T4 lysozyme was fused to the pesticin domain that is responsible for 
recognition and binding of this bacteriocin to the OM transporter FyuA. The fusion was 
shown to traverse the OM and kill Yersinia and pathogenic E. coli strains (Lukacik et al., 
2012). 
 
1.5.2 Enzibiotic therapy: aren’t we missing something? 
 
In spite of the wealth of reports pointing for the therapeutic potential of endolysins as 
antibacterial agents, it is important to perform a careful and critical analysis of these 
studies. Most endolysins and derived chimeras have only been tested in vitro, usually 
after washing and resuspension of target bacteria in nutrient-depleted, buffered solutions, 
which are unable to sustain normal pmf. As discussed above, these conditions generally 
make bacteria more prone to lysis and for some species they are even sufficient to induce 
autolysis. In fact, this could explain why the high lytic activity observed in these 
conditions sometimes does not translate to the expected results in vivo, in animal infection 
models. In most cases, satisfactory numbers of animal survival are only obtained when 
lytic enzymes are administrated to animals soon after the injection of the deadly bacterial 
inoculum, which generally is also prepared in a buffer solution (Loeffler et al., 2003; Gu 
et al., 2011; Oechslin et al., 2013). This experimental setting vaguely parallels what 
happens in real scenarios of infection. A study with a staphylococcal phage enzyme with 
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high lethality against MRSA, both in vitro and in a mouse model, showed that the enzyme 
could be used to decolonize staphylococci from the nares of mice as well as to protect the 
animals from an intraperitoneal challenge with MRSA. However, in the latter experiment, 
the best protection was observed if the endolysin was added up to 30 minutes after the 
MRSA challenge (Rashel et al. 2007). As already pointed out, better results can be 
achieved when endolysins are used in conjugation with other antimicrobial agents, such 
as the lantibiotic nisin (Garcia et al., 2010), penicillin and glycopeptide antibiotics 
(Rashel et al. 2007; Djurkovic et al., 2005). 
 
It is important to note that endolysins are naturally designed to act from the cell inside 
and always after bacterial death caused by the holin pmf-dissipating action. In fact, it has 
been estimated that less than one thousand endolysin molecules per cell are sufficient to 
lyse phage-infected bacteria in a few seconds or minutes (Young and Wang, 2006). In a 
typical in vitro setting with 108 to 109 infected cells/ml this would correspond to an 
endolysin concentration clearly below the μg/ml scale (sometimes mg/ml) that is usually 
used to achieve lysis from the outside. Having this in mind, it is interesting to note that 
the fusion of a CWBD of a c-endolysin (Lys170) to a CD of a VAL resulted in a drastic 
improvement of bacterial cell lysis when compared with the parental endolysin Lys170 
(Proença et al., 2015a) (Table 1.1). Unlike endolysins, VALs, as structural proteins of the 
phage virus particle, are naturally designed to act from without in actively growing 
bacteria. 
 
Thus, the obvious question is why are bacterial cells apparently more resistant to 
exogenously-added endolysins when compared to their action in the phage-infection 
context, in which they reach the CW from inside. Although certainly the PG substrate 
facing the extracellular media exhibits differences in composition, ionic environment and 
accessibility relatively to the PG facing the CM, it is also possible that the holin pmf-
dissipating action may be important to efficiently sensitize cells to all endolysins, and not 
just to e-endolysins (see next chapters). 
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1.6 Thesis goals 
 
The main goal of this doctoral project was to contribute to the understanding of the 
mechanisms and factors that influence the lytic performance of phage endolysins, and 
how they might impact the current exploitation of these enzymes as antibacterial agents. 
 
In the phage infection context all known endolysins act after holin-mediated cell death. 
Enzybiotic therapy envisages the exogenous application of recombinant forms of these 
enzymes to lyse viable bacterial cells. Previous work showing reduced solubility and poor 
lytic activity of different recombinant endolysins has motivated the first goal of this work, 
that is, the production of chimeric endolysins active against clinically relevant strains of 
S. aureus (Chapter 2). 
 
Despite the interesting results obtained with the chimeras, we still observed that these and 
other endolysins failed to efficiently lyse bacteria when growing actively in rich media. 
This fact, combined with the previous findings on e-endolysins, led us to hypothesize that 
the holin-pmf dissipating function could be a general factor that guarantees full activity 
of endolysins (c- and e-endolysins). Taking advantage of the accumulated knowledge on 
the molecular biology of B. subtilis and its phage SPP1, and profiting from the availability 
of molecular tools for their genetic manipulation, we have selected this bacterium/phage 
system as a model to test our hypothesis. To that end we have addressed the following 
essential questions (Chapter 3): can fully energized bacterial cells naturally counteract 
the activity of exogenously added c-endolysins? Can this counteraction be abolished in 
presence of drugs that dissipate the pmf? ii) Is the holin-mediated dissipation of the pmf 
required to render cells fully susceptible to c-endolysins? With the knowledge and tools 
that emerged from this study we extended our goals to perform a functional 
characterization of the phage SPP1 holin (Chapter 4). 
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Abstract 
 
Due to their bacterial lytic action, bacteriophage endolysins have recently gained great 
attention as a potential alternative to antibiotics in the combat of Gram-positive 
pathogenic bacteria, particularly those displaying multidrug resistance. However, large-
scale production and purification of endolysins is frequently impaired due to their low 
solubility. In addition, a large number of endolysins appear to exhibit reduced lytic 
efficacy when compared with their action during phage infection. Here, we took 
advantage of the high solubility of two recently characterized enterococcal endolysins to 
construct chimeras targeting Staphylococcus aureus. The putative cell wall binding 
domain of these endolysins was substituted by that of a staphylococcal endolysin that 
showed poor solubility. Under appropriate conditions the resulting chimeras presented 
the high solubility of the parental enterococcal endolysins. In addition, they proved to be 
broadly active against a collection of the most relevant methicillin-resistant S. aureus 
epidemic clones and against other Gram-positive pathogens. Thus, fusion of endolysin 
domains of heterologous origin seems to be a suitable approach to design new potent 
endolysins with changed and/or extended lytic spectrum that are amenable to large-scale 
production.
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2.1 Introduction 
 
After decades of almost exclusive use of antibiotics in the treatment of infectious diseases 
caused by pathogenic bacteria, the emergence of multiresistant bacterial strains combined 
with a slowdown in the discovery of new classes of antibiotics is currently viewed as a 
major public health problem (Doyle et al., 2011; Willems et al., 2011; Woodford et al., 
2011). Among the different bacterial pathogens that have acquired antibiotic resistance 
Staphylococcus aureus is still one of the most serious threats worldwide, being able to 
develop resistance to virtually all classes of antibiotics (de Lencastre et al., 2007). 
Methicillin-resistant S. aureus (MRSA) has been a leading cause of nosocomial infections 
for some decades and more recently has also emerged as a community-associated 
pathogen (Annual report, EARS-Net 2010; Chambers, 2001, Furuya and Lowy, 2006, 
Klevens et al., 2007). S. aureus is responsible for a wide number of infectious diseases 
ranging from skin and soft tissues to fatal bloodstream infections, endocarditis, meningitis 
and bovine mastitis in dairy herds (Gruet et al., 2001; Larkin et al., 2007). For all these 
reasons there is an urgent need to develop new antibacterials that ensure elimination of 
multidrug-resistant pathogenic bacteria, particularly MRSA strains. 
 
Among the different approaches to obtain new antibacterials one that has recently caught 
great attention is the exploitation of bacteriophage endolysins (Fenton et al., 2010; 
Fischetti, 2010; Loessner, 2005; O’Flaherty et al., 2009). Endolysins are bacterial cell 
wall hydrolyzing enzymes that promote host cell lysis in the end of the lytic cycle of 
double-stranded DNA phages, thus allowing efficient release of the viral progeny to the 
extracellular medium (São-José et al., 2007). Despite the fact that endolysins have been 
evolutionarily designed to operate from the inside of infected cells, when applied 
exogenously as purified recombinant proteins they have been shown to promote lysis of 
different Gram-positive pathogenic bacteria, including S. aureus (Loeffler et al., 2001; 
Nelson et al., 2001; O´Flaherty et al., 2005; Yoong et al., 2004). 
 
Most endolysins have a modular organization with a conserved N-terminal catalytic 
domain (CD) and a more diverse C-terminal cell wall binding domain (CWBD) (Fischetti, 
2008; Garcia et al., 1990). However, several S. aureus phages produce endolysins with 
two catalytic domains in their N-terminus, such as those from phages K, ϕ11 and ϕMR11. 
These lytic enzymes present a CHAP (cysteine, histidine-dependent 
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amidohydrolases/peptidases) domain followed by an Amidase-2 domain (N-
acetylmuramoyl-L-alanine amidase), where the CHAP seems to be the most effective in 
inducing lysis (Navarre et al., 1999; O´Flaherty et al., 2005; Raschel et al., 2007). Other 
feature commonly reported for S. aureus phage endolysins is their poor solubility when 
overexpressed in Escherichia coli, frequently leading to low yields of soluble protein 
(Becker et al., 2008; Garcia et al., 2010; Manoharadas et al., 2009; O´Flaherty et al., 
2005). 
 
We have experienced this insolubility problem when attempting to purify a broad-host-
range anti-staphylococcal endolysin available in our lab, Lys87 (Cantante, 2008). Here, 
we describe a new strategy to overcome this problem that consisted in the construction of 
new chimerical endolysins composed of the Lys87 CWBD fused to the highly soluble 
CDs of two Enterococcus faecalis phage endolysins, Lys168 and Lys170 (Proença et al., 
2012). By employing this strategy, complemented with optimized expression conditions, 
we obtained two highly soluble lytic enzymes that are broadly active against a large 
cohort of S. aureus strains, including MRSA, as well as against other staphylococcal, 
streptococcal and enterococcal species. To our knowledge, this corresponds to the first 
report of chimeras comprising domains of S. aureus and E. faecalis phage endolysins. 
 
2.2 Results 
 
2.2.1   Production of chimerical endolysins targeting S. aureus 
 
We have recently characterized three phage endolysins, two from E. faecalis phages 
F170/08 and F168/08 and another from S. aureus phage F87s/06 (Cantante, 2008; 
Proença et al., 2012). In silico analysis of the endolysin from phage F170/08, that is, 
Lys170 identified a CD of the Amidase-2 family in its amino terminal region (Figs 2.1A 
and S2.21A). This family includes zinc amidases that have N-acetylmuramoyl-L-alanine 
amidase activity (Cheng et al., 1994). The same analysis performed with endolysins 
Lys168 and Lys87 from phages F168/08 and F87s/06, respectively, revealed a CD of the 
CHAP family (Bateman and Rawlings, 2003; Layec et al., 2008; Rigden et al., 2003), 
also located in the enzymes’ N-terminal region (Figs 2.1A and S2.1A). Enzymes from 
this family have been shown to cleave different amide bonds in the peptidoglycan mesh, 
frequently displaying amidase or endopeptidase activity. 
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Lys170 and Lys168 could be easily produced in E. coli in its soluble form whereas Lys87 
showed a high propensity to precipitate as inclusion bodies in all tested conditions 
(Cantante, 2008; Proença et al., 2012). The enterococcal endolysins exhibited a narrow 
lytic spectrum with their activity being basically restricted to E. faecalis cells (Proença et 
al., 2012). This feature might result from CWBD binding to a specific epitope present on 
the cell wall of E. faecalis cells and/or dependence of the CD on CWBD binding for 
activity (Low et al., 2011). Lys170 showed better lytic performance when both 
enterococcal endolysins were tested against a large number of E. faecalis clinical strains 
(Proença et al., 2012). 
 
Having this in mind we have envisaged that replacing the CWBD of Lys170 and Lys168 
by that of Lys87 would result in chimerical endolysins (Figs 2.1A and S2.1B) maintaining 
the high solubility properties of the parental enterococcal enzymes and the ability to 
recognize and act on S. aureus cells conferred by the parental Lys87 CWBD. 
 
  
Fig. 2.1. Schematic representation of parental (A) and resulting chimerical endolysins (B). 
N-terminal conserved domains (CD) are depicted as filled rectangles with indication of functional 
families (CHAP and Amidase-2). Dashed rectangles delimit the C-terminal region that must 
contain the putative cell-wall binding domain (CWBD). Linker regions connecting CD and 
CWBD are indicated by a line with the filling code and thickness of parental endolysins. The 
black rectangle at the end of each chimera represents the C-terminal hexahistidine tag used for 
affinity chromatography purification. The amino acidic coordinates of functional and linker 
domains as well as the total length of each endolysin are indicated above and below the schemes.  
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The coding sequences of the functional domains composing each chimerical endolysin 
were PCR-amplified, fused by OE-PCR and cloned in the E. coli expression vector 
pIVEX2.3d, which allowed production of the chimeras C-terminally fused to a 
hexahistidine tag (Figs 2.1B, S2.1B and Materials and methods). The ability of the 
chimerical enzymes Lys168-87 and Lys170-87 to lyse S. aureus cells was initially 
confirmed by growing the resulting protein-expressing E. coli clones on a dense lawn of 
autoclavated staphylococcal cells and checking for the presence of lysis halos around the 
E. coli colonies (Fig. S2.2). 
 
By employing standard protein expression conditions (37ºC, 3-4 h production after 
culture induction) with selected clones we could obtain much higher soluble amounts of 
the chimerical endolysins than those we had obtained previously with Lys87. However, 
the quantity of soluble Lys168-87 and Lys170-87 did not match the levels we achieved 
with the parental enterococcal endolysins as we anticipated (not shown). This could be 
overcome though by simply incubating the induced cultures at 16ºC during 14 h. In these 
conditions we achieved similar or higher soluble quantities of the chimeras when 
compared to the native enterococcal enzymes. The chimeras were subsequently purified 
from total soluble extracts by affinity chromatography using nickel columns. Pure 
fractions were pooled and subjected to a desalting step for protein exchange to an 
imidazole-free, sodium phosphate-based buffer (Fig. 2.2). Average yields were 20 and 30 
g of pure Lys168-87 and Lys170-87, respectively, per ml of induced culture. 
 
 
Fig. 2.2. SDS-PAGE analysis of Lys168-87 (A) and Lys170-87 (B) purification.  M, molecular 
weight marker; TSE, total soluble extract loaded in the affinity column; FT, flowthrough of the 
affinity column; PAF, eluted fraction of the affinity peak; PDS, eluted fraction of the desalting peak.  
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2.2.2   Lytic action of the chimerical endolysins against clinical S. aureus 
 
The lytic action of Lys168-87 and Lys170-87 against S. aureus was firstly assessed using 
a panel of 100 clinical isolates from Technophage’s collection (Table S2.1), which were 
isolated from different infection contexts and obtained both from Portuguese community 
and hospital settings. This panel included 42 isolates identified as MRSA. The lytic 
capacity of each chimera was evaluated by spotting four different amounts of pure 
enzyme (10, 5, 1 and 0.2 g) on a dense lawn of viable cells from each tested isolate, 
which was produced by incorporating cells from exponentially growing cultures in a soft-
agar, phosphate-buffered medium (see Material and methods). The chimera-induced lysis 
was qualitatively evaluated by scoring the relative diameter and turbidity of the lysis halos 
produced after overnight incubation at 37ºC (Table S2.2).  
 
For the highest tested protein amount (10 g) we observed that both chimeras were able 
to produce lysis halos in more than 90% of the isolates (Fig. S2.3). For each protein 
quantity though, Lys168-87 generally produced larger and more transparent lysis halos 
than Lys170-87 (Table S2.2). The narrowing of the lytic spectrum of this chimera as the 
spotted protein amount decreased was more pronounced than that observed with Lys168-
87 (Fig. S2.3). Interestingly, these results were basically opposite to those we obtained 
with the parental Lys168 and Lys170, where the later exhibited better lytic performance 
against E. faecalis (Proença et al., 2012). 
 
Although both chimerical endolysins revealed to be very effective in lysing this panel of 
S. aureus clinical isolates (n = 100), these were not typed and therefore the diversity 
present in this group was unknown. In order to have a more precise view on the lytic 
potential of the chimeras against S. aureus, the enzymes were similarly tested in a panel 
composed of diverse and typed MRSA and MSSA strains (Table 2.1). This strain 
collection was previously characterized in terms of their genetic background and included 
representatives of the most relevant MRSA pandemic clones from different parts of the 
world and representatives of the dominant of MSSA clones. 
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Table 2.1. Detailed Description of Typed S. aureus Clinical Strains 
Strain ID Origin 
Isolation 
date 
spa 
typing 
Ridom 
MLST 
(ST) 
CC1 
SCC
mec 
type 
Reference2 
MRSA, n = 30 
N315 Japan 1982 t002 5 5 II 15, 18 
USA100 USA 1995-2003 t002 5 5 II 16 
JP1 Japan 1987 t002 5 5 II 3, 18  
BM18 USA 1989 t002 5 5 IVa 6, 18 
HDE288 Portugal 1996 t311 5 5 VI 18, 21 
COB3 Colombia 1996 t1107 5 5 IVNT 10, 18 
USA300 USA 1995-2003 t008 8 5 IVa 5 
GRE120 Greece 1993 t036 8 5 IVh 1 
JH1 USA 2000 t002 105 5 II 24 
JH9 USA 2000 t002 105 5 II 24 
ANS46 Australia 1982 t037 239 5 III 8,12,18 
DEN907 Denmark 2001 t037 239 5 NT 9, 12 
HDG2 Portugal 1992 t421 239 5 IIIB 12, 23 
HPV107 Portugal 1992 t051 247 5 IA 18, 22 
BK1953 USA 1995 t051 247 5 IA 18, 19 
PER184 Spain 1991 t121 247 5 IA 7, 18 
BK793 Egypt 1961 t008 250 5 I 14, 18 
COL UK 1965 t051 250 5 I 18 
MW2 USA 1998 t128 1 15 IVa 4 
USA400 USA 1995-2003 t558 1 15 IVa 16 
HAR22 Finland 2002 t032 22 22 IVh 11, 20 
HGSA146 Portugal 2003 t032 22 22 IVh 1 
DEN2294 Denmark 2001 t019 30 30 IVc 9 
DEN2946 Denmark 2001 t975 30 30 IVc 9 
USA200 USA 1995-2003 t018 36 30 II 16 
HAR24 Finland 2002 t018 36 30 II 11, 20 
HAR38 Belgium 1995 t004 45 45 IVa 11, 20 
WIS Australia 1995 t123 45 45 V 13 
GRE14 Greece 1998 t044 80 80 IV 1 
DEN114 Denmark 2001 t044 80 80 IVc 9 
MSSA, n = 13 
HSA29 Portugal 1992-1993 t002 5 5 NA 2 
NCTC8325 UK 1943 t211 8 5 NA 5, 17 
DCC403 Portugal 1996-1997 t148 615 5 NA 2 
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Table 2.1 (continued) 
Draftees728 Portugal 1996-1997 t213 12 12 NA 2 
IPOP33 Portugal 2001 t1071 9 15 NA 2 
DCC192 Portugal 1996-1997 t084 15 15 NA 2 
DCC750 Portugal 1996-1997 t078 25 15 NA 2 
IPOP58 Portugal 2001 t189 188 15 NA 2 
Draftees721 Portugal 1996-1997 t790 22 22 NA 2 
DCC1060 Portugal 1996-1997 t012 30 30 NA 2 
IPOP34 Portugal 2001 t884 34 30 NA 2 
DCC457 Portugal 1996-1997 t330 45 45 NA 2 
IPOP74 Portugal 2001 t645 121 121 NA 2 
1Clonal complexes (CC) were determined using the E-burst software http://saureus.mist.net/, last accessed on January 
25, 2012. 2The references corresponding to the numbers indicated in the Table can be found in section 2.6.1. 
Abbreviations: NA, not applied; NT, non-typeable; MLST (ST), Multilocus Sequence Typing (Sequence Type); 
SCCmec, Staphylococcal Chromosomal Cassette mec 
 
Remarkably, the chimerical endolysins lysed between 70 to 100% of this panel of typed 
S. aureus clinical strains, depending on the amount of tested enzyme (Fig. 2.3). Lys168-
87 showed again a better lytic performance when compared to Lys170-87 since 0.2 g of 
the former were sufficient to produce a lysis halo in 83% of the tested MRSA strains, 
whereas Lys170-87 lysed only 70%. A detailed description of the lytic activity of the 
endolysins in each particular S. aureus strain is shown in Table S2.3. 
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Fig. 2.3. Susceptibility of a panel of diverse and typed S. aureus clinical strains to the lytic 
action of Lys168-87 and Lys170-87. Typed MRSA and MSSA strains (Table 2.1) were 
challenged by the spot assay (see text) with the indicated amounts of each chimera. The 
percentage of strains that developed a lysis halo after overnight incubation at 37ºC is plotted as a 
function of each enzyme amount. A detailed description of the susceptibility of each strain to both 
chimeras is presented in Table S2.3. 
 
2.2.3   Lys168-87 and Lys170-87 have a synergistic lytic effect in liquid media 
 
The chimerical endolysins were also able to induce lysis of viable S. aureus cells in dense 
liquid suspensions, as shown in the example of Fig. 2.4 for the MRSA epidemic clone 
USA200. When applied separately, each endolysin caused a drop of cell suspension 
turbidity to about 40% of the initial value, after 1 h incubation, which translated into a 
corresponding decrease of the initial CFU/ml. However, if simultaneously added to 
cultures, each at half of the concentration when used separately, the chimerical enzymes 
decreased the cell suspension turbidity to almost 5% of the initial value and eliminated 
ca. 99% of the initial CFU/ml (Fig. 2.4). These results indicate a synergistic effect of both 
endolysins in the effective lysis and killing of S. aureus. 
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Fig. 2.4. Lytic action of Lys168-87 and Lys170-87 against S. aureus strain USA200 in liquid 
media. The graphic shows the change of cell suspensions OD600 over time, after adding each 
chimera separately (10 g/ml) or in combination (5 g/ml each). Endolysin buffer was added to 
the negative control (C-) instead of the enzymes. Values are the means of three independent 
experiments with indication of standard deviation. The values on the right side indicate the 
percentage of the initial CFU/ml after 60 min of enzymes’ action and the corresponding standard 
deviation. 
 
2.2.4 Activity of the chimerical endolysins against other Gram-positive 
pathogenic bacteria  
 
As mentioned before, the parental enterococcal endolysins Lys168 and Lys170 showed a 
clear preference for E. faecalis when tested against a representative group of typed strains 
of this species and of Enterococcus faecium. When comparing their lytic action, Lys170 
showed to be more effective than Lys168 (Proença et al., 2012). By replacing their 
putative CWBD by that of the staphylococcal endolysin Lys87 we could efficiently 
retarget their activity towards S. aureus, as initially envisaged (see above). Next we 
studied how the chimeras acted on Gram-positive pathogenic bacteria other than S. aureus 
(Table S 2.4). When tested against the indicated E. faecalis and E. faecium clinical 
isolates, the chimerical enzymes essentially reproduced the lytic profile displayed by the 
parental enterococcal endolysins (Proença et al., 2012), with Lys170-87 producing larger 
and clearer lysis halos compared to Lys168-87 (Fig. 2.5 and Table S 2.5). Note that the 
E. faecalis and E. faecium isolates tested here were not genetically characterized and the 
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vast majority of them have been shown previously to be susceptible to both Lys168 and 
Lys170 (Proença et al., 2012). 
 
Interestingly, and in contrast to the parental enterococcal endolysins, the chimeras were 
also able to cause lysis of clinical isolates of other staphylococcal pathogens and Group 
A streptococci (Fig. 2.5A and Table S2.5). Qualitatively, Lys168-87 demonstrated equal 
or superior lytic action than Lys170-87 against all tested bacteria, except for the 
enterococcal isolates where Lys170-87 showed to be more powerful (Fig. 2.5B and Table 
S2.5). 
 
 
Fig. 2.5. Lytic action of Lys168-87 and Lys170-87 in other Gram-positive bacterial 
pathogens. (A) Bar plot showing the percentage of isolates from each species (Table S2.4) that 
developed a lysis halo after spotting 10 µg of each chimera. A detailed description of the 
susceptibility of each isolate to this and lower quantities of each chimera is presented in Table 
S2.5. (B) Representative lysis halos for the indicated amounts of each chimera in a dense lawn of 
viable cells from S. aureus and E. faecalis isolates 196/06 and 926/05, respectively. 
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2.3 Discussion 
 
A survey of the literature indicates that researchers frequently have to deal with the poor 
solubility of different endolysins, including those of S. aureus phages, when aiming their 
production and purification (Becker et al., 2008; Garcia et al., 2010; Manoharadas et al., 
2009; O´Flaherty et al., 2005; Schmitz et al., 2011; Yoong et al., 2004). This is also a 
recurrent problem in our lab and generally the available technical approaches to increase 
solubility, or to refold proteins recovered from inclusions bodies, are time consuming and 
poorly effective. 
 
We propose here that construction of chimeras, where we take advantage of the 
heterologous, highly soluble endolysin functional domains, may represent a solution to 
obtain large amounts of active lytic enzymes with retargeted and/or extended lytic 
spectrum relatively to parental endolysins. As far as we know, this is the first time that 
such approach is employed with the specific objective of obtaining highly soluble lytic 
enzymes targeting S. aureus. There is though at least one report where a similar strategy 
was attempted to solve the insolubility problem of an S. aureus phage endolysin. In this 
case the putative CD of the endolysin P16 from phage P68 was fused to the inferred 
CWBD of the virion associated lysin P17, also from the same phage. However, the 
resulting chimera remained insoluble and accumulated as inclusion bodies (Manoharadas 
et al., 2009).  
 
The construction of chimerical enzymes as a mean to improve the lytic efficacy or change 
the lytic spectrum, both in vitro and in vivo, towards relevant pathogens has been 
previously described. Recently, a chimerical endolysin (ClyS) assembling a CD and a 
CWBD from different S. aureus phages, and in which the latter displayed 
Staphylococcus-specific binding, was shown to lyse different S. aureus MRSA and 
MSSA strains and several coagulase-negative Staphylococcus species (Daniel et al., 
2010). This chimera revealed to be more effective than mupirocin for skin decolonization 
of MRSA and MSSA (Pastagia et al., 2011). In another example of homologous fusion, 
the CHAP domain of LysK, the endolysin from S. aureus phage K, was fused to the 
CWBD of the bacteriocin lysostaphin from Staphylococcus simulans (Idelevich et al., 
2011). The recombinant endolysin PRF-119 exhibited antimicrobial activity against a 
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great number of MSSA and MRSA clinical isolates, with an average MIC90 of 0.391 
g/ml.  
 
Heterologous fusion constructs where the native CWBD of the streptococcal LambdaSa2 
endolysin Cpl-7 was replaced by that of either lysostaphin or LysK resulted in a 5-fold 
increase in staphylolytic activity mediated by the Cpl-7 CD, while maintaining significant 
streptolytic activity (Becker et al., 2009). The results suggested that the CWBD of S. 
aureus lytic enzymes may not always be staphylococcal-specific. Yet in another example, 
chimeras composed of the streptococcal phage endolysin B30, or of its CHAP CD only, 
fused to the mature form of lysostaphin were shown to display lytic specificity for 
streptococcal pathogens and S. aureus (Donovan et al., 2006).  
 
In the work reported here we have fused the CD of two highly soluble E. faecalis phage 
endolysins, Lys168 and Lys170, to the CWBD of the staphylococcal phage endolysin 
Lys87, which showed high propensity to precipitate in the form of inclusion bodies. Our 
rational was that the CD of the enterococcal enzymes would confer high solubility to the 
resulting chimerical endolysins. In addition, the fact that Lys168 and Lys170 CDs were 
of the CHAP and Amidase-2 families, respectively, increased the chances of these 
domains to act on the S. aureus cell wall, if targeted by the Lys87 CWBD. Actually, the 
Lys168 CHAP domain, as deduced by Pfam analysis, shares 98% identity with that of the 
endolysin of S. aureus phage SAP6 (Proença et al., 2012). Lys170 Amidase-2 CD should 
confer N-acetylmuramoyl-L-alanine amidase activity as this was the activity 
experimentally determined for ORF9, an endolysin which is virtually identical to Lys170 
(Proença et al., 2012; Uchiyama et al., 2011). Amidases cleave the amide bond that links 
the N-acetyl muramic acid of glycan strands to the L-alanine residue of peptide stems. 
This bond and linked residues are common to the vast majority of bacterial cell wall 
peptidoglycans, including that of S. aureus (Schleifer et al., 1972). 
 
The chimeras thus constructed proved to efficiently lyse S. aureus clinical strains. When 
tested at their highest concentration each recombinant endolysin was able to induce lysis 
in more than 96% of 143 S. aureus clinical isolates. The lytic efficiency of each chimera 
varied among the different isolates, as judged by the relative size and transparency of the 
lysis halos (Tables S2.2 and S2.3). Remarkably, all the 30 typed strains composing a panel 
representative of the most relevant MRSA epidemic clones (Table 2.1) showed to be 
2. CHIMERICAL ENDOLYSINS TARGETING MRSA 
71 
susceptible to both chimerical enzymes. Very few anti-staphylococcal endolysins have 
been tested in such a representative group of MRSA typed strains. 
 
Also interesting was the fact that these chimerical endolysins not only essentially 
maintained the lytic performance of the parental enterococcal endolysins when tested 
against Enterococcus (Proença et al., 2012), but were also extended in their lytic spectrum 
being active against other Staphylococcus species and S. pyogenes. This suggests that the 
Lys87 CWBD may target a bacterial cell wall epitope that is common to several Gram-
positive bacterial species, while that of the parental enterococcal endolysins binds to a 
ligand predominantly found on enterococcal cell wall. This apparent wider target range 
of the CWBD of anti-staphylococcal lytic enzymes was also observed for lysostaphin and 
LysK, as mentioned above. Thus, Lys168-87 and Lys170-87 can be added to the small 
list of broadly active, phage-derived lytic enzymes (Becker et al., 2009; Donovan et al., 
2006; Yoong et al., 2004). 
 
A curious difference was observed when we compared the lytic efficiency of Lys168 and 
Lys170 with that of the derived chimeras Lys168-87 and Lys170-87. When tested against 
their natural target, E. faecalis, Lys170 generally produced larger and more transparent 
lysis halos than Lys168. However, this scenario was inverted when Lys168-87 and 
Lys170-87 were assayed against S. aureus (see illustrative example in Fig. 2.5B). This 
seems to indicate that the lytic performance of a given endolysin is not a mere function 
of the affinity and binding of the CWBD to the cell wall. In fact, other parameters such 
as the affinity of the CD to its substrate may influence lytic activity (Low et al., 2011). 
 
Lys168-87 and Lys170-87 could also lyse liquid cell suspensions of viable S. aureus. In 
addition, they showed a clear synergistic effect when simultaneously added to cells (Fig. 
2.4). To the best of our knowledge, such synergy between phage-derived hydrolytic 
enzymes in the effective lysis and killing of S. aureus has never been reported. Several 
studies though have demonstrated the occurrence of synergy between S. aureus phage 
endolysins and bacteriocins such as nisin (Garcia et al., 2010) or lysostaphin (Becker et 
al., 2008) or between endolysins and conventional antibiotics (Daniel et al., 2010; 
Djurkovic et al., 2005; Manoharadas et al., 2009; Rashel et al., 2007).  
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In conclusion, our results indicate that the engineering of chimerical endolysins from 
heterologous functional domains can be a good strategy to obtain large quantities of 
soluble and highly effective peptidoglycan hydrolases, either with narrow or broad lytic 
spectrum. The efficacy of the chimeras Lys168-87 and Lys170-87 is currently under 
study in animal models of S. aureus infection. 
 
2.4 Materials and methods 
 
2.4.1   Bacteria, culture media and growth conditions 
 
The E. coli cloning strain XL1-Blue MRF' and its derivatives were grown at 37ºC with 
aeration in Luria-Bertani (LB) medium (Sambrook and Russel, 2001). The E. coli 
expression strain CG61 (São-José et al., 2000) and its derivatives were grown in LB in 
the same conditions, except that incubation temperature was 28ºC before induction of 
protein production and 16ºC afterwards. When appropriate, LB medium was 
supplemented with kanamycin (40 g/ml) and/or ampicillin (100 g/ml) for plasmid 
selection. Lytic action of chimerical endolysins was assayed in 200 bacteria clinical 
isolates (Tables 2.1, S2.1 and S2.4). Table 2.1 corresponds to a panel of 30 MRSA and 
13 Methicillin-sensitive S. aureus (MSSA) typed strains. Table S2.1 lists 100 S. aureus 
isolates from Technophage’s collection, 42 MRSA, 29 MSSA and 29 with unknown 
methicillin susceptibility, which were obtained from different Portuguese community and 
hospital settings between 2005 and 2008. Recombinant lytic enzymes were also tested in 
clinical isolates of other species, namely against Staphylococcus epidermidis (n = 10), 
Staphylococcus haemolyticus (n = 9), Staphylococcus saprophyticus (n = 7), 
Enterococcus faecalis (n = 12), Enterococcus faecium (n = 10), and Streptococcus 
pyogenes (n = 9) (Technophage collection, Table S2.4). The growth media for these 
bacteria were purchased from Biokar Diagnostics, Beauvais, France. Staphylococcus and 
Enterococcus species were cultured in Brain-Heart Infusion (BHI) and S. pyogenes in 
Todd-Hewitt broth supplemented with 2% of yeast extract (THY). Bacteria were grown 
at 37ºC, with aeration, except for Enterococcus that was grown without agitation. When 
necessary, 1.5% or 0.7% agar was added to these culture media in order to obtain solid or 
soft-agar plates, respectively. E. faecalis and S. aureus phages were propagated and 
purified by standard methods (Clokie and Kropinski, 2009; Kutter and Sulakvelidze, 
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2004), either in soft-agar media or liquid broth supplemented with CaCl2 and MgCl2 (5 
mM each). 
2.4.2   Identification and bioinformatics analysis of phage endolysins 
 
Genomic DNA from E. faecalis and S. aureus phages was extracted from CsCl-purified 
lysates (Vinga et al., 2012) and their complete nucleotide sequence determined (service 
purchased to Macrogen, Seoul, Korea). DNA homology searches were carried out with 
BLASTN (Zhang et al., 2000), using the NCBI non-redundant nucleotide sequences 
database. Recognition of phage genome putative genes was performed by integrating the 
results obtained with GeneMark.hmm and MetaGeneAnnotator web software (Besemer 
and Borodovsky, 2005; Noguchi et al., 2008). Endolysins Lys168 and Lys170 from E. 
faecalis phages F168/08 and F170/08, respectively, were characterized previously 
(Proença et al., 2012). Identification of S. aureus phage F87s/06 endolysin gene was 
based on BLASTP homology searches (Altschul et al., 1997) against the NCBI non-
redundant protein sequences database, using the deduced gene product, and on prediction 
of protein functional domains using NCBI’s CDD (Marchler-Bauer et al., 2011) and Pfam 
(http://pfam.xfam.org/). Assignment of putative linkers connecting protein functional 
domains was performed with SVM (Ebina et al., 2009) and the SVM-joint output. 
Multiple protein sequence alignments were performed with ClustalW2 (Larkin et al., 
2007). 
 
2.4.3   Construction and cloning of lys168-87 and lys170-87 chimerical genes 
 
The coding sequences of the N-terminal regions of the enterococcal phage endolysins 
Lys168 and Lys170, which included CHAP and Amidase-2 CDs, respectively (Proença 
et al., 2012) (Figs 2.1A and S2.1A), were PCR amplified from the corresponding phage 
DNA using a high fidelity Pfu DNA Polymerase (Fermentas Molecular Biology Tools, 
Thermo Scientific). The sequence encoding the C-terminal region of the staphylococcal 
phage endolysin Lys87 (Figs 2.1A and S2.1A), and which harbored the putative CWBD, 
was similarly amplified by PCR in a separate reaction. The forward primers used for CD 
amplification carried in their 5’ end an NcoI restriction site whereas the reverse primer 
employed in CWBD amplification contained an XmaI site. The reverse and forward 
primers used in CD and CWBD amplification, respectively, carried a 26-bp 
complementary segment in their 5’ end. This allowed fusing the coding sequence of each 
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enterococcal endolysin CD to that of the CWBD of Lys87 by the technique of Overlap-
Extension by Polymerase Chain Reaction (OE-PCR) (Ho et al., 1989), using the CD 
forward and CWBD reverse primers and a mixture of the initial PCR products as template. 
The resulting PCR products, corresponding to the chimerical genes lys168-87 and lys170-
87 (Figs 2.1B and S2.1B), were purified using the High Pure PCR Product Purification 
Kit (Roche Applied Science), double-digested with NcoI and XmaI and ligated to the 
equally digested pIVEX2.3d expression vector (Roche Applied Science). This vector is 
designed to drive the expression of cloned genes under the control of the phage T7 ϕ10 
promoter and to allow the production of the corresponding proteins C-terminally fused to 
a hexahistidine tag. The E. coli strain XL1-Blue MRF' was transformed with these 
ligations as described previously (Chung et al., 1989). Transformants were selected in 
presence of 100 g/ml ampicillin and screened for the presence of the desired 
recombinant plasmids by PCR using insert and vector complementary primers. Plasmid 
DNA from positive clones was extracted (Pure Link Quick Plasmid Miniprep Kit, 
Invitrogen) and the correct DNA structure confirmed by endonuclease restriction and 
DNA sequencing (Macrogen, Seoul, Korea). The constructs pSF168-87 and pSF170-87 
are pIVEX2.3d derivatives carrying lys168-87 and lys170-87, respectively. 
 
2.4.4   Production and purification of the chimerical endolysins Lys168-87 and 
Lys170-87 
 
E. coli strain CG61, which overproduces phage T7 RNA polymerase upon temperate 
upshift (São-José et al., 2000) was transformed with plasmids pSF168-87 and pSF170-
87 and transformants selected at 28ºC in presence of 100 g/ml ampicillin and 40 g/ml 
kanamycin. Production of soluble and active Lys168-87 and Lys170-87 by CG61 
transformants was firstly confirmed by growing them over a dense lawn of autoclavated 
staphylococcal cells, incorporated in soft-agar LB medium, and checking for the presence 
of lysis halos around E. coli colonies (Fig. S2.2).  
 
Selected clones of each chimera were grown at 28ºC until an optical density at 600 nm 
(OD600) of 0.8-1.0, after which protein production was induced by changing cultures to a 
shaking water bath set to 42ºC. After 30min, cultures were transferred to an incubator at 
16ºC and agitated for an additional period of 14h. Cells from induced cultures were 
pelleted by centrifugation (8,000xg, 30min, 4ºC) and resuspended in 1/50 volume of lysis 
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buffer (20 mM Hepes, 500 mM NaCl, 20 mM imidazole, 1% glycerol, 1 mM DTT, pH 
6.5) supplemented with 1x Complete Mini EDTA-free Protease Inhibitor Cocktail (Roche 
Applied Science). Cells were kept on ice and disrupted by sonication (Vibra Cell MS2T, 
Sonic Materials) by performing about 10 bursts of 1 min (amplitude 50, pulse 3, 30–40 
W) intercalated with pauses of 1min. Insoluble material was sedimented by centrifugation 
(20,000xg, 30 min, 4ºC). The supernatant corresponding to the total soluble extract was 
filtered through 0.22m and the chimerical enzymes purified by affinity chromatography 
using HisTrapTM HP columns (GE Healthcare) coupled to an AKTA-Prime system (GE 
Healthcare). The column and elution buffers had the same composition of the lysis buffer, 
except that the imidazole concentration in the elution buffer was 500 mM. Eluted 
fractions were analyzed by SDS-PAGE and Coomassie blue staining (Laemmli et al., 
1970). Chimeras pure fractions were pooled, concentrated and changed to an imidazole-
free, phosphate-based endolysin buffer (50 mM phosphate-Na, 500 mM NaCl, 25% 
glycerol, 1 mM DTT, pH 6.5) using HiTrapTM Desalting columns (GE Healthcare). 
Protein concentrations were determined by the Bradford method (Bio-Rad Laboratories) 
using bovine serum albumin as standard. The enzymes were divided in small aliquots and 
kept at -20ºC. 
 
2.4.5  Evaluation of the lytic action of chimerical endolysins against bacterial 
pathogens 
 
The ability of chimeras Lys168-87 and Lys170-87 to induce lysis of clinical strains from 
different bacterial species was evaluated by two different assays. When tested against a 
large number of bacterial isolates, these were individually cultured as indicated above 
until an OD600 of 0.8-1.0. Cells were recovered by centrifugation and resuspended in 
1/100 volume of fresh medium. A 100µl sample of these cellular suspensions was diluted 
in 10ml of incorporation buffer (25 mM phosphate-Na, 250mM NaCl, pH6.5) 
supplemented with 0.7% agar and poured in a Petri dish. Four quantities of the purified 
chimeras (10, 5, 1 and 0.2 μg, in 10 μl final volume) were spotted on each bacterial lawn 
and after overnight incubation at 37ºC checked for the presence of lysis halos. These were 
evaluated and scored (- to +++) according to their relative diameter and transparency.  
 
Bacterial cell lysis was also studied in liquid medium. Selected strains were grown until 
an OD600 of 0.3-0.4, centrifuged and cells recovered in 1/2 volumes of a phosphate buffer 
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(25mM phosphate-Na, 250mM NaCl, pH 6.5). One-milliliter cell suspensions were 
challenged with 10 g/ml of each chimera separately or with a mixture of both enzymes, 
each at 5 g/ml. The OD600 variation was followed over time. At the end of each assay 
the surviving CFU (colony forming units)/ml were determined. Negative controls were 
equally prepared except that endolysin buffer was added instead of endolysin.  
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2.6 Supplementary materials 
 
  
Fig. S2.1. Primary sequence of enterococcal (Lys168 and Lys170) and staphylococcal 
(Lys87) parental endolysins (A) and of the resulting chimeras Lys168-87 and Lys170-87 (B). 
N-terminal catalytic domains (CD) were defined by Pfam (http://pfam.sanger.ac.uk/) and are 
indicated as shaded sequences. The bioinformatics tool DLP-SVM 
(http://www.tuat.ac.jp/~domserv/cgi-in/DLP-SVM.cgi) and the output SVM-joint were used to 
define the linker domain in each endolysin (indicated by decreased-size letters and italics). 
Segments containing putative CW binding domains are in boldface. The C-terminal tag added by 
the expression vector is underlined. 
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Fig. S2.2. Production of active chimerical endolysins by E. coli CG61 derivatives carrying 
pSF168-87 and pSF170-87. CG61 derivatives were cultured in an LB soft-agar lawn containing 
0.2% (w/v) of autoclavated S. aureus cells, 0.1% Triton-X100, 100 µg/ml ampicillin and 40µg/ml 
kanamycin and incubated overnight at 28ºC. Afterwards plates were incubated at 37ºC during16h. 
Lytic action of Lys168-87 and Lys170-87 was evidenced by development of lysis halos around 
CG61 colonies (Yokoi et al., 2005). 
 
 
 
Fig. S2.3. Lytic spectrum of Lys168-87 and Lys170-87 against a panel of 100 non-typed S. 
aureus clinical isolates (Tables S2.1 and S2.2). Each isolate was grown until an OD600 of 0.8-
1.0, cells were recovered by centrifugation and concentrated 100-fold in fresh culture medium. 
Samples of 100 µl of these suspensions were incorporated in a buffer (25 mM phosphate-Na, 
250mM NaCl, pH6.5) supplemented with 0.7% agar and poured in a Petri dish. The indicated 
amounts of each enzyme were spotted on these cell lawns and plates incubated overnight at 37ºC. 
The percentage of isolates that presented lysis halos (Table S2.2) is plotted as a function of each 
chimera quantity. 
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Table S2.1. Non-Typed S. aureus Clinical Isolates 
Isolate and code ID  Clinical specimens Sample origin 
MRSA, n=42 
  1011/05 Wound exudate Hospital  
  1018/05 Wound exudate Hospital 
  1275/05 Pus from ulcer Hospital 
  1463/05 Skin exudate Hospital  
  1641/05 Pressure sore exudate Hospital 
  1644/05 Wound exudate Hospital 
  1862/05 Pressure sore exudate Hospital  
  2121/05 Exudate Hospital  
  124/06 Wound exudate Hospital 
  623/06 Pus from phlegmon Hospital 
  644/06 Foot exudate Hospital  
  746/06 Ulcer exudate Hospital 
  748/06 Exudate Hospital 
  815/06 Exudate Hospital  
  1035/06 Exudate Hospital 
  1037/06 Wound exudate Hospital 
  1076/06 Wound exudate Hospital  
  1077/06 Exudate Hospital 
  1102/06 Wound exudate Hospital 
  1149/06 Exudate Hospital  
  1157/06 Wound exudate ND/NK 
  1201/06 Fistula exudate   Hospital  
  1204/06 Wound exudate Hospital 
  84/07 Exudate Hospital 
  161/07 Pus Hospital  
  86/07 Exudate Community  
  163/07 Wound exudate Community  
  166/07 Purulent exudate Hospital  
  400/07 Exudate Hospital 
  322/07 Exudate Hospital 
  162/07 Pus Hospital  
  465/07 Pus Hospital 
  590/07 Pus Hospital 
  97/08 Pressure sore exudate Hospital  
  1020/05 Synovial fluid ND/NK 
  965/05 Blood  Hospital  
  1094/05 Blood Hospital 
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Table S2.1 (continued) 
  2013/05 Blood Hospital 
  862/06 Blood Hospital  
  2030/05 Urine Community  
  1007/06 Urine Community  
  1211/06 Urine Community  
MSSA, n=29 
  1538/05 Exudate Hospital  
  1623/05 Skin exudate Hospital 
  1745/05 Umbilical exudate Hospital 
  1976/05 Pressure sore exudate Hospital  
  399/06 Umbilical exudate Hospital 
  400/06 Pus Hospital 
  920/06 Exudate Hospital  
  1038/06 Exudate Hospital 
  1039/06 Exudate Hospital 
  1156/06 Cellulitis exudate Community  
  1159/06 Exudate Hospital  
  1203/06 Exudate Hospital 
  1209/06 Wound exudate ND/NK 
  214/07 Wound exudate Hospital  
  224/07 Exudate Hospital 
  463/07 Exudate Hospital 
  464/07 Exudate Hospital  
  662/07 Exudate Hospital 
  171/07 Ulcer exudate Hospital 
  223/07 Exudate Community 
  586/07 Exudate Community  
  663/07 Exudate Community  
  325/07 Exudate Hospital 
  466/07 Pus Hospital 
  53/08 Exudate Hospital 
  55/08 Exudate Hospital 
  56/08 Exudate Hospital 
  129/08 Exudate Hospital 
  130/08 Umbilical exudate Hospital 
S. aureus (ND/NK), n= 29 
  919/05 Pus Hospital 
  964/05 Drain exudate Hospital 
  1013/05 Catheter tip  Hospital 
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Table S2.1 (continued) 
  1133/05 Catheter tip exudate Hospital 
  1152/05 Pus Hospital 
  1154/05 Catheter   Hospital 
  1319/05 Skin lesion exudate Hospital 
  1390/05 Pressure sore exudate Hospital 
  1627/05 Skin exudate   Hospital 
  1872/05 Catheter tip  Hospital 
  351/06 Skin exudate Hospital 
  196/07 Wound exudate Hospital 
  545/07 Umbilical exudate Hospital 
  547/07 Exudate Hospital 
  565/07 Pharyngeal exudate Hospital 
  566/07 Pharyngeal exudate Hospital 
  567/07 Pharyngeal exudate Hospital 
  546/07 Exudate Community 
  578/07 Pressure sore exudate Community 
  594/07 Exudate Community 
  743/06 Exudate Hospital 
  941/05 Blood Hospital 
  793/06 Blood  Hospital 
  455/05 Urine Community 
  755/05 Urine Community 
  1389/05 Urine Hospital 
  1649/05 Urine Hospital 
  2144/05 Urine Community 
  541/06 Urine Hospital 
Abbreviations: ND/NK, methicillin susceptibility not determined/not known. 
 
Table S2.2 Lytic Action of Lys168-87 and Lys170-87 Against the Group of Non-Typed S. 
aureus Clinical Isolates (n = 100)1 
Isolates and code ID Lys168-87 (µg) Lys170-87 (µg)   Illustrative 
  lysis halos 10 5 1 0.2 10 5 1 0.2 
 MRSA, n=42 
  919/05 +++ ++ + +/- ++ + + 
 
 
  1011/05 +++ ++ + +/- ++ + + +/-  
  1152/05 +++ ++ - - ++ + - -  
  1319/05 ++ +/- - - +/- - - -  
  1623/05 ++ + - - + - - -  
  1627/05 ++ + - - + - - - 
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Table S2.2 (continued)  
 
  1644/05 + + +/- - +/- +/- - - 
  1872/05 +++ ++ +/- - - - - - 
  1976/05 ++ + - - +/- - - - 
  399/06 +++ +++ +/- +/- + +/- - - 
  400/06 +/- +/- +/- - +/- +/- - - 
  623/06 + - - - +/- - - - 
  644/06 +++ +++ + +/- + + +/- - 
  746/06 +++ ++ ++ +/- + +/- - - 
  815/06 +++ +++ + +/- ++ + + -  
  920/06 +++ +++ ++ + + + +/- +/-  
  1038/06 +++ ++ + +/- + +/- - -  
  1039/06 +++ ++ ++ + ++ + +/- - 
 
  1076/06 +++ +++ ++ ++ ++ ++ + - 
  1077/06 +++ ++ ++ + + + +/- +/- 
  1149/06 +++ +++ ++ + ++ + +/- - 
  1157/06 +++ +++ +++ +/- ++ ++ ++ - 
  1201/06 +++ ++ ++ +/- + + +/- +/- 
  1204/06 ++ ++ +/- - - - - - 
  1209/06 +++ ++ + - + +/- - - 
  84/07 +++ +++ ++ + ++ ++ + - 
  161/07 +++ +++ ++ + + + +/- +/- 
  86/07 +++ ++ + +/- + +/- - - 
  214/07 ++ ++ + +/- + +/- - - 
  594/07 - - - - - - - - 
  325/07 +++ +++ ++ +/- ++ ++ + - 
  743/06 +++ +++ ++ + + + + +/- 
  465/07 +++ ++ + - ++ ++ + +/- 
  55/08 +++ +++ ++ +/- + + +/- - 
  129/08 +++ +++ +++ ++ + + + +/- 
  1020/05 +++ ++ + + +++ ++ + + 
  941/05 ++ + +/- - +/- - - - 
  965/05 +++ ++ + - +/- - - - 
  2013/05 +++ + +/- - + - - -  
  1389/05 +++ +++ ++ + ++ + +/- -  
  2144/05 +++ ++ + +/- + +/- - -  
  541/06 +++ +++ ++ +/- +/- - - -  
  1390/05 +++ ++ + - ++ - - -  
MSSA, n=29 
  1463/05 ++ + +/- - ++ + +/- -   
+++ 
 ++ 
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Table S2.2 (continued) 
  1641/05 ++ + - - + - - - 
  1862/05 +++ ++ +/- - ++ +/- - - 
  124/06 +++ ++ + - + + +/- - 
  351/06 +++ ++ + - + +/- - - 
  748/06 + + +/- - + + - 
 
  1035/06 +++ +++ ++ + ++ ++ + 
 
  1037/06 +++ ++ + + +++ ++ + 
 
  1102/06 +++ ++ + +/- ++ + +/- 
 
  1156/06 +++ +++ ++ + + +/- - - 
  1159/06 ++ ++ + + + + +/- - 
  1203/06 +++ +++ ++ +/- + +/- - -  
  166/07 + + +/- - + + - -  
  196/07 +++ +++ ++ + + + + -  
  224/07 + + +/- +/- +/- +/- - +  
  400/07 +++ +++ ++ + + + +/- -  
  566/07 +++ +++ +++ + +++ ++ + -  
  567/07 +++ +++ ++ + + + + +/-  
  662/07 ++ ++ + +/- + +/- +/- +/-  
  546/07 +++ ++ + +/- + + + -  
  586/07 +++ +++ ++ + +++ ++ ++ +/- 
  663/07 +++ +++ ++ - ++ ++ + + 
  162/07 +++ +++ ++ + + + + - 
  466/07 +++ ++ + +/- ++ + + + 
  590/07 +++ +++ ++ +/- ++ ++ + - 
  53/08 +++ +++ ++ +/- ++ ++ + +/- 
  56/08 ++ ++ + +/- + +/- - - 
  97/08 +++ +++ ++ - ++ + + - 
  964/05 +++ +++ + + +++ ++ + +/- 
 S. aureus (ND/NK), n= 29 
  1013/05 +++ ++ + +/- + + +/- +/- 
  1018/05 +++ +++ ++ + +++ ++ ++ +/- 
  1133/05 ++ + - - + +/- - -  
  1154/05 ++ + - - + +/- - -  
  1275/05 +++ + + - ++ + - -  
  1538/05 +++ + +/- - ++ + - -  
  1745/05 ++ - - - + - - -  
  2121/05 - - - - +/- - - -  
  163/07 +++ ++ + + + + - -  
  463/07 +++ ++ + +/- + + +/- -  
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Table S2.2 (continued) 
  464/07 +++ ++ + - + + +/- -  
  545/07 +++ +++ ++ + ++ + + -  
  547/07 +++ +++ ++ +/- ++ ++ + +  
  565/07 ++ ++ +/- - + +/- - - 
 
  171/07 +++ ++ + +/- + +/- - - 
  223/07 ++ ++ + +/- +/- - - - 
  578/07 +++ +++ ++ - + + + - 
  322/07 + + + - +/- +/- +/- - 
  130/08 ++ ++ +/- - + + + - 
  1094/05 +++ +++ ++ ++ ++ ++ + +/- 
  793/06 ++ ++ + +/- +/- - - - 
  862/06 - +/- +/- - - +/- - - 
  455/05 - - - - - - - - 
  755/05 +++ +++ ++ + ++ + +/- -  
  1649/05 +++ ++ + +/- ++ + +/- -  
  2030/05 ++ + - - +/- - - -  
  1007/06 ++ + +/- - + +/- - -  
  1211/06 +++ +++ +++ ++ + + + -  
Abbreviations: ND/NK, methicillin susceptibility not determined/not known. 
1Four different quantities of each chimerical endolysin were spotted on a dense cell lawn of each isolate, which was 
prepared by incorporating cells from exponentially growing cultures in a soft-agar, phosphate-buffered medium. Lytic 
action was scored (- to +++) according to the relative size and transparency of lysis halos after overnight incubation at 
37ºC. 
 
Table S2.3. Lytic Action of Lys168-87 and Lys170-87 Against the Panel of Typed S. aureus 
Clinical Strains (n= 43)1 
Strain ID Lys168-87 (μg) Lys170-87 (μg) 
10 5 1 0.2 10 5 1 0.2 
MRSA, n=30 
  N315 +++ +++ ++ + +++ ++ ++ + 
  USA100 +++ ++ + + ++ + + + 
  JP1 +++ ++ + +/- ++ ++ + +/- 
  BM18 +++ +++ ++ + ++ ++ ++ + 
  HDE288 ++ ++ + + ++ + + + 
  COB3 + + +/- - + +/- +/- - 
  USA300 ++ ++ + +/- + +/- +/- - 
  GRE120 +++ +++ ++ ++ +++ +++ ++ ++ 
  JH1 +++ +++ ++ + + + + + 
  JH9 + +/- - - +/- - - - 
  - 
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  ANS46 +++ +++ ++ ++ +++ +++ ++ + 
  DEN907 +++ ++ + + ++ ++ + + 
  HDG2 +++ ++ + + ++ ++ + + 
  HPV107 + + + +/- + + +/- - 
  BK1953 ++ + + + + + +/- - 
  PER184 + + +/- - + + +/- - 
  BK793 +++ ++ + +/- ++ + + +/- 
  COL +++ +++ ++ + ++ ++ + + 
  MW2 ++ ++ + + ++ + + + 
  USA400 ++ ++ + - + + + +/- 
  HAR22 + + +/- +/- + + + +/- 
  HGSA146 +++ ++ + + +++ ++ ++ + 
  DEN2294 +++ ++ + + ++ + + + 
  DEN2946 ++ + +/- +/- + + +/- - 
  USA200 +++ +++ ++ + +++ ++ ++ + 
  HAR24 ++ ++ + + ++ + + + 
  HAR38 +++ +++ ++ + +++ ++ ++ + 
  WIS ++ + + - + +/- +/- - 
  GRE14 +++ ++ + +/- + +/- - - 
  DEN114 +++ ++ + + ++ + + + 
MSSA, n=13 
  HSA29 ++ ++ + + + + +/- +/- 
  NCTC8325 +++ +++ ++ + +++ ++ ++ + 
  DCC403 +++ +++ ++ + ++ ++ + +/- 
  Draftees728 ++ ++ + + ++ ++ + + 
  IPOP33 +++ +++ ++ + +++ ++ + + 
  DCC192 ++ ++ + +/- ++ ++ + +/- 
  DCC750 ++ + + + +++ ++ + +/- 
  IPOP58 +++ ++ + +/- + + + +/- 
  Draftees721 +++ +++ ++ ++ + +/- +/- - 
  DCC1060 +++ +++ ++ + + ++ + + 
  IPOP34 +++ +++ ++ +/- ++ ++ + - 
  DCC457 +++ ++ + +/- ++ ++ + +/- 
  IPOP74 ++ + + +/- + + +/- +/- 
1Four different quantities of each chimerical endolysin were spotted on a dense cell lawn of each isolate, which was 
prepared by incorporating cells from exponentially growing cultures in a soft-agar, phosphate-buffered medium. Lytic 
action was scored (- to +++) according to the relative size and transparency of lysis halos after overnight incubation at 
37ºC. 
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Table S2.4. Non-Typed Clinical Isolates of Gram-Positive Pathogenic Cocci other than S. 
aureus 
 
Isolate ID   Clinical specimens 
Staphylococcus epidermidis, n= 10 
  1736/05 Catheter tip exudate 
  107/08 Wound exudates 
  114/08 Wound exudate 
  158/08 Central venous catheter exudate 
  546/06 Urine 
  111/07 Urine 
  921/05 Catheter 
  222/06 Blood  
  223/06 Blood  
  224/06 Blood  
Staphylococcus  haemolyticus, n= 9 
  1318/05 Sputum  
  1703/05 Sputum  
  1930/05 Catheter tip  
  05/06 Blood  
  06/06 Urine 
  761/06 Blood  
  1065/06 Blood  
  198/07 Sputum  
  110/08 Wound exudates 
Staphylococcus saprophyticus, n= 7 
  1847/05 Urine 
  1908/05 Urine 
  1909/05 Urine 
  1910/05 Urine 
  1911/05 Urine 
  424/07 Urine 
  123/09 Urine 
Enterococcus faecalis, n= 12 
    926/05 Blood culture 
    1518/05 Pus 
    1551/05 Urine 
    1558/05 Urine 
    43/06 Urine 
    44/06 Pus 
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Table S2.4 (continued) 
    46/06 Peritoneal pus 
    127/06 Urine 
    750/06 Blood culture 
    751/06 Blood culture 
    1113/06 Blood culture 
    563/07 Blood culture 
Enterococcus faecium, n=10 
    186/06 PR 
    187/06 PR 
    188/06 Blood culture 
    198/06 Bile 
    226/06 Urine 
    267/06 Anal swab 
    268/06 PR 
    269/06 Blood culture 
    389/06 Blood culture 
    74/07 Urine 
Streptococcus pyogenes, n=9 
  1332/05 Wound exudates 
  1749/05 Vaginal exudates 
  2110/05 Pharyngeal exudates 
  422/06 Blood  
  790/06 Pharyngeal exudates 
  1070/06 Blood  
  54/07 Pharyngeal exudates 
  12/08 Pharyngeal exudates 
  13/08 Pharyngeal exudates 
 
 
Table S2.5. Lytic Action of Lys168-87 and Lys170-87 Against Non-Typed Clinical Isolates 
of Gram-Positive Pathogenic Cocci other than S. aureus1  
Isolates and code ID Lys168-87 (μg) Lys170-87 (μg) 
10 5 1 0.2 10 5 1 0.2 
Staphylococcus epidermidis, n= 10 
  1736/05 ++ + - - + +/- - - 
  107/08 +++ ++ + +/- - - - - 
  114/08 ++ ++ + - +/- - - - 
  158/08 +++ +++ ++ + + + - - 
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Table S2.5 (continued) 
  546/06 +++ ++ + +/- ++ ++ +/- - 
  111/07 +++ ++ + - +++ + +/- - 
  921/05 ++ + +/- - + + +/- - 
  222/06 +/- + - - + - - - 
  223/06 + + +/- - + - - - 
  224/06 ++ + + +/- + + +/- - 
Staphylococcus haemolyticus, n= 9 
  1318/05 ++ + - - + +/- - - 
  1703/05 ++ ++ + +/- + +/- - - 
  1930/05 ++ ++ + + ++ + + - 
  05/06 +++ ++ ++ + + + + + 
  06/06 +++ ++ + + ++ ++ + +/- 
  761/06 + + + +/- ++ + + + 
  1065/06 + +/- - - +/- - - - 
  198/07 + + +/- - + + +/- - 
  110/08 ++ ++ + + ++ ++ + - 
Staphylococcus saprophyticus, n= 7 
  1847/05 +/- - - - + +/- - - 
  1908/05 - - - - - - - - 
  1909/05 ++ ++ + + ++ ++ + - 
  1910/05 ++ + + +/- + + +/- - 
  1911/05 + + + +/- + + +/ - 
  424/07 + + - - + +/- +/- - 
  123/09 +/- + +/- - + + +/- - 
Enterococcus faecalis, n= 12 
  926/05 ++ ++ + +/- +++ +++ ++ + 
  1518/05 +/- +/- - - ++ + +/- + 
  1551/05 + + +/- - ++ ++ + - 
  1558/05 ++ + + +/- +++ +++ ++ +/- 
  43/06 +/- - - - + +/- + + 
  44/06 ++ + + + +++ +++ + - 
  46/06 ++ ++ + +/- +++ +++ ++ + 
  127/06 + +/- +/- - +++ +++ ++ + 
  750/06 +/- - - - + - - - 
  751/06 - - - - - - - - 
  1113/06 + +/- +/- +/- ++ + +/- - 
  563/07 ++ + + +/- ++ + +/- - 
Enterococcus faecium, n=10 
  186/06 - - - - - - - - 
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Table S2.5 (continued) 
  187/06 + +/- - - + + - - 
  188/06 +/- - - - ++ + +/- - 
  198/06 + + +/- - ++ + +/- - 
  226/06 + + - - +++ ++ + - 
  267/06 + - - - + +/- - - 
  268/06 - - - - + - - - 
  269/06 + + - - ++ + + - 
  389/06 +/- - - - +/- +/- - - 
  74/07 + - - - ++ - - - 
Streptococcus  pyogenes, n=9 
  1332/05 + + + - + + + - 
  1749/05 + + +/- - + +/- - - 
  2110/05 ++ + +/- - ++ + +/- - 
  422/06 + + + - + + + - 
  790/06 + + +/- - +/- +/- - - 
  1070/06 + - - - + + + - 
  54/07 + +/- - - + - - - 
  12/08 + + +/- - ++ ++ + - 
  13/08 ++ + - - + +/- - - 
1Four different quantities of each chimerical endolysin were spotted on a dense cell lawn of each isolate, which was 
prepared by incorporating cells from exponentially growing cultures in a soft-agar, phosphate-buffered medium. Lytic 
action was scored (- to +++) according to the relative size and transparency of lysis halos after overnight incubation at 
37ºC. 
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Abstract 
 
Double-strand DNA bacteriophages employ the holin-endolysin dyad as core components 
of different strategies to lyse bacterial hosts. In the so-called canonical model the holin 
holes play an essential role in lysis as they provide a conduit for passage of the cytoplasm-
accumulated endolysin to the cell wall (CW), where it degrades the peptidoglycan. It is 
considered that once synthesized canonical endolysins immediately acquire their fully 
active conformation, having thus the capacity to efficiently cleave the peptidoglycan if 
contact to the CW is allowed. We show here however that holin-mediated cell death may 
be required to fully sensitize cells to the lytic action of canonical endolysins, a role that 
is obviously masked by the key function of the holin in endolysin release. We demonstrate 
that in certain conditions Bacillus subtilis cells are capable of counteracting the activity 
of the phage SPP1 endolysin attacking the CW either from within or from without. This 
capacity is lost after holin action or in presence of agents that mimic its membrane-
depolarizing role. We have observed a similar relationship between lytic activity and 
membrane proton motive force for a staphylococcal endolysin. The possible implications 
of these findings in the exploitation of endolysins as enzybiotics are discussed. 
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3.1 Introduction 
 
The precise regulation of host cell lysis is a key factor during phage infection. Delayed 
lyses can compromise the opportunity to infect new hosts whereas a premature burst 
results in the release of none or very few descendants (Wang et al., 2000). Phages with 
double-stranded DNA (dsDNA) genome evolved a strategy to swiftly lyse infected 
bacteria at the appropriate time for virion progeny release. This strategy relies on the 
concerted action of two fundamental phage-encoded proteins, an endolysin and a holin 
(Catalão et al., 2013; Young, 2014). Endolysins are designed to cleave the peptidoglycan, 
the main component of bacterial cell wall (CW), and these enzymes are instrumental for 
phages to achieve rapid and effective bacteriolysis (Young et al., 2000; São-José et al., 
2003; Loessner et al., 2005). Holins are hydrophobic proteins that oligomerize in the host 
cell cytoplasmic membrane (CM) during the course of infection. At a genetically-
programmed time holins trigger to form holes that collapse the membrane proton motive 
force (pmf), leading to immediate growth cessation and cell death (Gründling et al., 2001, 
Young, 2013). In the canonical lysis model, represented by the Escherichia coli phage , 
these holes must be large enough to allow passage of the cytoplasm-accumulated 
endolysin to the CW, an essential requirement for cell lysis (Young, 2002, 2014). Hole 
formation by canonical holins establishes therefore the onset of cell lysis by providing a 
pathway for endolysin access to the CW (Wang et al., 2000; Young et al., 2000).  
 
In the last years different non-canonical lysis systems have been described where 
endolysins are exported to the CW compartment in a holin-independent way. For most of 
the studied examples, endolysin export was shown to rely on the host general secretion 
pathway (the Sec system), which starts to secrete the lytic enzyme to the CW very early 
during the viral reproductive cycle. These are the cases of phages fOg44 from 
Oenococcus oeni and P1 from E. coli, which produce endolysins endowed with a typical 
Sec-type signal peptide (SP) and a “signal-anchor-release” (SAR) domain, respectively 
(São-José et al., 2000; Xu et al., 2004; Young, 2014), and of the mycobacteriophage Ms6 
amidase whose Sec-mediated secretion depends on the activity of a phage-encoded 
chaperone (Catalão et al., 2010). As an alternative to the Sec pathway, endolysins might 
be able to bind precursors of wall secondary polymers while in the cytoplasm and be co-
transported during their incorporation in the CW. This seems to be the case of the 
endolysin of Streptococcus pneumoniae phage SV1, whose translocation to the CW was 
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proposed to be coupled to the synthesis and transport of choline-containing teichoic acids 
(Frias et al., 2013). 
 
A key aspect of all studied phages exhibiting non-canonical release of endolysins is that 
they still produce holin-like proteins (Schmidt et al., 1996; São-José et al., 2004a; Frias 
et al., 2009; Catalão et al., 2011), a function that could be considered dispensable at first 
glance. However, it rapidly became clear that in these systems activity of the exported 
endolysins (e-endolysins) needs to be restrained to avoid premature lysis and it was found 
that mechanisms depending on an energized CM were responsible for counteracting the 
lytic action of these enzymes. In fact, in these systems holins still maintain the key role 
of defining the proper time for lysis thanks to their scheduled pmf-dissipating action, 
which directly or indirectly relieves the mechanisms restraining lytic activity of e-
endolysins (Xu et al., 2004, 2005; Nascimento et al., 2008; Sun et al., 2009; Catalão et 
al., 2010; Frias et al., 2013). As previously anticipated (São-José et al., 2000), it was 
shown that the lethal character of the holin function can also result in the recruitment of 
host bacteria autolysins, which together with e-endolysins bring about fast and efficient 
lysis (Frias et al., 2009, 2013). 
 
With exception of the motifs required for export, e-endolysins, canonical endolysins (c-
endolysins) and autolysins can be highly related regarding primary sequence and 
functional domains (São-José et al., 2000, 2003; López et al., 2004; Oliveira et al., 2013), 
being the relationship between membrane pmf and lytic activity well documented for 
most autolysins (Rice and Bayles, 2008 and references therein, Biswas et al., 2012; Lamsa 
et al., 2012). Most importantly, regardless the type of lysis strategy used by dsDNA 
phages, one rule seems to have been conserved: endolysins do not act (or act very poorly) 
until infected cells are first killed by the holin function. Having all this in mind, and 
considering our recent observations that bacteria actively growing in rich media are able 
to counteract the lytic action of externally-added c-endolysins (Proença et al., 2015, and 
unpublished results), we raised the possibility that holins may have an additional role in 
canonical lysis, that is, that of sensitizing bacteria to the lytic action of c-endolysins. This 
putative function would be camouflaged by the essential role of holin holes, which 
provide the necessary conduit for c-endolysin release to the CW. 
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In this work we used the lysis system of B. subtilis phage SPP1, which encodes a c-
endolysin, to study how conditions depressing or supporting the pmf affected lysis 
promoted by the endolysin reaching the CW either from the cell inside (lysis from within) 
or outwardly (lysis from without). The ability of a known staphylococcal c-endolysin to 
induced lysis from without was similarly studied. The results support a general and 
important function of holins in sensitizing host bacteria to the lytic action of endolysins, 
irrespective of the lysis mechanism. 
 
3.2 Results 
 
3.2.1   Actively growing B. subtilis cells can resist to the lytic action of secreted 
SPP1 endolysin  
 
The gene encoding the SPP1 endolysin has been assigned to orf 25 (Alonso et al., 1997). 
The deduced gp25, here called LysSPP1 harbors a putative amidase catalytic domain in 
its N-terminal region and a putative SH3_3 cell binding domain in its C-terminus (Nelson 
et al. 2012, Oliveira et al., 2013) (Fig. S3.1). LysSPP1 is predicted to be a canonical 
endolysin as it has no recognizable export signal that could enable its translocation to the 
bacterial CW (see below for results supporting this prediction). Thus, its transport to the 
CW must rely on the SPP1 holin function, which should be encoded by the flanking holin-
like genes 24.1 and/or 26 (see below and Fig. S3.1). 
 
The current view is that canonical endolysins accumulate in the cytoplasm in its active 
form, being capable of displaying lytic activity once access to the CW is provided. 
However, considering the hypothesis of the holin lethal function being a general 
requirement to turn host cells fully susceptible to the lytic action of endolysins, we 
wondered how B. subtilis growth would be affected by the intracellular production of 
LysSPP1 and its immediate translocation to the CW. To test this, we replaced the start 
codon of gene 25 by the coding sequence of the cleavable, Sec-type signal peptide (SP) 
of B. subtilis bacillopeptidase F (also known as Bpr, Sloma et al., 1990; Tjalsma and van 
Dijl, 2005). The SP of Bpr, which corresponds to the first 32 amino acid residues of the 
enzyme, was previously shown to promote efficient secretion of heterologous proteins 
(Brockmeier et al., 2006). The recombinant gene of the artificial e-endolysin thus 
generated (SP-LysSPP1) was then cloned in a replicative plasmid under the control of an 
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IPTG-inducible promoter and of the native translation signals of bpr. SP-LysSPP1 was 
also tagged with a hexahistidine C-terminal tail to follow its production by western blot 
(see methods). A similar construct producing and accumulating the native LysSPP1 in 
the cytoplasm was used as control. 
 
Growth of B. subtilis cells carrying either the recombinant plasmids or the empty 
expression vector was indistinctive until mid-exponential phase, after which protein 
synthesis was induced by adding IPTG (time point t = 160 min in Fig. 3.1A). Remarkably, 
growth of the three cultures was not perturbed for at least 40 min after induction, with the 
cell density doubling within this period, which indicated that synthesis and Sec-mediated 
translocation of the potentially lethal endolysin to the CW had no obvious negative impact 
on actively growing B. subtilis cells. Cultures producing SP-LysSPP1 reached 
nevertheless stationary growth phase somewhat earlier than the other two (Fig. 3.1A), but 
no lysis was detected even after prolonged incubation (not shown). 
 
The production of LysSPP1 and of SP-LysSPP1 precursor and mature forms 40 min after 
induction was confirmed by western blot analysis (Fig. 3.1B and C). The cytoplasmic 
LysSPP1 and the processed SP-LysSPP1 polypeptide seemed to accumulate at similar 
levels. However, the latter protein displayed a slightly retarded electrophoretic mobility 
when compared to the native endolysin. Resequencing of the constructs revealed a point 
mutation in the plasmid-encoded synthetic linker that connected the endolysin moiety to 
the hexahistidine tail in SP-LysSPP1. As result, the linker in SP-LysSPP1 had the amino 
acid sequence PGGDS, whereas in LysSPP1 it had the expected PGGGS sequence. 
Although not impairing enzyme activity (see below), this substitution might be 
responsible for the slightly different migrations of the processed SP-LysSPP1 and 
LysSPP1.  
 
The extracytoplasmic localization and lytic character of the processed form of SP-
LysSPP1 was readily evidenced when half of the 40-min-induced cultures was treated 
with gramicidin D (“G” in Fig. 3.1A). Gramicidin D is an ionophore that dissipates the 
electrical and pH gradients of the pmf. It inserts in the CM and forms small-sized channels 
that are only permeable to monovalent cations such as K+, Na+ and H+ (Harold, 1972; 
Jolliffe et al., 1981; Kelkar and Chattopadhyay, 2007). In this, as well as in the assays 
described below, the gramicidin concentration and growth conditions allowed the drug to 
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exert its pmf-dissipating action without causing significant autolysis during the course of 
the experiments. As expected, addition of gramicidin to the three cultures led to 
immediate growth interruption. However, rapid and extensive cell lysis could only be 
observed in the cultures producing SP-LysSPP1, which was a strong indication that the 
endolysin was secreted and accumulated extracellularly. Actively growing cells 
synthesizing either LysSPP1 or SP-LysSSP1 did not release detectable amounts of 
endolysin polypeptides to culture supernatant (Fig. S3.2). This suggested tight association 
of the SP-LysSPP1 mature form with the CW after translocation and SP removal (see 
below). The fact that addition of the ionophore to cultures synthesizing LysSPP1 resulted 
in none or very poor lysis supported the canonical character of the SPP1 endolysin. 
Interestingly, stopping the aeration of cultures that accumulated SP-LysSPP1 was 
sufficient to evoke lysis, although not as efficiently as with gramicidin (Fig. S3.3). 
 
 
Fig. 3.1. Production of the phage SPP1 endolysin in B. subtilis and effect on cell growth. (A). 
Exponentially growing cells harboring the empty expression vector (Control) or derivatives 
producing LysSPP1 (Lys) or SP-LysSPP1 (SP-Lys) were IPTG-induced at the indicated time and 
growth followed until late exponential phase. At this point, gramicidin (G) was added to half of 
the cultures (filled symbols) and cultures optical density at 600 nm (OD600nm) followed for 60 min. 
Each curve is the average of at least three independent assays. (B). Coomassie blue-stained, SDS-
PAGE gel analyzing equal amounts of total protein extracts produced from cultures described in 
panel A at time point t = 200 min (before gramicidin addition), in absence (-) or presence of IPTG 
(+). The molecular weight of bands composing the protein ladder (L) is indicated on the left side. 
(C). Detection by western blot analysis of the SPP1 endolysin polypeptides in the protein extracts 
described in panel B, using anti-His6 specific antibodies. Note the production of precursor (p) and 
mature (m) forms in the cultures producing SP-LysSPP1 (SP-Lys).  
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In conclusion, the results showed that as long as B. subtilis cells are maintained in an 
energized state they can cope with secretion to the CW of the potentially lethal SPP1 
endolysin. With pmf dissipation, cells become susceptible to the lytic action of the 
enzyme.  
 
3.2.2   LySPP1-mediated lysis from without is enhanced in conditions leading to 
CM depolarization 
 
We asked next if the B. subtilis cell energy state could also affect susceptibility to 
LysSPP1 lytic action when the endolysin reaches the CW from the outside (from without). 
LysSPP1 was overproduced in E. coli with its C-terminus fused to a His6 tag and 
subsequently purified by affinity chromatography (see methods and Fig. S3.4A). B. 
subtilis cells at mid-exponential growth phase were two-fold concentrated in fresh LB 
medium and two sample sets were prepared in spectrophotometer cells. One set was 
supplemented with gramicidin while the other received the ionophore solvent. After 10 
min equilibration, cells from both sets were challenged with different concentrations of 
purified LysSPP1 (ranging from 0.5 to 10 µg/ml) and lysis monitored under static 
conditions by following the optical density (OD600nm) of cell suspensions. 
 
In absence of the ionophore the lowest LysSPP1 concentrations (0.5 and 1 µg/ml) failed 
to elicit any measurable cell lysis during the time course of the assays (Fig. 3.2A), despite 
efficient endolysin binding to cells in these conditions (Fig. S3.5). Cell lysis could be 
detected for the remaining endolysin concentrations (2.5, 5 and 10 µg/ml), with the rate 
and extent of OD600nm decrease correlating with the enzyme concentration. Interestingly, 
in analogous experiments with cultures maintained under permanent shaking cells 
revealed to be much more resistant to lysis (see below). When cells were treated with 
gramicidin before LysSPP1 addition, the three highest endolysin concentrations produced 
fastest and more extensive lysis and the enzyme dose effect became less obvious (Fig. 
3.2B). Most importantly, lysis could also be detected for the two lowest LysSPP1 
concentrations. 
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Fig. 3.2. B. subtilis lysis from without under pmf-supporting and pmf-dissipating conditions. 
(A) and (B). Cells from exponentially-growing cultures were recovered in fresh LB medium in 
absence (A) or presence (B) of gramicidin (“G” in panel B). After 10 min equilibration, cells were 
challenged with LysSPP1 (Lys) at the indicated concentrations (µg/ml) and lysis monitored under 
static conditions. Controls with cells only (“Control” curves) or with cells plus gramicidin (“G” 
curve) were similarly prepared. Each curve is the average of at least three independent assays. 
For clarity, error bars were omitted. (C) and (D). Exponentially-growing cells were collected in 
minimal medium with (C) or without (D) energy sources. After 10 min equilibration, cells were 
challenged with LysSPP1 and lysis monitored as described above. Controls with cells only 
(“Control” curves) were similarly prepared. Each curve is the average of at least three independent 
assays. Error bars were omitted for clarity. 
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Bacterial sensitization to lysis upon gramicidin treatment could result from a specific 
effect of this ionophore or be a general response to any stress causing dissipation of the 
membrane potential. To test if other conditions compromising pmf resulted also in lysis 
enhancement, cell suspensions were prepared as above but using minimal medium with 
or without energy sources, instead of LB medium (see methods). After 10 min 
equilibration, LysSPP1 was added as described above and lysis monitored over time. In 
presence of energy sources, lysis profiles for the different endolysin concentrations were 
similar to those observed in complex medium in absence of gramicidin (Fig. 3.2A and 
C). On the other hand, in the condition leading to collapse of the pmf (no energy sources), 
lysis was akin to that registered in presence of gramicidin (Fig. 3.2B and D). We should 
also note that nisin, a lantibiotic that induces pore formation in the CM with concomitant 
membrane depolarization (Hasper et al., 2004; Tol et al., 2015) behaved essentially as 
gramicidin in promoting lysis from without by LysSPP1 (data not shown). 
 
Overall, the results indicated that conditions leading to dissipation of the membrane pmf 
render cells more susceptible to lysis from without. 
 
3.2.3   LySPP1 concentration requirements in lysis from within and from 
without 
 
Results from the previous sections suggested that B. subtilis lysis by LysSPP1 in absence 
of the holin function, or of agents mimicking its pmf-dissipating action, could require 
significantly higher amounts of the enzyme. In order to have an estimation of the 
endolysin quantities operating in the context of SPP1 infection we constructed a mutant 
phage producing LysSPP1 fused to a hexahistidine tag (SPP1g25His, see methods). 
Phage SPP1g25His plated with normal plaque morphology and lysed B. subtilis liquid 
cultures within the expected time, indicating that the phage growth parameters were not 
significantly affected (not shown). 
 
B. subtilis cultures infected with the mutant phage at mid-exponential growth phase 
(OD600nm = 0.3-0.4) started to lyse at an OD600nm of about 0.8 (Fig. 3.3A), which was the 
cell density set for the lysis assays described previously (Figs 3.1A and 3.2). As showed 
above, lysis of B. subtilis cells producing SP-LysSPP1 could be elicited by adding 
gramicidin (“SP-Lys + G” curve in Fig. 3.1A). The superimposition of the lysis curve 
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obtained in presence of the ionophore with that resulting from SPP1g25His infection 
suggested comparable lysis kinetics in both conditions (Fig. 3.3A). 
 
Western blot analysis indicated that immediately before lysis onset, LysSPP1 content of 
infected cells was slightly lower than the amount detected in cells producing SP-LysSPP1 
from the recombinant plasmid (Fig. 3.3B and C). To estimate the level of endolysin 
production in these two scenarios of lysis from within, the intensities of the corresponding 
LysSPP1 bands and that of bands resulting from known quantities of purified endolysin 
(Fig. 3.3B and C) were analyzed by densitometry. After correcting for the cell 
concentration factor inherent to the production of protein extracts (50-fold), we estimated 
about 0.3 and 0.4 µg of LysSPP1 produced per milliliter of culture lysed from within after 
SPP1g25His infection and after production of SP-LysSPP1, respectively. To lyse from 
without exponentially growing cultures with identical cell densities, under the same 
aerated conditions, we needed to add 30 µg/ml of LysSPP1 to the cultures (Fig. 3.3A). 
This concentration could be reduced 60-fold in presence of gramicidin (Fig. 3.3A), in 
agreement with the results reported above. 
Although factors like enzyme local concentration probably facilitate lysis from within in 
the two scenarios studied here (SPP1g25His infection and SP-LysSPP1 in presence of 
gramicidin), the results strongly suggest that cells with dissipated pmf require much lower 
endolysin amounts for lysis, both from within or from without. Therefore, it is most likely 
that in the context of phage infection the holin action results in a stimulation of endolysin 
activity, in addition to its essential role in releasing the lytic enzyme to the CW  
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Fig. 3.3. LysSPP1 quantities in lysis from within and from without. (A). Representative lysis 
curve of a B. subtilis culture infected with phage SPP1g25His (“Lys phage” curve). The culture 
was infected at the indicated time point (P) and immediately before lysis onset (t = 180 min) a 
sample was collected for endolysin detection by western blot (panels B and C). For lysis profile 
comparison, 3 curves (dashed lines) were overlaid on that of infected cells using as reference the 
time point just before lysis start: the curve “SP-Lys + G” from Fig. 3.1A and two curves of lysis 
from without obtained after treating cells with gramicidin plus 0.5 µg/ml LysSPP1 (G + Lys 0.5) 
or with 30 µg/ml LysSPP1 only (Lys 30). Note that here lysis from without occurred under aerated 
conditions. The indicated endolysin concentrations for the “Lys phage” and “SP-Lys + G” curves 
(0.3 and 0.4 µg/ml, respectively) are rough estimations based on densitometry analysis of 
endolysin bands of panel C.  (B). Coomassie blue-stained, SDS-PAGE gel of total protein extracts 
prepared from the SPP1g25His-infected culture (Lys phage) and from cultures producing SP-
LysSPP1 (SP-Lys) or LysSPP1 (Lys) (see Fig. 3.1). The 3 extracts were produced from culture 
samples collected immediately before lysis onset (OD600nm 0.8) and after 50-fold cell 
concentration. Ten microliters of these extracts and of preparations of purified LysSPP1 at the 
indicated concentrations (right side of the protein ladder, L) were run in parallel. The molecular 
weight of bands composing the protein ladder is indicated on the left side. (C). Detection of 
LysSPP1 polypeptides in the protein samples described in panel B using anti-His6 specific 
antibodies. Note that the endolysin bands in lanes “SP-lys”, “Lys” and “Lys phage” are detected 
in extracts prepared from 50-fold-concentrated cell suspensions. 
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3.2.4 Expression of SPP1 holin-like genes in B. subtilis increases cell 
susceptibility to LysSPP1 
 
Lysis enhancement by gramicidin (see above) was interpreted as the ionophore being able 
to mimic the pmf-dissipating action of the SPP1 holin function, resulting somehow in 
increased susceptibility of the depolarized B. subtilis cells to LysSPP1. To have a more 
direct link between holin action and sensitization to endolysin-mediated lysis, we wanted 
to study how expression of the SPP1 holin function in B. subtilis affected its capacity to 
counteract LysSPP1 attack. In the annotated SPP1 genome sequence the holin function is 
predicted to be encoded by orf 26, which follows immediately downstream of the 
endolysin gene (Alonso et al., 1997 and Fig. S3.1). However, as noticed previously 
(Catalão et al., 2013) the gene product of orf 24.1, which lays immediately upstream of 
the endolysin-holin pair also has holin-like features. In fact, gp24.1 and gp26 share 
sequence homology and overall predicted membrane topology with the holin-like proteins 
XlhA and XhlB, respectively, which together with the amidase XlyA constitute the lysis 
cassette of the B. subtilis defective prophage PBSX (Fig. S3.1). Krogh et al. (1998) 
observed that expression in B. subtilis of either XhlA or XhlB in pairwise combinations 
with the XlyA did not result in the expected host cell lysis phenotype. This was only 
observed when the three genes were co-expressed, leading the authors to propose that in 
PBSX the holin “functional unit” allowing endolysin release is most probably a 
membrane complex made of XhlA and XhlB. 
 
A hallmark of the holin function is its ability to convert into lethal holes after reaching a 
critical concentration in the membrane (Young, 2013). We cloned in a replicative plasmid 
the SPP1 holin-like genes 24.1 and 26 as a transcriptional fusion, under the control of a 
xylose-inducible promoter (see methods). B. subtilis cells carrying the transcriptional 
fusion presented delayed growth when compared to cells harboring the empty expression 
vector and 10 min xylose-induction was sufficient to cause almost 2-log reduction of cell 
viability (3 x 107 and 6 x 105 cfu/ml immediately before and after induction, 
respectively). We are currently studying the contribution of each gene to the observed 
lethal phenotype, but the available results suggest that the SPP1 holin function likely 
requires the concerted action of the two holin-like proteins, as observed for PBSX.  
In agreement with our hypothesis, cells killed by the SPP1 holin(s) were rapidly and 
extensively lysed from without with as low as 0.5 µg/ml of purified LysSPP1 (Fig. 3.4A), 
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a protein concentration that caused no measurable lysis of healthy bacteria in analogous 
conditions (Fig. 3.2A). Yet, the same amount of endolysin slightly lysed control cultures 
that were not induced for holin expression (Fig. 3.4A). This suggested leaky expression 
of 24.1-26 in absence of xylose, something that fitted also the already mentioned delayed 
growth of the cultures in absence of the inducer. Somewhat unexpectedly, 10 min 
induction of 24.1-26 expression was sufficient to support significant cell lysis in absence 
of the endolysin after transferring cultures to static conditions (Fig. 3.4A). In contrast to 
previous assays with gramicidin (Fig. 3.2B), here the holin action seemed to rapidly 
activate the B. subtilis autolytic machinery (Jolliffe et al., 1981; Kemper et al., 1993; 
Lamsa et al., 2012). This was confirmed when we performed the same experiment in a B. 
subtilis background deleted of the major autolysin LytC (Kuroda and Sekiguchi, 1991; 
Blackman et al., 1998). In these new conditions the sole expression of 24.1-26 did not 
induce significant lysis (Fig. 3.4B), although it still resulted in cell death (confirmed by 
the decrease of viable cell counts, data not shown). As expected, these killed cells were 
susceptible to lysis with 0.5 µg/ml of LysSPP1 in contrast to control cell suspensions 
(non-induced cultures treated with the same endolysin concentration) (Fig. 3.4B). We 
have tried also to study the effect of 24.1-26 expression during lysis from within, that is, 
in cells producing either SP-LysSPP1 or LysSPP1. However, we were unable to stably 
maintain the constructs expressing both the endolysin and holin genes within the same B. 
subtilis cell, probably due leaky transcription in absence of the inducers. 
 
In conclusion, the results confirmed that B. subtilis cells killed by the SPP1 holin function 
lose the capacity to restrain LysSPP1 lysis from without. In addition, holin-induced CM 
depolarization seems to recruit host cell autolytic enzymes that contribute to lysis. A 
similar observation was previously reported for the holin of the pneumococcal phage SV1 
(Frias et al., 2009, 2013). 
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Fig. 3.4. Effect of holin activity on B. subtilis susceptibility to LysSPP1 endolysin. (A). Cells 
carrying a transcriptional fusion of the SPP1 holin-like genes 24.1 and 26 (24.1-26) under control 
of a xylose-inducible promoter were grown until exponential growth phase and the culture split 
in two halves. One half was induced for 10 min with xylose (xyl) after which 0.5 µg/ml of 
LysSPP1 (Lys) were added (filled symbols). The optical density of cell suspensions was then 
followed for 60 min in static conditions. Controls consisted of non-induced cultures added of the 
same concentration of LysSPP1 and of induced cultures added of the equivalent volume of 
endolysin buffer. Each curve is the average of at least three independent assays. (B). Same assay 
as in panel A except that carried out in a B. subtilis lytC genetic background.  
 
3.2.5   Lytic action of the staphylococcal 11 endolysin is drastically incremented 
in gramicidin-treated cells 
 
Finally, we wanted to see if the increased sensitivity of B. subtilis cells to endolysin-
mediated lysis promoted by gramicidin could be extended to other Gram-positive 
bacteria. Multidrug-resistant S. aureus is a widely known pathogen whose infections are 
becoming increasingly difficult to treat, and endolysins from staphylococcal phages have 
been proposed as potential therapeutic alternatives to fight this bacterium (Schmelcher et 
al., 2015). One such endolysin is that of phage 11, a two-catalytic domain enzyme 
displaying endopeptidase and amidase activities (Navarre et al., 1999, Sass and 
Bierbaum, 2007). 
 
As for LysSPP1, we purified the 11 endolysin (here called Lys11) as a hexahistidine-
tagged protein (Fig. S3.4B) and tested its lytic action against S. aureus. Cells from mid-
exponential growth phase were collected in half volume of fresh culture medium and 
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challenged with 20 μg/ml of Lys11, either in absence or presence of gramicidin. Lysis 
was followed under static or aerated conditions. Standing cell suspensions suffered some 
lysis (less than 50% decrease of the initial OD600nm), which could be greatly increased if 
cells were first treated with gramicidin (Fig. 3.5A). This followed therefore the same lysis 
pattern observed for LysSPP1 (Fig. 3.2A and B). Remarkably however, if S. aureus 
cultures were kept under permanent agitation in absence of gramicidin they were 
completely resistant to Lys11 attack and quickly resumed growth (Fig. 3.5B). Under 
aerated conditions Lys11-mediated lysis was thefore dependent on pre-treatment of target 
cells with the ionophore (Fig. 3.5B). 
 
 
Fig. 3.5. Lysis of S. aureus by the 11 endolysin under pmf-supporting and pmf-dissipating 
conditions. (A). Cells from exponentially-growing cultures were recovered in fresh TSB medium 
in absence or presence of gramicidin (G). After 10 min equilibration, cells were treated with 20 
µg/ml of the endolysin (Lys11, filled symbols) and lysis monitored under static conditions. 
Controls with cells only (“Control” curve) or with cells plus gramicidin (“G” curve) were 
similarly prepared. Each curve is the average of at least three independent assays. (B) Same as in 
panel A except that performed under aerated conditions. 
 
We concluded therefore that the lytic action of different endolysins can be facilitated 
when the pmf of target cells is first dissipated. In addition, the level of “resistance” to 
lysis of actively growing, fully energized cells may vary according to the 
bacterium/endolysin pair. 
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3.3 Discussion 
 
Phage holins are commonly described has having two major roles in canonical lysis: i) to 
define the end of phage infection by killing host cells through membrane hole formation, 
and ii) allow escape of the cytosol-accumulated endolysins through these holes for CW 
degradation. These two interconnected functions define the timing of cell lysis. In this 
work we present several evidences supporting that holin activity can have an additional 
important role in canonical lysis, which is to sensitize cells to the lytic action of 
endolysins. Naturally, this role is concealed by the essential function of holins in releasing 
c-endolysins to the CW. We showed that B. subtilis cells could grow almost normally 
when secreting to the CW the phage SPP1 c-endolysin, which was equipped with a host 
cell Sec-type SP for that purpose. The exported, processed form of the enzyme 
accumulated to similar or even higher levels than those observed for the native c-
endolysin during phage infection, indicating that the secreted enzyme remained in an 
“inactive” state after translocation and SP removal. Addition of a pmf-dissipating agent 
immediately elicited endolysin activity and cell lysis, in striking similarity to the general 
lysis features of known e-endolysins. These results seem to challenge the accepted view 
that c-endolysins are designed to instantly degrade the peptidoglycan no matter the 
pathway followed to reach the CW. In other words, our results indicate that activity of c-
endolysins can be restrained by other means besides their physical separation from the 
CW, imposed by the cytoplasmic membrane, as postulated by the canonical lysis model. 
 
We did not rule out the possibility that secretion guided the endolysin to particular regions 
on the CW where its activity could be tightly controlled. This would provide an alternative 
explanation to our results, assuming that this preferential localization and/or control 
cannot occur when c-endolysins are released to the CW through the holin holes. However, 
we showed that dissipating the membrane pmf by different means increased also cell 
susceptibility to the c-endolysins added from without. This suggests that mechanisms 
restraining endolysin activity are generally operating in the CW as long as the cell pmf is 
maintained. Since the simple membrane de-energization by nutrient exhaustion or by 
permeation to small ions was sufficient to increase c-endolysin activity, we concluded 
that it is the holin pmf-dissipating action that boosts enzyme activity, and not its ability 
to promote the release of eventual cytoplasmic factors activating endolysins. It was 
previously shown for at least two other predicted c-endolysins that treatment of target 
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cells with the pore-forming lantibiotic nisin resulted in a drastic enhancement of lytic 
activity (García et al., 2010, Proença et al., 2015).  
 
Triggering of lytic activity upon holin-inflicted CM damage is well established for the e-
endolysins with SAR export signal and for the putative amidase of S. pneumoniaee phage 
SV1, an e-endolysin which is believed to be translocated to the CW along with choline-
containing teichoic acids (Frias et al., 2013). In the former case, e-endolysins are exported 
by the host cell Sec system but the SAR sequence retains them in the periplasm as inactive 
forms tethered to the CM. Dissipation of the pmf after holin trigger releases the N-
terminal SAR domain from the CM, which is followed by conformational and/or 
intramolecular chemical changes that generate the active, soluble forms of the endolysins 
in the periplasm (Xu et al., 2004, 2005, Sun et al., 2009; Kuty et al., 2010). 
 
For the SV1 amidase and the e-endolysins known to be secreted by the Sec system in 
Gram-positive and mycobacterial systems (São-José et al., 2000; Catalão et al., 2010) it 
is still unknown how the observed or assumed holin action leads to endolysin activation. 
What seems clear is that the mechanisms restraining e-endolysin activity are abolished 
upon dissipation of the host cell membrane pmf. For this reason, it has been speculated 
(São-José et al., 2000; Nascimento et al., 2008; Catalão et al., 2010; Frias et al., 2013) 
that e-endolysin activity on the CW could be controlled by the same processes that 
regulate bacterial endogenous peptidoglycan hydrolases, some of which (autolysins) are 
well-known for lysing bacteria in response to conditions that collapse the pmf (Jolliffe et 
al., 1981; Kemper et al., 1983; Moreillon et al., 1990; Bayles, 2000; Martínez-Cuesta et 
al., 2000; Lamsa et al., 2012). The exact mechanisms modulating autolysin activity, and 
which probably regulate the abovementioned e-endolysins and the c-endolysins studied 
here, are poorly understood. Several studies though have implicated the level of 
protonation (pH) of the CW compartment, which is directly linked to the pmf, and its 
possible effects on the conformation, distribution and/or chemical composition of 
secondary CW polymers in such regulation (Calamita et al., 2001; Neuhaus and Baddiley, 
2003; Rice and Bayles 2008; Biswas et al., 2012). 
 
As already mentioned, the results suggest that under pmf-supporting conditions bacteria 
may counteract the activity of some c-endolysins, likely by the same mechanisms that 
regulate autolysin and e-endolysin activities. This is somewhat expected if we consider 
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the evolutionary relationship between phage endolysins and host cell peptidoglycan 
hydrolases (São-José et al., 2000, 2003; López et al., 2004; Oliveira et al., 2013). The 
rule “holins (or other pmf-dissipating agents) first kill and only then cell lysis occurs” is 
common to c- and e-endolysin-mediated lysis and also to different autolysis phenomena. 
It appears thus that a great number of peptidoglycan hydrolases have evolved to be fully 
effective only against energy-depleted bacteria. Theoretically, lysis of phage-infected 
cells can result in the release of endolysins to the surrounding medium, which might be 
harmful to neighbour bacteria lacking an external membrane. If these bacteria are 
potential hosts for new rounds of infection, it can be advantageous to phages that the pmf-
dependent mechanisms controlling lytic activity can also operate against c-endolysins 
reaching the CW from without. 
 
Phage endolysins have been extensively explored as potential antimicrobial agents to 
fight antibiotic resistant Gram-positive pathogens (for reviews see Nelson et al., 2012; 
Schmelcher et al., 2012; Pastagia et al., 2013). The underlying idea is that these enzymes 
should be able to efficiently lyse viable bacteria when added exogenously in the form of 
purified proteins. In apparent conflict with the ideas conveyed here, a great number of in 
vitro studies (fewer in vivo), including some emanating from our group (Fernandes et al., 
2012; Proença et al., 2012) seem to support the lytic efficacy of endolysins added 
externally to Gram-positive bacteria. However, a large number of these studies have been 
performed in conditions that do not support bacterial growth, i.e., before endolysin 
challenge cells are typically washed and suspended in nutrient-depleted, buffered 
solutions which are unable to sustain normal pmf. Still, although our study shows that the 
lytic efficacy of c-endolysins can be dramatically improved upon pmf dissipation, it also 
suggests that the capacity and limits of energized cells to counteract endolysin attack may 
vary depending on growth conditions and on the particular bacterium/endolysin pair. This 
should account for those examples where c-endolysins proved effective in vitro against 
bacteria in growth-promoting conditions and in vivo (for reviews see Nelson et al., 2012; 
Pastagia et al., 2013). The take home message is that when exploring endolysins as 
enzybiotics one should be aware that their killing efficacy may be significantly affected 
by the energetic state of target cells.  
 
In summary, our findings indicate that “activation” of endolysin lytic activity as result of 
the holin action may be a general feature in bacterial lysis mediated by dsDNA phages, 
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independently of the pathway used to deliver the lytic enzyme to the CW. As suggested 
recently (Proença et al., 2015), this should be taken in consideration as it may be 
necessary to choose or engineer endolysins that can bypass this holin sensitization 
requirement, and thus achieve maximal killing efficacy. 
 
3.4 Materials and methods 
 
3.4.1   Bacterial strains, phages and growth conditions 
 
Bacterial strains and phages used in this study are indicated in Table S3.1. B. subtilis and 
E. coli were routinely grown in LB medium (Sambrook and Russell, 2001) with orbital 
shaking (220 rpm), whereas S. aureus was propagated in tryptic soy broth (TSB), also 
with aeration. Culture media components were purchased from Biokar Diagnostics, 
France. B. subtilis was pre-cultured overnight (ON) at 30ºC, whereas ON growth of E. 
coli cloning strains and S. aureus was at 37ºC. New cultures were initiated by diluting 
pre-cultures 100-fold in fresh media. For details on the growth conditions of the E. coli 
expression strain CG61 (São-José et al., 2000) and its derivatives see below. When 
selecting for DNA constructs, LB medium was supplemented with appropriate antibiotics 
such as ampicillin (100 µg/ml), kanamycin (40 µg/ml) or chloramphenicol (20 µg/ml) for 
E. coli strains, and kanamycin (20 µg/ml), neomycin (7.5 µg/ml), chloramphenicol (5 
µg/ml) and erythromycin (0.5 µg/ml) for B. subtilis strains. Bacterial growth was 
monitored by taking OD600nm measurements at regular intervals. SPP1 phages were 
propagated in B. subtilis strain YB886 as described previously (Jakutytè et al., 2011). 
When indicated, YB886 cultures at an OD600nm of 0.4 (5.0 x 107 cfu/ml) were infected 
with phages at an input multiplicity of 10. 
 
3.4.2   General DNA techniques  
 
Plasmids and primers used in this work are listed in Tables S3.1 and S3.2, respectively. 
Standard recombinant DNA techniques were applied to construct all plasmids used in this 
study (Sambrook and Russell, 2001). Extraction of B. subtilis and phage DNA was as 
reported previously (São-José et al., 2004b; Vinga et al., 2012). High-fidelity polymerase 
chain reaction (PCR) was carried out with Kod Hot Start Master Mix (Novagen, USA), 
whereas routine PCR was performed with DNzyTaq green 2x master mix (NZYTech, 
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Portugal). Different commercial kits (Roche Applied Science, Germany and NZYTech) 
were used for purification of plasmid DNA and DNA fragments (PCR products or DNA 
restriction fragments). When necessary, DNA fragments were extracted from agarose gels 
with the Wizard SV gel and PCR Clean-Up System (Promega, USA). FastDigest 
restriction enzymes (Fermentas, Thermo Ficher Scientific, USA) were used to cleave 
DNA according to the manufacturer instructions. T4 DNA ligase and the 1 kb Plus DNA 
Ladder were from Invitrogen (Thermo Fisher Scientific, USA). Development of 
competence and transformation of E. coli and B. subtilis strains was as described by 
Chung et al. (1989) and Yasbin et al. (1975), respectively. Constructs were confirmed by 
DNA sequencing (GATC Biotech, Germany). 
 
3.4.3   General protein techniques  
 
For production of B. subtilis total protein extracts 2 or 4 ml-samples were collected from 
cultures at OD600nm = 0.8 and cells recovered in 1/50 volumes of lysis buffer (50 mM 
Tris.Cl pH 7.5, 300 mM NaCl, 10 mM MgCl2, 100 µg/ml lysozyme and 10 µg/ml DNase 
I) supplemented with a protease inhibitor cocktail (1x Complete Mini EDTA-free 
Protease Inhibitor Cocktail, Roche Applied Science). After 15 min at 37ºC, cell lysates 
were put on ice and supplemented with 0.1% NP-40. Protein quantification was carried 
out with the Bradford reagent (Bio-Rad Laboratories, USA) with bovine serum albumin 
(Bio-Rad Laboratories) as standard. Total protein extracts or endolysin purification 
fractions (see below) were analyzed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and western blotting as described elsewhere (Sambrook and 
Russell, 2001). The NZYColour Protein Marker II (NZYTech) or the BenchMark Pre-
Stained Protein Ladder (Invitrogen, Thermo Fisher Scientific) were used as protein 
molecular weight markers. His6-tagged endolysin proteins were immunodetected with 
0.3-0.4 µg/ml of anti-His6 antibodies (Roche Applied Science), with antigen/antibody 
complexes being revealed either with the BM Chemioluminescence Western Blotting Kit 
(Roche Applied Science) or with the Luminata Forte Western HRP Substrate (Merck 
Millipore, USA).  
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3.4.4   Cloning and expression of endolysin genes in E. coli 
 
Genes 25 and 53, which encode the endolysins LysSPP1 and Lys11 of phages SPP1 and 
11, respectively (Acc. No. X97918 and NC_004615), were PCR amplified from the 
corresponding phage DNA using the primer pairs Gp25-NcoI/Gp25-XmaI (for gene 25) 
and Gp53-NcoI/Gp53-XmaI (for gene 53). The amplified DNA fragments were double-
digested with NcoI/XmaI and ligated to the equally digested expression vector pIVEX2.3d 
(Roche Applied Science). This vector allows expression of cloned genes under the control 
of the phage T7 ϕ10 promoter and the production of the corresponding proteins C-
terminally fused to a hexahistidine tail. The resulting recombinant plasmids pIV::25His 
and pIV::53His were obtained in E. coli strain XL1-Blue MRF’ and then transferred to 
the E. coli expression strain CG61, which produces phage T7 RNA polymerase upon 
temperate up-shift (São-José et al., 2000). CG61 cells carrying pIV::25His 
(CG/pIV::25His) or pIV::53His (CG/pIV::53His) were selected and maintained at 28ºC 
until induction of protein synthesis (see next).  
 
3.4.5   Production and purification of His6-tagged endolysins 
 
E. coli strains CG/pIV::25His and CG/pIV::53His were used for heterologous production 
of endolysins LysSPP1 and Lys11, respectively. Both strains were pre-cultured ON at 
28ºC and then the protocols followed to produce and purify endolysins differed. 
CG/pIV::25His cultures were 100-fold diluted in fresh LB medium and further grown at 
28ºC until OD600nm of 0.8-1.0. After a 10-min period at room temperature in static 
conditions, protein production was induced by incubating cultures for 30 min at 42ºC in 
a shaking water bath. Induced cultures were then transferred to an orbital incubator and 
growth continued at 37ºC for 2.5 h. Cells were pelleted by centrifugation (8,000 g, 30 
min, 4ºC) and resuspended in 1/50 volumes of lysis buffer (50 mM Hepes-Na, pH 7.0, 
500 mM NaCl, 0.1% Triton, 1% glycerol and 50 mM imidazole) supplemented with the 
protease inhibitor cocktail. Cells were disrupted by sonication and the endolysin purified 
by metal chelate affinity chromatography (Fig. S3.4A) as described previously 
(Fernandes et al., 2012). LysSPP1 pure fractions were pooled, concentrated and finally 
exchanged to an imidazole-free buffer (same composition of lysis buffer but without 
imidazole) using a HiPrep 26/10 Desalting column (GE Healthcare, UK). 
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Production and purification conditions were optimized to improve solubility of Lys11 
endolysin. After ON growth, CG/pIV::53His cultures were 100-fold diluted in LB 
medium prepared in 0.1 M phosphate buffer pH 7.2 and supplemented with 0.5 M D-
sorbitol. Cells were grown at 28ºC until OD600nm of 0.5, after which cultures were 
supplemented with 80 mM KCl and protein synthesis induced as explained above. 
Induced cultures were transferred to a shaking water bath set to 16ºC and incubated for 
12-14 h. Cells were recovered by centrifugation and resuspended in 1/50 volume of lysis 
buffer (50 mM Hepes-Na, pH 6.8, 500 mM NaCl, 10 mM MgCl2, 0.1% Triton, 1 mM 
TCEP, 10 % glycerol and 50 mM imidazole) supplemented with the protease inhibitor 
cocktail. Cells were disrupted in a French press and Lys11 purified as described above 
(Fig. S3.4B). Lys11 was kept in an imidazole-free buffer (same composition of lysis 
buffer but without imidazole). 
 
Purified preparations of both endolysins lacked significant amounts of large protein 
aggregates as revealed by analytical size-exclusion chromatography in a column 
Superdex 200 5/150 GL column (GE Healthcare). Purified endolysins were kept at – 80ºC 
as small aliquots of 20 mg/ml (LysSPP1) and 2 mg/ml (Lys11). Before use, aliquots 
were centrifuged (15,000 g, 30 min, 4ºC) to eliminate eventual aggregates formed during 
storage. 
 
3.4.6   Cloning and expression of SPP1 lysis genes in B. subtilis 
  
LysSPP1 and SP-LysSPP1. The SPP1 endolysin gene fused to the hexahistidine coding 
sequence was PCR-amplified from plasmid pIV::25His with the primer pair 
lysSPP1Fw/pIV23d-His-Eco and cloned between the SpeI and EcoRI sites of the E. coli 
vector pBluescript II KS(+) (pKS, Stratagene, USA). The 25His DNA fragment was then 
recovered from the resulting plasmid pKS::25His through XbaI/SalI cleavage and inserted 
in the equally digested E. coli/B. subtilis shuttle vector pDG148 (Stragier et al., 1988), 
originating plasmid pDG::25His. As the restriction site XbaI in pDG148 is blocked by 
Dam methylation, the vector was prepared from a dam E. coli strain (SCS110, 
Stratagene). Genes cloned in pDG148 are expressed from the IPTG-inducible promoter 
Pspac. To construct the gene encoding the artificial e-endolysin SP-LysSPP1, two 
independent PCR products were first generated. One corresponded to the SP coding 
sequence and native ribosome binding site (RBS) of the serine protease Bpr (Acc. No. 
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NC_000964), which was amplified from the B. subtilis genome with primers SPbprFw 
and SPbprRv. The other matched the 25His sequence, starting from the second codon, 
and was amplified with the primer pair SPbprLYSfw/pIV23d-His-Eco using pIV::25His 
as template. The DNA segments SPbpr and 25His carried 3’ and 5’ complementary ends, 
respectively, which allowed their fusion by overlap-extension (OE)-PCR in a reaction 
employing primers SPbprFw and pIV23d-His-Eco. The OE-PCR product was cloned 
between the SpeI and EcoRI sites of pKS, originating pKS::SP-25His. Finally, the SP-
25His DNA segment was released from the latter plasmid with XbaI/SalI and inserted in 
pDG148, yielding pDG::SP-25His. Plasmids pDG::25His and pDG::SP-25His were first 
obtained in E. coli strain XL1-Blue MRF’ and then transferred to B. subtilis strain YB886, 
originating YB/pDG::25His and YB/pDG::SP-25His, respectively. An YB886 derivative 
carrying the empty pDG148 (YB/pDG) was used as control in the indicated experiments. 
Gene expression in YB886 strains carrying the pDG148 derivatives was induced with 1 
mM IPTG when cultures reached mid-exponential growth phase (OD600nm = 0.3-0.4). 
After reaching an OD600nm of 0.8-1.0, a fraction of the induced cultures was treated with 
5 µg/ml of gramicidin from Bacillus brevis (Prod. No. G5002, Sigma-Aldrich, USA) and 
cell lysis monitored for 60 min. Stock solutions of gramicidin (2 or 10 mg/ml) were 
prepared in absolute ethanol. 
 
SPP1 holin-like genes. To express the SPP1 holin-like genes 24.1 and 26 (Fig. S3.1) we 
constructed first the expression vector pNPxyl, which is a derivative of the E. coli/B. 
subtilis shuttle vector pNW33N (Mee and Welker, unpublished, Acc. No. AY237122) 
carrying the XylR repressor and the xylose-inducible promoter PxylA from B. megaterium 
(Kim et al., 1996). The xylR-PxylA cassette together with the upstream terminator t0 from 
phage  were amplified from plasmid pAX01 (Härtl et al., 2001) with primers Pxyl-Mfe 
and Pxyl-Kpn. The resulting fragment was inserted between the EcoRI and KpnI sites of 
pNW33N, resulting in pNPxyl. Next, the primer pairs gp24.1SPP1fw/gp24.1-
holSPP1rev2 and gp24.1-holSPP1fw/holSPP1rv were used to amplify genes 24.1 and 26, 
respectively, from the SPP1 DNA. The two PCR products carried complementary ends 
allowing the transcriptional fusion of 24.1 and 26 by OE-PCR with primers 
gp24.1SPP1fw and holSPP1rv. The fusion 24.1-26 maintained the native translation 
signals for both genes. The DNA fragment 24.1-26 was digested with KpnI and ClaI and 
ligated to the equally digested pMutin-cMyc (Kaltwasser et al., 2002), resulting in the 
translation fusion of the 3’ end of gene 26 to the coding sequence of the c-Myc epitope. 
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The DNA segment 24.1-26cMyc was PCR-amplified from the ligation reaction using the 
primer pair gp24.1SPP1fw/HAcMycrv, the PCR product was cleaved with KpnI and SphI 
and finally inserted into the similarly digested pNPxyl. The resulting plasmid pNP::24.1-
26cMyc was directly obtained in B. subtilis YB886 in presence of 0.1% of glucose, 
yielding strain YB/pNP::24.1-26cMyc. Plasmid pNP::24.1-26cMyc was also used to 
transform a YB886 derivative deficient for the major autolysin LytC (YBΔLytC), giving 
rise to strain YBΔLytC/pNP::24.1-26cMyc. Strain YBΔLytC was obtained by 
transforming the recipient strain YB886 with DNA from the donor lytC strain L16648 
(Margot et al., 1999), and selecting for neomycin resistance. YB886 strains harboring 
pNPxyl derivatives were grown until OD600nm of 0.6-0.7 and expression of SPP1 holin-
like genes induced in half of the cultures by adding 0.5% xylose. Cultures were 
maintained in growth conditions (37ºC with shaking) for 10 min, after which they were 
distributed to 1-ml spectrophotometer cells. The cell suspensions were then challenged 
with 0.5 μg/ml of purified LysSPP1 or the equivalent volume of endolysin protein buffer. 
OD600nm was monitored during 60 min after endolysin addition.  
 
3.4.7   Construction of an SPP1 phage producing a His6-tagged endolysin 
 
The SPP1 endolysin gene 25 together with the 3’ hexahistidine-coding tail was PCR-
amplified from pIV::25His with primers lysSPP1FwSac and pIV23d-His-Sal, and the 
resulting PCR product cloned between the SacI and SalI sites of the E. coli/B. subtilis 
shuttle vector pGKV259 (Kok et al., 1984). The resulting plasmid pGK::25His was 
isolated in E. coli strain TG1. A second PCR product encompassing gene 26 (including 
its translation signals) and the first 127 bp of the downstream gene 27 was amplified from 
the SPP1 DNA with primers HolSPP1fwSal and gp27rvNsi. This DNA fragment was 
digested with SalI/NsiI and inserted between sites SalI and PstI of the previously 
constructed pGK::25His. The resulting plasmid pGK::25His-26-27’ was isolated in B. 
subtilis YB886, giving rise to strain YB/pGK::25His-26-27’. This strain served as host to 
propagate the wild type (WT) phage SPP1 in solid media and thus promote recombination 
events between the phage DNA and homologous regions carried in pGK::25His-26-27’. 
At each round of infection, phages from a confluent lysis plate were recovered with 3ml 
TBT buffer (100 mM Tris.Cl pH 7.5, 100 mM NaCl, 10 mM MgCl2) an the relative 
proportion of recombinant phages qualitatively assessed by PCR using 1 μl of serial 
dilutions of the lysates and the primer pairs gp24.1SPP1fw/lysSPP1rv (detects WT and 
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recombinant phages) and gp24.1SPP1fw/pIV2.3d-His-Sal (detects recombinant phages 
only). After 4 rounds of infection the proportion of the mutant phage in the lysate 
appeared close to 10%. This lysate was then plated in the plasmid-free WT strain YB886 
and 19 pools of 5 isolated phage plaques each (total of 95 plaques) were similarly 
analyzed by PCR. One of the positive pools was again diluted and plated in strain YB886 
and 10 isolated phage plaques screened individually, revealing 5 clearly positive for the 
His-tagged endolysin gene. Finally, one plaque of the recombinant phage (SPP1g25His) 
was used to produce a medium scale lysate, with purity of the recombinant phage being 
controlled by PCR at each amplification step. 
 
3.4.8   Assays of lysis from without  
 
Target cells from exponentially-growing cultures (OD600nm = 0.4) were recovered in half 
volume of fresh medium (LB for B. subtilis and TSB for S. aureus) and for each cell 
suspension two sample sets were prepared in 1-ml spectrophotometer cuvettes. One set 
was supplemented with gramicidin (5 µg/ml for B. subtilis and 30 µg/ml for S. aureus) 
while the other received the equivalent volume of the ionophore solvent. After 10 min 
equilibration at 37ºC, cells from both sets were challenged with the indicated endolysin 
concentrations (or the equivalent volume of endolysin buffer) and lysis monitored in static 
conditions by taking OD600nm measurements at defined time points after endolysin 
addition. Analogous assays were performed where the LB medium was substituted by 
complete GM1 minimal medium (Yasbin et al., 1975) or GM1 lacking the energy sources 
(0.5% glucose, 0.1% yeast extract and 0.02% acid-hydrolyzed casein). Lytic activity was 
also tested against cells actively growing under aerated conditions when cultures reached 
an OD600nm of 0.8, both in absence or presence of gramicidin. 
 
3.4.9   Bioinformatics tools 
 
Protein homologies were revealed by BLASTP analysis (Altschul et al., 1997) using 
NCBI (National Center for Biotechnology Information, USA) non-redundant protein 
sequence database. Protein conserved domains were identified with tools CDD 
(Marchler-Bauer et al., 2015) and HHpred (Söding et al., 2005). Putative transmembrane 
helices were predicted with TMHMM (Krogh et al., 2001). Signal quantification of 
western blot bands was carried out with ImageJ (Schneider et al., 2012). 
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3.6 Supplementary materials 
 
 
Fig. S3.1. Lysis genes of B. subtilis phages PBSX and SPP1. Representation of the genome 
segments of phages PBSX (Acc. No. NC_000964) and SPP1 (Acc. N0. X97918) encompassing 
the endolysin (white or stripped arrows) and holin-like (black or gray arrows) genes. Genes 
encoding homologous proteins have the same filling pattern. Conserved domains were identified 
with tools CDD (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) and HHpred 
(http://toolkit.tuebingen.mpg.de/hhpred). Putative transmembrane helices in gene products were 
predicted with TMHMM (http://www.cbs.dtu.dk/services/TMHMM/). XhlA and gp24.1 are 
members of the Pfam family XhlA (pfam10779), which includes cell-surface associated 
haemolysins. XhlB and gp26 are members of the Pfam family Phage_holin (pfam04688), which 
includes several holin-like proteins from Siphoviridae bacteriophages. Endolysin XlyA exhibits 
3 conserved domains, a catalytic Amidase_2 domain (pfam01510) and the cell wall binding 
motifs LysM (pfam01476) and PG_Binding_1 (pfam01471). The CDD tool identified a single 
conserved domain, the catalytic Amidase_3 (pfam01520) in gp25 (LysSPP1). The SH3_3 domain 
(PF08239) in the gp25 C-terminus is only revealed by HHpred analysis (probability = 95.9%, E-
Value = 0.15).  
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Fig. S3.2. Endolysin detection in the supernatants of B. subtilis cultures producing LysSPP1 
or SP-LysSPP1. Cultures synthesizing LysSPP1 (Lys) or SP-LysSPP1 (SP-Lys) were collected 
at a time point equivalent to t = 200 min of Fig. 3.1A and the corresponding cell-free supernatants 
concentrated 100-fold by TCA-DOC precipitation. As control of the procedure, purified LysSPP1 
(Pure Lys) set to a concentration of 0.2 µg/ml in LB medium was similarly precipitated. Ten 
microliters of the solubilized precipitate (in 50 mM Tris.Cl pH 8.8, 7 M urea and 2 M thiourea) 
were analyzed by SDS-PAGE/Coomassie blue staining (left panel) and by western blot using anti-
His6 antibodies (right panel, overexposed film).  
 
  
Fig. S3.3. Effect of aeration on B. subtilis resistance to secreted SP-LysSPP1. Exponentially 
growing cells harboring the empty expression vector (Control) or derivatives producing LysSPP1 
(Lys) or SP-LysSPP1 (SP-Lys) were IPTG-induced at the indicated time and growth allowed for 
40 min under orbital shaking. After this point, samples of the cultures were transferred to 
spectrophotometer cells and lysis of cell suspensions monitored under static conditions. Each 
curve is the average of at least three independent experiments. 
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Fig. S3.4. SDS-PAGE analysis of different steps of endolysins LysSPP1 (A) and Lys11 (B) 
purification by affinity chromatography (AF). L, Protein ladder; Te, total protein extract; Se, 
soluble protein extract loaded in the AF column; Ft, flowthrough of the AF column; PAF, AF peak 
fractions; PDS, desalting peak fractions. The molecular weight of bands composing the protein 
ladders is indicated on the left side. 
 
   
Fig. S3.5. LysSPP1 binding to B. subtilis cells. Cells from a 4-ml sample of an exponentially 
growing culture of B. subtilis strain YB886 (OD600nm = 0.4) were recovered in 2 ml of fresh LB 
medium (“cells” lanes) and transferred to a BSA-coated microtube (Proença et al., 2015). For 
control purposes, a BSA-coated microtube was filled with the same volume of fresh LB only 
(“LB” lanes).  Both tubes were then supplemented with 0.5 µg/ml of pure LysSPP1 and incubated 
for 30 min at room temperature, with occasional tapping of the tubes. After this period, tubes were 
centrifuged for cell sedimentation, washed with fresh LB and resuspended in 50 µl of lysis buffer 
(“pellet” fractions, with cells lysed as described in text). The 2-ml supernatants were filtered 
through a 0.25 µm membrane and concentrated to 50 µl by passing through a 10 kDa-cutoff 
Centricon (Millipore) (“supernatant” fractions). Ten microliters of pellet and supernatant 
fractions were analyzed by western blot using anti-His6 antibodies. Note that nearly all added 
LysSPP1 specifically co-sedimented with cells, indicating that the endolysin efficiently binds to 
B. subtilis in the conditions of Fig. 3.2A.   
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Table S3.1. Bacterial Strains, Phages and Plasmids Used in This Study 
Bacteria, Bacteriophages and Plasmids  
 Genotype and/or relevant features 
Reference1
/Source 
E. coli strains 
XLIBlue-MRF’ 
Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 gyrA96 relA1 lac [F’ proAB lacIq lacZΔM15 
Tn10 (Tetr)]; cloning host 
Stratagene 
TG1 
supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5, (rK-mK-) [F' 
traD36 proAB+ lacIq lacZΔM15]; cloning host 
Stratagene 
SCS110 
rpsL (Strr) thr leu endA thi-1 lacY galK galT ara tonA tsx 
dam dcm supE44 ∆(lac-proAB) [F ́ traD36 proAB lacIq 
lacZ∆M15]; for preparation of plasmid free of Dam or 
Dcm methylation 
Stratagene 
CG61 
BL21 derivative harboring pGP1-2 (kanr); allows T7 RNA 
polymerase production upon temperature upshift 
9 
CG/pIV::25His CG61 derivative harboring pIV::25His This work 
CG/pIV::53His CG61 derivative harboring pIV::53His This work 
B. subtilis strains 
L16648 
lytABC::neo lytD::tet lytE::cam lytF::spc; multiple 
autolysin-deficient mutant 
6/BGSC2 
YB886 
B. subtilis 168 derivative cured of prophages PBSX and 
SPβ; wild-type strain; SPP1 indicator strain 
11 
YB/pDG::25His YB886 derivative harboring pD::25His This work 
YB/pDG::SP-25His YB886 derivative harboring pDG::SP-25His This work 
YB/pDG YB886 derivative harboring pDG148 This work 
YB/pNP::24.1-26cMyc YB886 derivative harboring pNP::24.1-26cMyc This work 
YBΔLytC 
YB886 derivative lytABC::neo; deficient for the major 
autolysin LytC 
This work 
YBΔLytC/pNP::24.1-
26cMyc 
YBΔLytC derivative harboring pNP::24.1-26cMyc This work 
YB/pGK::25His-26-27’ YB886 derivative harboring pGK::25His-26-27’ This work 
S. aureus strains 
RN4220 
prophage cured, restriction-deficient mutant of strain 
8325-4 
1, 5 
Bacteriophages 
SPP1 B. subtilis strictly lytic phage 8 
SPP1g25His 
SPP1 derivative carrying the 3’ end of endolysin gene 25 
fused to a His6 tag sequence 
This study 
3. HOLIN FUNCTION AND ENDOLYSIN ACTIVITY 
 
138 
 
Table S3.1 (continued) 
Plasmids 
pIVEX2.3d 
E. coli expression vector; genes expressed from T7 ϕ10 
promoter and proteins synthesized with a C-terminal His6 
tag; Ampr 
Roche 
Applied 
Science 
pBluescript II KS(+) 
(pKS)  
E. coli cloning vector; Ampr Stratagene 
pDG148 
E. coli/B. subtilis shuttle vector; genes expressed from the 
IPTG-inducible promoter Pspac; Ampr Kanr 
10/BGSC2 
pNW33N E. coli/B. subtilis shuttle vector; Cmr 
Mee and 
Welker, 
unpublished/
BGSC2 
pAX01 
E. coli replicative/B. subtilis integrative vector; source of 
the B. megaterium expression cassette t0-xylR-PxylA; Ampr 
Eryr 
2/BGSC2 
pMutin-cMyc 
E. coli replicative/B. subtilis integrative vector; source of 
cMyc epitope; Ampr Eryr 
3/BGSC2 
pGKV259 E. coli/B. subtilis shuttle vector; Eryr Cmr 4 
pIV::25His  pIVEX2.3d derivative carrying SPP1 endolysin gene 25  This work 
pIV::53His  pIVEX2.3d derivative carrying 11 endolysin gene 53 This work 
pKS::25His 
pKS derivative carrying the 25His coding sequence from 
pIV::25His 
This work 
pKS::SP-25His 
pKS derivative carrying SPbpr fused to 25His from 
pIV::25His 
This work 
pDG::25His pDG148 derivative carrying 25His from pKS::25His  This work 
pDG::SP-25His 
pDG148 derivative carrying SP-25His from pKS::SP-
25His 
This work 
pNPxyl 
Expression vector; pNW33N derivative carrying the 
expression cassette t0-xylR-PxylA 
This work 
pNP::24.1-26cMyc  
pNPxyl derivative carrying a transcriptional fusion of the 
SPP1 holin-like genes 24.1 and 26 
This work 
pGK::25His  pGKV259 derivative carrying 25His from pIV::25His  This work 
pGK::25His-26-27’  
pGKV259 derivative carrying 25His from pIV::25His 
transcriptionally fused to gene 26 and the first 127 bp of 
gene 27.  
This work 
1The references corresponding to the numbers indicated in the Table can be found in section 3.6.1; 2Bacillus Genetic 
Stock Center, Ohio State University, USA. 
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Table S3.2. List of Primers Used in This Work 
Name Sequence (5' → 3')1 
Gp25-NcoI GAAAGACCATGGGTAAATTAGTTTGGTTGGATGCAG 
Gp25-XmaI ATTTTCCCCGGGCTTCTCCTTTACCGTTACATATTTA 
Gp53-NcoI TGGCGACCATGGAAGCAAAATTAACTAAAAATGAGTTT 
Gp53-XmaI TATGTCCCCGGGACTGATTTCTCCCCATAAGTCA 
lysSPP1Fw CCGGTACCACTAGTAATGAAGGAGAGTGAAAGAATATGAGTAA 
pIV23d-His-Eco CGCCAGTGTGCTGGAATTCG 
SPbprFw TAAAAAACTAGTTGAAAAAGGGGGATGAAAATGAG 
SPbprRv TGCCCCGGCTGCTCCCGGA 
SPbprLYSfw CTGCTGTTTCCGGGAGCAGCCGGGGCAAGTAAATTAGTTTGGTTGGATGCAGGTCATG 
Pxyl-Mfe GAACAATTGATCTCTGCAGTCGCGATGATTA 
Pxyl-Kpn CGGGGTACCGGATCCCATTTCCCCCTTTGA 
gp24.1SPP1fw AAGGTACCGTCGACTAAAAGGGGGATGAAGAAAATGCCGGA 
gp24.1-holSPP1rev2 TTAGTTCTTTACAAGGTTCCATACA 
gp24.1-holSPP1fw 
ACAATTGTATGGAACCTTGTAAAGAACTAACGGTAAAGGAGAAGTAAAATGAAAATGG
ATACA 
holSPP1rv TGGCATCGATCTTCGTCAATCCGTTTTTCTTCAATG 
HAcMycrv TTGCATGCCCGCGGGCTTGCATGGAAAAAAGCCCGCTCA 
lysSPP1fwSacI AGTGAGAGCTCATGAGTAAATTAGTTTGGTTGGATG 
pIV23d-His-Sal CCAGTCGACTGGAATTCGCCCTTTTATTAATGA 
HolSPP1fwSal  ATGGTCGACTAAAGGAGAAGTAAAATGAAAATGGA 
gp27rvNsi GCTACTATGCATATGGAATAACCGTCAACCGGGT 
lysSPP1rv TTTCATCGATCTTCTCCTTTACCGTTACATATTTACT 
1Restriction sites are in bold case and underlined: CCATGG, NcoI; CCCGGG, XmaI; GGTACC, KpnI; ACTAGT, 
SpeI; GAATTC, EcoRI; CAATTG, MfeI; GTCGAC, SalI; ATCGAT, ClaI; GCATGC, SphI; CCGCGG, SacII; 
GAGCTC, SacI; ATGCAT, NsiI. 
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Abstract 
 
Double-stranded DNA bacteriophages employ holin and endolysin functions to lyse host 
bacteria after virus multiplication. Holins oligomerize in the cytoplasmic membrane and 
trigger to form holes that cause cell death. For most systems these holes are also required 
for endolysin release to the cell wall, where it cleaves the peptidoglycan network. Orfs 
25 and 26 of Bacillus subtilis phage SPP1 were predicted to encode the endolysin and 
holin functions, respectively. However, the product of the upstream orf 24.1 exhibits also 
holin features. We show that production of gp24.1 or gp26 in B. subtilis causes no major 
impact on cell growth, despite their ability to insert in the cytoplasmic membrane. Instant 
growth cessation and cell death is observed only upon co-production of the two holin-like 
proteins. Surprisingly, a constitutive promoter was identified within orf 24.1, which we 
propose to correspond to the previously described SPP1 early promoter PE5. 
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4.1 Introduction  
 
The holin and endolysin lytic functions seem to be universal players in the strategies used 
by double-stranded DNA phages to lyse bacterial hosts and to allow escape of the viral 
progeny (for reviews on holin and endolysin features and mode of action see Catalão et 
al., 2013; Young, 2013, 2014). Endolysins are enzymes that cleave the cell wall (CW) 
peptidoglycan, whereas holins are proteins with one or more transmembrane domains 
(TMDs) that insert and accumulate in the cytoplasmic membrane (CM). At a genetically-
defined time holins suddenly induce the formation of holes, which lead to collapse of the 
CM proton motive force (pmf) and instant cell death (the holin lethal effect). For phages 
following the so-called canonical lysis model, of which phage  is the best studied 
example, the holin holes are crucial for lysis of infected cells as they provide a channel 
for passage of the cytosol-accumulated endolysin to the CW (the holin transport effect, 
Savva et al,. 2014). In non-canonical systems the endolysins are typically exported to the 
CW by holin-independent mechanisms. In these cases the key holin role is its lethal effect, 
which is essential to liberate endolysins from activity-restraining mechanisms that act on 
the exported enzymes (for details see Catalão et al., 2013; Frias et al., 2013; Young, 2013, 
2014). The pmf-dissipating action of the holin can also be important to potentiate the lytic 
action of canonical endolysins after reaching the CW (Fernandes and São-José, 2016). 
 
Holins constitute a very diverse functional group. Frequently they are small hydrophobic 
proteins (<150 aa) with at least 1 TMD and with a hydrophilic and highly charged C-
terminus (Wang et al., 2000; Young, 2002). Holins oligomerize within the CM of the 
bacterium and, as long as the pmf is maintained above a certain threshold, they assemble 
into oligomers and rafts of intrinsic stability. Below this threshold holins trigger for hole 
formation (Wang et al., 2000; Young et al., 2000; Young and Wang, 2006). From a 
mechanistic point of view holins can be divided in canonical holins and pinholins. As 
described above, in canonical lysis the holin makes pores large enough to allow the 
translocation of the endolysin from the cytoplasm to the CW (Young, 2013). Pinholin is 
the term used to describe holins that form small-holes that are meant for passage of small 
ions and CM depolarization (Park et al., 2007). Pinholins are typically associated to 
phages that produce exported endolysins (Catalão et al., 2013; Young, 2013, 2014). 
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From the above it is easily concluded that the holin action needs to be delayed during the 
initial stages of phage infection to avoid premature cell death and/or lysis. In addition to 
mechanisms controlling holin transcription and translation (Catalão et al., 2013), phages 
can employ a holin antagonist, the antiholin, for the fine tuning of lysis timing. The 
antiholin mode of action is best studied in lambdoid phages and in phage T4 (Young, 
2013, 2014 and references therein). In lambdoid phages the holin gene itself, through a 
dual-start motif encodes both the lysis and the inhibitor functions (Bläsi and Young, 
1996), whereas in T4 these functions are encoded by separate genes (Ramanculov and 
Young 2001). The antiholin exerts its function by interacting and/or by oligomerizing 
with the holin, but after pmf-collapse both can contribute to hole formation (Gründling et 
al., 2000; Tran et al., 2005).  
 
Interestingly, it was reported for at least two phages that well-timed and efficient lysis 
required the concerted action of two holin-like proteins produced from two separate genes 
in the lysis cassette. These are the proteins Gp4 and Gp5 of mycobacteriophage Ms6 
(Catalão et al., 2011) and XhlA and XhlB of the B. subtilis defective prophage PBSX 
(Krogh et al., 1998). It was proposed for both phages that the two holin-like proteins 
interact to form the holin functional unit responsible for efficient endolysin release at the 
proper timing for lysis (Catalão et al., 2011; Krogh et al., 1998).  
 
We showed recently that the PBSX lytic gene cluster shares some features with the 
putative lysis cassette of the B. subtilis phage SPP1 (Fernandes and São-José, 2016). 
Previous genome sequence analysis assigned orfs 25 and 26 (Fig. 4.1) as the endolysin 
and holin genes of phage SPP1, respectively (Alonso et al., 1997). We have confirmed 
the endolysin function of gp25 (renamed LysSPP1) and have highlighted the sequence 
and structural relatedness between XhlB and gp26 and between XhlA and gp24.1 
(Fernandes and São-José, 2016). The latter is the product of orf 24.1, which lies 
immediately upstream of gene 25 in SPP1 (Fig. 4.1).   
 
In agreement with their holin-like features, preliminary work showed that co-expression 
of orfs 24.1 and 26 in B. subtilis resulted in rapid loss of cell viability (Fernandes and 
São-José, 2016). In the present study we performed a functional characterization of 
gp24.1 and gp26, assessing the contribution of each protein to the cell killing effect. The 
results indicate that the typical lethal character of the holin action is only observed when 
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gp24.1 and gp26 are simultaneously produced. We reveal also the presence of a 
constitutive promoter within orf 24.1 and discuss its possible role in SPP1 lysis 
regulation. 
 
4.2 Results 
 
4.2.1   Impact of 24.1 and 26 expression in B. subtilis cells 
 
As mentioned above, one paramount feature of holin activity is its capacity to insert in 
the host cell CM and form lethal holes (Young, 2013). In order to gain insight on the 
putative holin function of SPP1 gp24.1 and gp26, the corresponding orfs were expressed 
in B. subtilis, either individually or as a transcriptional fusion, and the effect on cell 
growth and viability evaluated. This was achieved by cloning 24.1, 26 and the 24.1-26 
fusion in a replicative plasmid under control of a xylose-inducible promoter (plasmid 
pNPxyl). The constructs allowed production of gp24.1 and gp26 C-terminally fused to 
the c-Myc tag when the corresponding orfs were individually expressed. When co-
synthesized from the transcriptional fusion the tag was only added to gp26 (see materials 
and methods). In the three constructs the native translation signals of 24.1 and 26 were 
preserved, including an in frame alternative start codon and ribosome binding site that we 
have identified upstream of the annotated translation signals of 24.1 (Fig. 4.1).  
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Fig. 4.1. Lysis genes of B. subtilis phages SPP1 and PBSX. Representation of the genome 
segments of phages SPP1 (Acc. N0. X97918) and PBSX (Acc. N0. NC_000964) encompassing 
the endolysin (white and stripped arrows) and holin-like (black and gray arrows) genes. 
Homology between deduced gene products is highlighted by the same filling pattern. XhlA and 
gp24.1 are members of the Pfam family XhlA (pfam10779), which includes cell-surface 
associated haemolysins. XhlB and gp26 are members of the Pfam family Phage_holin 
(pfam04688), which includes several holin-like proteins from Siphovirus phages. The white 
regions in the holin-like genes indicate the number and relative position of putative 
transmembrane domain coding sequences, according to the TMHMM tool 
(http://www.cbs.dtu.dk/services/TMHMM). Endolysins XlyA and gp25 (LysSPP1) display 
catalytic domains of the families Amidase_2 and Amidase_3, respectively, as defined by Pfam 
analysis (http://pfam.xfam.org). The bent arrow indicates the presence of promoter activity within 
24.1 (see text). Sequence details (from nucleotide positions 20526 to 20579 of Acc. N0.  X97918) 
of the two putative translation start signals of 24.1 are shown below, with indication of the 
deduced N-terminal amino acid sequence (the annotated start in sequence databases is depicted 
in bold/underlined). 
 
In absence of the inducer growth of B. subtilis cells carrying either 24.1 or 26 was 
indistinguishable from that of cells carrying the empty pNPxyl. In contrast, the strain 
carrying the 24.1-26 fusion presented delayed growth in the same conditions, suggesting 
some toxicity derived from basal expression of the putative holin-like genes (Fig. 4.2A). 
Induction of half of the cultures with xylose at mid-exponential phase did not affect 
growth of cells harboring either of the holin-like genes, except that cells expressing orf 
26 appeared to reach slightly lower optical densities (OD600nm) values when entering 
stationary growth (Fig. 4.2A). Quite oppositely, induction of the cultures carrying 24.1-
PBSX
xhlA xhlB xlyA
holin
SPP1
24.1 25 26
(300 bp)
…AAAAGGGGGATGAAGAAAATGCCGGAATTGCAGGAGGTCAACACCATGGAGCAA…
M    P      E      L     Q     E      V     N    T     M E     Q…
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26 resulted in instant growth interruption, which was accompanied by a drastic decrease 
of cell viability (2-log reduction of cfu counts) (Fig. 4.2A). 
 
The production of gp24.1 and gp26 upon xylose induction was accessed by western blot 
analysis using anti-c-Myc antibodies (Fig. 4.2B and C). Note that in the strain used to co-
synthesize gp24.1 and gp26 only the latter is tagged with c-Myc. As observed in Fig. 
4.2C, when produced separately gp24.1 and gp26 were only detected after addition of the 
inducer, with gp24.1 apparently accumulating in larger amounts than gp26. In some 
western blots gp24.1 seemed to be detected as a band doublet (see below). Surprisingly, 
gp26 was detected in the extracts of non-induced cultures of the 24.1-26 strain at levels 
comparable to those of the induced 26 strain (Fig. 4.2C). The gp26 signal further 
increased after xylose addition to the 24.1-26 cultures. Since we did not find any mutation 
in the construct of the transcriptional fusion 24.1-26 that could justify the production of 
gp26 in absence of xylose, we raised the hypothesis that constitutive promoter sequences 
within orf 24.1 could be driving the expression of orf 26 (see next). 
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Fig. 4.2. Expression of orfs 24.1 and 26 in B. subtilis and effect on cell growth. (A) Growth 
curves of B. subtilis cells expressing orfs 24.1, 26 or co-expressing both (24.1-26). The “control” 
curves correspond to cells carrying the empty expression vector pNPxyl. Expression was induced 
in half of the cultures (filled symbols) at the indicated time points (black arrows) by adding 0.5 
% xylose (xyl). Cell viability (cfu/ml) of cells co-expressing 24.1 and 26 was scored at the 
indicated time points in absence or presence of xylose. (B) Coomassie blue-stained SDS-PAGE 
gel of total protein extracts produced from the cultures described in panel A at time points t = 180 
min (control, 24.1 and  26) and t = 200 min (24.1-26), in absence or presence of xylose. The 
molecular weight of bands composing the protein ladder (L) is indicated on the left side. (C) 
Detection by western blot analysis of recombinant gp24.1 and gp26 in the protein extracts 
described in panel B, using anti-c-Myc specific antibodies. Note the production of gp26 in 
absence of xylose in cells carrying the 24.1-26 fusion.  
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4.2.2   Orf 24.1 carries internal promoter sequences that are functional both in 
E. coli and B. subtilis 
 
To test the presence of transcription promoter sequences within 24.1, the naturally 
adjacent orfs 24.1 and 25 (Fig. 4.1) were cloned in the promoter-less shuttle vector 
pNW33N, with the 3’ end of the endolysin gene fused to a hexahistidine-coding sequence 
for protein detection. Endolysin production served thus as reporter of promoter activity 
located upstream gene 25. For control purposes we constructed a pNW33N derivative 
carrying the 25His fusion only. E. coli and B. subtilis strains individually carrying each 
of the constructs were generated. 
 
As shown in Fig. 4.3A and B, a strong gp25 (LysSPP1) signal was observed only when 
the endolysin gene was preceded by orf 24.1, both in E. coli and B. subtilis. The results 
strongly suggested that the 24.1 sequence carried a constitutive promoter active during 
bacterial vegetative growth, that is, a A- and 70-dependent promoter in B. subtilis and 
E. coli, respectively (Haldenwang, 1995). In fact, analysis of the 24.1 sequence in parallel 
with that of known SPP1 early promoters (A-dependent PE1 to PE3, Alonso et al., 1997; 
Pedré et al., 1994) revealed the -35 and -10 elements of a putative promoter (Fig. 4.3C). 
The -10 box displayed the “TG extension” typical of strong promoters (Helmann, 1995).  
In conclusion, the results indicated that 24.1 carries an internal A-dependent promoter 
that, in absence of xylose, was responsible for the constitutive production of gp26 by B. 
subtilis cells carrying the 24.1-26 fusion (Fig. 4.2). The nature and possible implications 
of this promoter in lysis regulation during SPP1 infection are discussed below. 
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Fig. 4.3. Analysis of promoter activity within orf 24.1. (A) Coomassie blue-stained SDS-PAGE 
gel of total protein extracts produced from E. coli and B. subtilis cells carrying either gene 25 or 
the natural 24.1-25 arrangement (Fig. 4.1) cloned in the promoter-less, shuttle vector pNW33N. 
In the constructs the 3’ end of gene 25 was fused to a His6 coding sequence. The molecular weight 
of bands composing the protein ladder (L) is indicated on the left side. (B) Detection by western 
blot analysis of recombinant gp25 in the protein extracts described in panel A, using anti-His6 
specific antibodies. The endolysin gp25 is detected as an intense band only when the 24.1 
sequence is present upstream gene 25. (C) Alignment of the nucleotide sequences of the 
previously identified SPP1 early promoters PE1, PE2 and PE3 with that of the putative promoter 
detected within 24.1, which we propose to correspond to PE5 (see text). Sequence coordinates 
are according to the SPP1 genome sequence (Acc. N0. X97918). The elements -35 and -10 and 
the “TG extension” are shadowed (putative in 24.1). Known transcription starts sites (+1) are 
bold/underlined (Pedré et al., 1994).  
 
4.2.3  The holin-like proteins gp24.1 and gp26 localize to the cytoplasmic 
membrane 
 
Holins, like that of phage  have been shown to insert and accumulate in the CM until 
they trigger for hole formation (Gründling et al., 2001). We have studied how gp24.1 and 
gp26 distributed between the cytosol and the CM when independently produced in B. 
C
PE1 (40520)TAAAAAGTGTTTACAACGTAACCCTAAGATGATATTATATGATTACAA(40567)
PE2 (35311)AAAAAACTATAGACAAGCTTAGACATTTGAGTTAAGATATCTTTAGAT(35358)
PE3 (30299)AAATAGTGGTTGCCTTTCTATGTTTTCTATGTTTTAATAGAATCATAG(30346)
P24.1(PE5?)(20754)ATTTCCACGCTCTCAACTGTTGTAGTAGGTGGTATACTTACAATTGTA(20801)
-35 -10
A
kDa
135
35
20
25
48
63
75
kDa
135
35
20
25
48
63
75
L
B
gp25 (LysSPP1)
E. coli B. subtilisE. coli B. subtilis
4. PHAGE SPP1 HOLIN 
 
157 
subtilis. The distribution of gp26 was also accessed when co-synthesized with gp24.1. In 
all situations the holin-like products were either exclusively detected or detected in much 
larger amounts in the CM fraction (Fig. 4.4), clearly indicating that these proteins are 
targeted to this cell compartment.  
 
  
Fig. 4.4. Membrane localization of gp24.1 and gp26. Xylose-induced cells of B. subtilis strains 
expressing orfs 24.1, 26 or co-expressing both (24.1-26) were fractionated into total (T), 
cytoplasmic (C) and membrane (M) protein extracts and analyzed by SDS-PAGE/Coomassie blue 
staining (top panels) and by western blot with anti-c-Myc specific antibodies (bottom panels). 
The molecular weight and position of bands composing the protein ladder (L) is indicated as in 
the previous figures. 
 
4.3 Discussion 
 
Probably due to the lack of suitable tools to control expression of their lethal character, 
holins from phages infecting Gram-positive bacteria have been almost exclusively studied 
in heterologous systems, mostly in E. coli. Frequently, putative holin genes are expressed 
from a plasmid vector, alone or in combination with their endolysin counterparts, and the 
effect on E. coli viability and cell lysis evaluated. In another approach, the holin function 
of a giving protein has been assumed based on its capacity to complement the lysis-
defective phenotype of mutant  phages affected in holin synthesis (Catalão et al., 2011; 
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Díaz et al., 1996; Martín et al., 1998; São-José et al., 2004; Vukov et al., 2000). A still 
open question though is if the results obtained in heterologous hosts can be easily 
transposed to the native systems. 
 
As referred to above, there are very few examples in the literature of vector-mediated 
holin expression in natural Gram-positive hosts (Martín et al., 1998). In some cases 
however, it has been possible to inactivate putative holin genes in prophages or phages 
and confirm the holin function when host cell lysis is affected. This was done for the 
holin-like proteins XhlA and XhlB of PBSX, Gp4 and Gp5 of mycobacteriophage Ms6 
and Svh1 and Svh2 of pneumococcal phage SV1 (Catalão et al., 2011; Frias et al., 2013; 
Krogh et al., 1998). 
 
In this work we have studied how expression of the SPP1 holin-like genes 24.1 and 26 
affected host cells growth and viability, with the goal of understanding their contribution 
to the holin function. We show that despite the capacity of gp24.1 and gp26 to insert in 
the CM when individually produced, growth interruption and cell death typical of holin 
activity seems to depend on the simultaneous expression of the two holin-like genes. This 
suggests that the SPP1 holin function requires the synthesis and probably the interaction 
of these two proteins, as suggested or demonstrated for the holin-like pairs in PBSX and 
Ms6. However, it is currently unknown how the production of gp24.1 and gp26 in our 
expression conditions compare to those occurring in the natural context of SPP1 infection. 
In addition, gp24.1 and gp26 appeared to accumulate at different levels, especially when 
produced separately, with gp24.1 being consistently detected with stronger signals than 
gp26 (Fig 4.2C). Therefore, one cannot totally exclude that higher levels of gp26 
accumulation would not result in increased cell toxicity. Still, we believe that the relative 
lower production of gp26 by induced cultures expressing orf 26 only (Fig. 4.2A) should 
not explain its poor effect on cell growth. In fact, because of the promoter sequences 
within 24.1, similar gp26 amounts were detected in non-induced cultures of cells co-
expressing orfs 24.1-26 (Fig. 4.2B and C), but in this case with a clear impact on cell 
growth rate (Fig. 4.2A). Our interpretation is that the delayed growth of the 24.1-26 strain 
in absence of the inducer probably results from a basal, undetectable level of gp24.1 
production, which in combination with gp26 induces some toxicity to the cell population. 
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An unexpected finding was the presence of a constitutive, A-dependent promoter 
internal to orf 24.1. Given its localization and apparent strength it is most likely that this 
promoter corresponds to the previously described SPP1 early promoter PE5 (Alonso et 
al., 1997; Montenegro and Trautner, 1981; Stüber et al., 1981). PE5, whose activity starts 
to be detected up to 5 min after the beginning of SPP1 infection, was tentatively mapped 
upstream orf 27 (Alonso et al., 1997; Montenegro and Trautner, 1981). We see this 
promoter activity initiated within orf 24.1 as indirect evidence supporting that the SPP1 
holin function should not rely exclusively on the gp26 action. In fact, its occurrence 
implies that the downstream endolysin and holin-like genes 25 and 26, respectively, 
belong to the class of genes that are early transcribed during B. subtilis infection by SPP1. 
Therefore, it is expected that LysSPP1 and gp26 start to be produced at early stages of 
phage multiplication. If gp26 was the sole protein responsible for the holin function it 
could result in premature host cell lysis.  
 
Gp24.1 could harmlessly accumulate at high levels in the B. subtilis CM. Curiously, of 
the two holin-like proteins of PBSX, XhlA (the gp24.1 homologue) was the one that 
seemed to cause cell damage when expressed in B. subtilis (Krogh et al., 1998). To 
discard the possibility that the C-terminal c-Myc was interfering with gp24.1 activity, we 
have similarly expressed in B. subtilis an untagged version of the protein. As observed 
for the tagged gp24.1, its production caused no effect on cell growth (data not shown). 
The holin-like gene 24.1 seems to carry two in frame alternative translation starts (Fig. 
4.1), which might explain the frequent detection of gp24.1 as a band doublet (Fig. 4.4). 
In xhlA of PBSX and PBSZ (the defective prophage in B. subtilis strain W23) there is also 
a putative ribosome binding site and ATG start cordon upstream that annotated in 
databases, but these are out of frame and interrupted by a stop codon (Fig. S4.1). Wether 
this is on the basis of the different gp24.1 and XhlA phenotypes when expressed in B. 
subtilis is currently unknown. The vast majority of the closest gp24.1 homologues are 
annotated as starting by a methionine equivalent to that of the first 24.1 start codon, but 
some exhibit also potential alternative start sites (not shown). Alternative translation 
initiation seems thus to be a common feature of holin and holin-like genes, as well 
exemplified by the phage  S gene and the Clostridium difficile tcdE, which is involved 
in toxin release (Bläsi and Young, 1996; Govind et al., 2015).  
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One key role of holins in canonical lysis is to form lesions in the CM large enough for 
endolysin escape to the CW. We have tried to produced LysSPP1 from a IPTG-inducible 
promoter (Fernandes and São-José, 2016) in cells expressing 24.1-25, with the goal of 
demonstrating the role of gp24.1 and gp26 in endolysin release to the CW. Unfortunately, 
probably because of leaky transcription in absence of the inducers we were unable to 
stably maintain the constructs expressing the three lysis genes within the same B. subtilis 
cell. 
 
In conclusion, considering the apparent requirement of gp24.1 and gp26 for holin lethality 
and the occurrence of a promoter inside orf 24.1 (most likely the SPP1 early promoter 
PE5), our hypothesis is that a steady state of LysSPP1 and gp26 production is achieved 
during early phage development without compromising the infected cell. Activation of 
late transcription from the upstream promoters PL3 to PL5, which peaks between 12 and 
30 min after infection (Alonso et al., 1997; Montenegro and Trautner, 1981), would result 
in the gradual accumulation of gp24.1 and in further increase of LysSPP1 and gp26 
production, ultimately leading to cell lysis. This tentative model for the regulation of 
SPP1-mediated host cell lysis is compatible with the transcription profile of the phage 
genome (Alonso et al., 1997; Montenegro and Trautner, 1981; Stüber et al., 1981). 
 
4.4 Materials and methods  
 
4.4.1   Biological material, growth conditions and general techniques 
 
Bacterial strains, phages, plasmids and primers used in this study are indicated in Table 
S4.1. E. coli and B. subtilis strains were routinely pre-cultured overnight at 37ºC and 
30ºC, respectively, in LB medium (Sambrook and Russel, 2001) under orbital shaking. 
New cultures were initiated by diluting pre-cultures 100-fold in fresh medium. Bacterial 
growth was monitored by taking OD600nm measurements at regular intervals. LB was 
supplemented with 0.01% glucose when growing B. subtilis strains carrying plasmid 
pNPxyl or its derivatives (see below) to minimize basal expression from the PxylA 
promoter. For selection of strains carrying vectors or recombinant plasmids LB was 
supplemented with 100 μg/ml ampicillin or 20 μg/ml chloramphenicol (for E. coli) and 5 
μg/ml chloramphenicol (for B. subtilis). SPP1 phages were propagated in B. subtilis strain 
YB886 as described previously (Jakutytè et al., 2011). 
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Plasmids were constructed following standard DNA techniques (Sambrook and Russel, 
2001). Phage DNA was isolated as described in Vinga et al. (2012). High-fidelity 
polymerase chain reaction (PCR) was carried out with Kod Hot Start Master Mix 
(Novagen, USA). Transformation of E. coli and B. subtilis strains followed the protocols 
described by Chung et al. (1989) and Yasbin et al. (1975), respectively. Constructs were 
confirmed by DNA sequencing (GATC Biotech). 
 
Two or 4 ml-samples of B. subtilis cultures were used for routine production of total 
protein extracts as described previously (Fernandes and São-José, 2016). Protein extracts 
were quantified with Bradford reagent (Bio-Rad Laboratories), using bovine serum 
albumin as standard. Approximately 20 ug of total protein were separated by SDS-PAGE 
(15% resolving gels for holin-like proteins and 11% for LysSPP1) and proteins analyzed 
by western blotting as described elsewhere (Sambrook and Russell, 2001). His6- and c-
Myc-tagged proteins were immunodetected with 0.4 μg/ml of anti-His6 and 1μg/ml of 
anti-c-Myc antibodies, respectively, according to manufacturer instructions (Roche 
Applied Science), and with antigen/antibody complexes being revealed with the 
Luminata Forte Western HRP Substrate (Merck Millipore). 
 
4.4.2   Plasmid constructions 
 
The putative holin-like genes 24.1 and 26 were PCR-amplified with the primer pairs 
gp24.1SPP1fw/gp24.1SPP1rv1 and gp26SPP1fw/gp26SPP1rv, respectively. The 
resulting products were digested with KpnI and ClaI and ligated to the equally digested 
pMutin-cMyc (Kaltwasser et al., 2002), resulting in the translation fusion of the 3’ end of 
each gene to the coding sequence of the c-Myc epitope carried in pMutin-cMyc. The 
DNA segments 24.1cMyc and 26cMyc were then PCR-amplified from the ligation 
reactions using the primer pairs gp24.1SPP1fw/HAcMycrv and 
gp26SPP1fw/HAcMycrv, respectively, the products were cleaved with KpnI and SphI 
and finally inserted into the similarly digested pNPxyl, yielding plasmids pNP::24.1cMyc 
and pNP::26cMyc. In these plasmids genes 24.1cMyc and 26cMyc are under the 
transcriptional control of the xylR-PxylA cassette, being their expression induced in 
presence of xylose (Fernandes and São-José, 2016). Plasmid pNP::24.1-26cMyc, which 
allows the xylose-inducible expression of the transcriptional fusion 24.1-26cMyc was 
constructed previously by following the same strategy (Fernandes and São-José., 2016). 
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Plasmid pNP::24.1cMyc was obtained in E. coli strain TG1 and then used to transform B. 
subtilis YB886, yielding the strain YB/pNP::24.1cMyc. Plasmid pNP::26cMyc was 
obtained directly in YB886, yielding strain YB/pNP::26cMyc. The YB886 recombinant 
strains carrying the described pNPxyl derivatives were selected in the presence of 0.1% 
of glucose for catabolite repression of promoter PxylA. 
 
The expression of gene 25 (encodes the SPP1 endolysin LysSPP1), when cloned 
downstream of orf 24.1, was used to confirm the presence of promoter sequences internal 
to the latter putative gene. For that, the region 24.1-25His was amplified from the mutant 
phage SPP1g25His (Fernandes and São-José., 2016) with the primer pair 
gp24.1SPP1fw/pIV23d-His-Sal. The PCR product was cleaved with SalI and ligated to 
similarly digested pBluescript II KS (+). The resulting plasmid pKS::24.1-25His was then 
double-digested with XbaI/KpnI and the released 24.1-25His DNA segment inserted into 
the equally digested, promoter-less E. coli/B. subtilis shuttle vector pNW33N, yielding 
plasmid pNW::24.1-25His. As control we constructed an analogous plasmid 
(pNW::25His) carrying only gene 25His, following the same strategy described above 
and using the previously constructed plasmid pKS::25His (Fernandes and São-José., 
2016) as template. Both pNW33N derivatives were first isolated in E. coli XLIBlue-
MRF’ and then used to transform B. subtilis YB886, yielding strains YB/pNW24.1-25His 
and YB/pNW25His. 
 
4.4.3   B. subtilis cell fractioning 
 
Five hundred milliliter cultures of B. subtilis strains harboring pNPxyl or its derivatives 
were grown until OD600nm = 0.3-0.4 (for YB/pNP, YB/pNP::24.1cMyc and 
YB/pNP::26cMyc) or OD600nm = 0.6-0.7 (for YB/pNP::24.1-26cMyc) and then induced 
with 0.5% xylose. Cells were collected at OD600nm 0.8-1.0 and resuspended in 10 ml lysis 
buffer (20mM Hepes, 300mM NaCl) supplemented with 100 µg/ml lysozyme and 1X 
protease inhibitor cocktail (Complete EDTA-free Protease Inhibitor Cocktail; Roche 
Applied Science). From this point on, cell disruption and production of total, cytoplasm 
and membrane fractions were as described in Jakutytè et al. (2011). 
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4.4.4   Bioinformatic analysis 
 
The tools used for analysis of protein homologies and for identification of conserved 
domains and putative transmembrane helices were those described in Fernandes and São-
José., 2016. 
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4.6 Supplementary materials 
 
 
Fig. S4.1. Putative translation signals in 24.1/xhlA-like genes. Putative ribosome binding sites 
and start codons are in bold and underlined. Annotated starts in databases are shaded in yellow 
whereas stop codons are in red. SPP1 (Acc. N0. X97918); Bacillus amyloliquefaciens DSM7 
(Acc. N0. FN597644); PBSX (Acc. N0. NC_000964); PBSZ (Acc. N0. ADM37359). 
 
Table S4.1. Bacterial Strains, Phages, Plasmids and Primers Used in This Study 
Bacteria, bacteriophages, plasmids and primers  
 Genotype and/or relevant features 
Reference1/ 
Source 
E. coli strains 
XLIBlue-MRF’ 
Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 gyrA96 relA1 lac [F’ proAB lacIq lacZΔM15 
Tn10 (Tetr)]; cloning host.  
Stratagene 
TG1 
supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5, (rK-mK-) [F' 
traD36 proAB+ lacIq lacZΔM15]; cloning host. 
Stratagene 
B. subtilis strains 
YB886 
B. subtilis 168 derivative free of prophages PBSX and 
SPβ; SPP1 indicator strain 
4 
YB/pNP::24.1cMyc YB886 derivative harboring pNP::24.1cMyc  This work 
YB/pNP::26cMyc YB886 derivative harboring pNP::26cMyc  This work 
YB/pNP::24.1-
26cMyc 
YB886 derivative harboring pNP::24.1-26cMyc  1 
YB/pNP YB886 derivative harboring pNPxyl 1 
YB/pNW::24.1-
25His 
YB886 derivative harboring pNW::24.1-25His This work 
>24.1 SPP1 
CAATAAAAGGGGGATGAAGAAAATGCCGGAATTGCAGGAGGTCAACACCATGGAGCAA 
                       M  P  E  L  Q  E  V  N  T  M  E  Q 
 
>xhlA1 B. amyloliquefaciens 
AGATAAAAGGGGGGCGTACTAATGTCACAAATGACGGAGGTACCGGAAGTGAATGCT 
                      M  S  Q  M  T  E  V  P  E  V  N  A 
 
>xhlA PBSX 
CCTCGGAAGGGAGGTGATCTGCATGTGAAGGAGGAGTGAGAGATGCAGCAAGAG 
                                           M  Q  Q  E 
 
>zhlA PBSZ  
CCTCGGAAGGGAGGTGATCCGCATGTAAAGGAGGAGTGAGTAATGCAGCAAGA 
                                           M  Q  Q  E 
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Table S4.1 (continued) 
YB/pNW::25His YB886 derivative harboring pNW::25His This work 
Bacteriophages 
SPP1 B. subtilis strictly lytic phage 3 
SPP1g25His 
SPP1 derivative carrying the 3’ end of endolysin gene 25 
fused to a His6-tag sequence 
1 
 
Plasmids 
pBluescript II 
KS(+) (pKS)  
E. coli cloning vector; Ampr Stratagene 
pNW33N E. coli/B. subtilis shuttle vector; Cmr 
Mee and Welker, 
unpublished/ 
BGSC2 
pMutin-cMyc B. subtilis integration vector;  source of c-Myc epitope 2/ BGSC2 
pNPxyl 
Expression vector; pNW33N derivative carrying the 
expression cassette t0-xylR-PxylA  
1 
pNP::24.1cMyc  
pNPxyl derivative carrying the SPP1 holin-like gene 
24.1  
This work 
pNP::26cMyc  pNPxyl derivative carrying the SPP1 holin-like gene 26 This work 
pNP::24.1-26cMyc  
pNPxyl derivative carrying a transcriptional fusion of the 
SPP1 holin-like genes 24.1 and 26 
1 
pKS::25His pKS derivative carrying gene 25 fused to a His6-tag 1 
pKS::24.1-25His 
pKS derivative carrying the 24.1-25His DNA segment 
from SPP1g25His 
This work 
pNW::25His 
pNW33N derivative carrying gene 25His from 
pKS::25His  
This work 
pNW::24.1-25His 
pNW33N derivative carrying the 24.1-25His DNA 
segment from pKS::24.1-25His  
This work 
Primers 
 Sequence (5' → 3')3  
gp24.1SPP1fw AAGGTACCGTCGACTAAAAGGGGGATGAAGAAAATGCCGGA  
gp24.1SPP1rv1  TCCTATCGATGTTCTTTACAAGGTTCCATACAATTGT 
gp26SPP1fw AAGGTACCGTCGACCGGTAAAGGAGAAGTAAAATGAAAATGGA 
gp26SPP1rv TGGCATCGATCTTCGTCAATCCGTTTTTCTTCAATG 
HAcMycrv TTGCATGCCCGCGGGCTTGCATGGAAAAAAGCCCGCTCA  
pIV23d-His-Sal CCAGTCGACTGGAATTCGCCCTTTTATTAATGA 
1The references corresponding to the numbers indicated in the Table can be found in section 4.6.1, 2Bacillus Genetic 
Stock Center, Ohio State University, USA.  
3Restriction sites are in bold case and underlined: GGTACC, KpnI; GTCGAC, SalI; ATCGAT, ClaI; GCATGC, 
SphI; CCGCGG, SacII  
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The golden era of antibiotic discovery occurred in the 1950s-1970s and very few new 
classes of these agents have been discovered since then. This, associated with the rise of 
antibiotic resistance among important pathogenic bacteria motivated the need to 
considerer new antibacterial approaches. A recent survey of the antibiotic alternatives 
pipeline has included endolysins amongst the agents with greatest potential, although the 
most optimistic projections indicate that they should not reach the registration phase of 
clinical development before 2022 (Czaplewski et al., 2016). Endolysins mode of action 
differs from that of antibiotics and therefore the lytic enzymes are capable of killing 
antibiotic resistant bacteria. In addition, bacterial resistance to endolysins has not been 
reported to date. There are nevertheless some potential limitations regarding the 
therapeutic application of endolysins, notably host immune response and enzyme 
inactivation by antibodies. The typical narrow spectrum of activity of endolysins and the 
high costs associated with their production may also be additional obstacles.  
 
Something that seems to emerge from the most recent literature is that in order to consider 
endolysins as a real alternative to antibiotics, probably their study needs to go beyond the 
simple identification and purification of native endolysins. Protein engineering may be 
required for large scale production of effective lytic enzymes and a better understanding 
of the factors influencing their activity in different environments is also needed. This 
doctoral project was developed in line with these ideas. From the one hand, we have 
demonstrated that the construction of chimeric endolysins using domains of heterologous 
origin can result in enzymes with improved features. On the other hand, we have shown 
that dissipation of the bacterial pmf, which occurs in the last stages of phage infection by 
the holin action, may be a general requirement for endolysins to display full lytic activity. 
We think these findings should be taken into consideration in the enzybiotics field, as it 
may be necessary to select or engineer endolysins that can bypass this holin sensitization 
requirement for maximal killing efficacy. 
 
We showed in the first part of this study that the construction of chimerical endolysins, 
combined with gene expression at low temperatures, can be a good strategy for the 
efficient production of soluble endolysins in E. coli. By following this approach we 
obtained recombinant enzymes displaying broad lytic activity in vitro against clinically 
relevant strains of S. aureus, including MRSA (Chapter 2). Heterologous overproduction 
and subsequent purification of endolysins frequently results in low yields of soluble 
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proteins, with reduced lytic efficacy. Additionally, most native endolysins exhibit a 
narrow lytic spectrum. Benefiting from other studies performed by our group, we fused 
the CD of highly soluble E. faecalis phage endolysins, Lys168 and Lys170 (Proença et 
al., 2012), to the CWBD of the staphylococcal insoluble endolysin Lys87 (Cantante, 
2008), obtaining the chimerical endolysins Lys168-87 and Lys170-87. Remarkably, in 
addition to their capacity to lyse S. aureus, the chimeras remained active against 
enterococcal isolates and were extended in their lytic spectrum to coagulase-negative 
staphylococci and S. pyogenes. This extended host range suggests that the chimerical 
enzymes recognized common epitopes on the cell surface of these different bacterial 
species. The comparison of Lys168-87 and Lys170-87 lytic performances indicated that 
Lys168-87 was the most effective against the tested strains of S. aureus and of other 
Gram-positive species. Curiously, the chimeras seemed to follow the lytic profile 
displayed by the parental enterococcal endolysins when used against E. faecalis and E. 
faecium strains, with Lys170-87 generally producing larger and more transparent lysis 
halos than Lys168-87. Such result strengthens the idea that the affinity of both endolysin 
domains, CWBD and CD, to the PG substrate can be important for lytic activity (Low et 
al., 2011; Mayer et al., 2011). When Lys168-87 and Lys170-87 were used against cells 
resuspended in a buffer that maintained cell viability, but which was unable to support 
cell growth, they could lyse and kill S. aureus. However, when tested in rich culture media 
against actively growing bacteria, the chimeras failed to elicit efficient cell lysis (data not 
shown). This and similar observations with other lytic enzymes studied by our group led 
us to consider the membrane pmf, and by extension the holin function, as factors 
influencing endolysin activity. 
 
It is commonly accepted that c-endolysins are synthesized in their fully active 
conformation, being ready to act once contact with the PG is allowed. For that reason c-
endolysins exploration as enzybiotics is based on the simple idea that these enzymes 
should be able to effectively attack the CW of target bacteria when added from the 
outside. This view is now challenged by the results presented in chapter 3, as we show 
that healthy bacteria with fully energized CM may be able to counteract the lytic action 
of c-endolysins when these reach the CW from without. Cells lose this capacity under 
pmf-collapsing conditions, such as nutrient depletion, treatment with CM ionophores or 
after holin action. In fact, until now the basic concept of lysis from without had 
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completely disregarded that, in their natural context of action, c-endolysins always act 
after the holin-mediated killing of host bacteria.  
 
The holin-mediated sensitization of bacterial cells to c-endolysins lytic action suggests 
that, in presence of an intact pmf, the lytic enzymes can be subjected to some sort of 
repression in the CW compartment. In that sense, at least some c-endolysins seem to 
behave similarly to e-endolysins, whose activity is known to be restrained in the CW until 
the holin trigger (Xu et al., 2004, 2005; Nascimento et al., 2008; Sun et al., 2009; Catalão 
et al., 2010; Frias et al., 2013). In agreement with this, we proved for the first time that 
the continuous Sec-mediated secretion of a c-endolysin (LysSPP1) to the CW did not 
interfere with cell growth, as long as the pmf was maintained. Therefore, the boosting of 
lytic activity upon collapse of the membrane pmf is extensible to at least some c-
endolysins, irrespectively of the route followed to reach the CW (Fig. 5.1). This implies 
that, in addition to the two previously known roles of the holin function in canonical lysis, 
that is, host cell killing and endolysin transport to the CW, a third role must be added 
which is that of sensitizing bacteria to the lytic action of endolysins.  
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Fig. 5.1. The cellular energy is a key factor in endolysins lytic activity. Bacterial cells under 
conditions supporting the membrane proton motive force (pmf) can counteract the lytic activity 
of canonical endolysins. Pmf dissipation by the holin or by ionophores mimicking its action 
results in drastic increase of endolysin lytic activity. Therefore, in canonical lysis the holin action 
may be crucial not only for endolysin transport to the cell wall, but also to turn bacteria fully 
susceptible to endolysin attack. 
 
As already mentioned, during phage infection exported and canonical endolysins always 
act in cells previously killed by the holin, suggesting that these proteins may have been 
shaped during evolution to act preferentially against dead cells. This should contribute 
for the fact that the amount of endolysin needed to lyse phage-infected cells is much lower 
than the amounts frequently used for enzybiotic therapy purposes. In the case of Gram-
positive systems, this feature may provide a mechanism to avoid accidental lysis of 
potential new hosts if endolysins are released to the media after burst of phage-infected 
cells. In this line of thought, a study developed by Proença et al., (2015) showed that the 
fusion of a specific CD of a virion-associated lysin, which is naturally designed to act 
outwardly in viable cells, to the CWBD of endolysin Lys170 generated an enzyme with 
lytic activity in rich bacterial growth media, a feature that was not observed with the 
parental Lys170. 
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The implications of our findings in the use of endolysins to eliminate bacteria in vivo, for 
instance in animal colonization or infection models, can be several. When bacteria 
propagate in animal hosts the growth conditions are for sure very different from those 
encountered in a rich culture medium, in which cells usually replicate much faster as long 
as nutrients are available. Nonetheless, we should considerer that when growing in animal 
hosts bacteria might be able to offer at least a certain level of resistance to endolysin 
attack. This may be one of the reasons why much higher endolysin doses are generally 
required to eliminate bacteria in vivo. In addition, the vast majority of the studies report 
protective rather than therapeutic endolysin effects, that is, animal survival is only 
achieved when endolysins are administered at the same time or soon after the deadly 
bacterial inoculum. In this regard, bacteria in colonizing states seem to be more prone to 
endolysin killing. Fortunately, the current evidences also suggest that bacteria have limits 
in their capacity to restrain endolysin lytic action and that this capacity varies among the 
different bacterium/endolysin systems and growth conditions. Therefore, we propose that 
the strategies aiming at the development of endolysins with therapeutic potential should 
contemplate the selection and/or engineering of lytic enzymes with the capacity to 
eliminate target bacteria in growth-promoting conditions, being these as close as possible 
to the ones found in in vivo scenarios. 
 
As referred to above, in addition to their role in the transport of c-endolysins to the CW, 
the action of holins as membrane-depolarizing agents can be crucial to sensitize bacterial 
cells to endolysin attack. With the work presented in chapter 4 we gave the first steps to 
identify and characterize the holin of phage SPP1. As already observed for phages PBSX 
and MS6 (Catalão et al., 2011; Krogh et al., 1998), SPP1 holin function seems to require 
the simultaneous presence of two membrane-associated proteins, gp24.1 and gp26, since 
their individual expression did no interfere with cell viability. An unexpected finding was 
that orf 24.1 carries an internal constitutive A-dependent promoter, probably 
corresponding to promoter PE5 (Alonso et al., 1997; Montenegro and Trautner, 1981; 
Stüber et al., 1981). Due to the presence of this promoter, we hypothesize that during 
SPP1 infection the endolysin LysSPP1 and the holin-like gp26 start to accumulate early 
and harmlessly in the host cell cytoplasm and CM, respectively. Later in infection, the 
other holin-like protein gp24.1 starts to be produced and inserts into the CM, probably 
interacting with gp26. Suddenly, when both holin-like proteins reach a critical 
concentration in the CM, they trigger to collapse the pmf and LysSPP1 is translocated to 
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the CW across the gp24.1/gp26 holes. Herein, in a dead cell, LysSPP1 is able to display 
full activity and quickly degrade the PG, allowing the efficient release of the newly 
formed SPP1 virions. 
 
After our study a question that remains open is how pmf is involved in the regulation of 
endolysin activity. This is clearly a topic that deserves to be investigated as it could 
provide answers not only regarding endolysin regulation, but also about related 
phenomena such as autolysis and bacterial lysis induced by killing agents like 
conventional antibiotics, bacteriocins and antimicrobial peptides. A simple explanation 
could be that the sudden and major ion and/or pH variations in the CW environment 
caused by pmf collapse are directly sensed by endolysins. Another hypothesis is that the 
membrane energy state is sensed by TAs (and their substituents) in the CW, which could 
act as negative regulators of endolysins under pmf-supporting conditions. This point of 
view is favored by the knowledge that these polyanion polymers suffer conformational 
changes depending on their ionization state and have been pointed out as regulators of 
autolysins (Biswas et al., 2012). Studying the effect of mutations that change the 
composition and/or structure of TAs on bacterial sensitivity to endolysins could be a good 
starting approach.  
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